Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
  • Curriculum.
  • Publications.
  • Projects.
  • Patent applications/Patents.
  • Presentations.
  • Advised theses.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Stauber Rudolf |

** = Publications listed in SCI/SSCI/Pubmed

2025

Full paper/article (Journal)

** , , Polaris, Observatory, Collaborators., Electronic, address:, hrazavi@cdafound.org;Polaris, Observatory, Collaborators Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies.
J Hepatol. 2025; Doi: 10.1016/j.jhep.2025.01.013
PubMed FullText FullText_MUG

 

** Scheiner, B; Kang, B; Balcar, L; Radu, IP; Reiter, FP; Adžić, G; Guo, J; Gao, X; Yuan, X; Cheng, L; Gorgulho, J; Schultheiss, M; Peeters, F; Hucke, F; Ben, Khaled, N; Piseddu, I; Philipp, A; Sinner, F; D'Alessio, A; Pomej, K; Saborowski, A; Bathon, M; Schwacha-Eipper, B; Zarka, V; Lampichler, K; Nishida, N; Lee, PC; Krall, A; Saeed, A; Himmelsbach, V; Tesini, G; Huang, YH; Vivaldi, C; Masi, G; Vogel, A; Schulze, K; Trauner, M; Djanani, A; Stauber, R; Kudo, M; Parikh, ND; Dufour, JF; Prejac, J; Geier, A; Bengsch, B; von, Felden, J; Venerito, M; Weinmann, A; Peck-Radosavljevic, M; Finkelmeier, F; Dekervel, J; Ji, F; Wang, HW; Rimassa, L; Pinato, DJ; Bouattour, M; Chon, HJ; Pinter, M Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy.
Hepatology. 2025; 81(6):1714-1727 Doi: 10.1097/HEP.0000000000001163
Web of Science PubMed FullText FullText_MUG

 

** Skok, K; Stift, J; Schirmacher, P; Kashofer, K; Stauber, R; Ranković, B; Lackner, K Molecular Landscape and Treatment Paradigms of Hepatocellular and Cholangiocarcinoma: A Multinational Review.
Z Gastroenterol. 2025; Doi: 10.1055/a-2548-0108
Web of Science PubMed FullText FullText_MUG

 

2024

Full paper/article (Journal)

** Balcar, L; Scheiner, B; Fulgenzi, CAM; D'Alessio, A; Pomej, K; Roig, MB; Meyer, EL; Che, J; Nishida, N; Lee, PC; Wu, L; Ang, C; Krall, A; Saeed, A; Stefanini, B; Cammarota, A; Pressiani, T; Abugabal, YI; Chamseddine, S; Wietharn, B; Parisi, A; Huang, YH; Phen, S; Vivaldi, C; Salani, F; Masi, G; Bettinger, D; Vogel, A; von, Felden, J; Schulze, K; Silletta, M; Trauner, M; Samson, A; Wege, H; Piscaglia, F; Galle, PR; Stauber, R; Kudo, M; Singal, AG; Itani, A; Ulahannan, SV; Parikh, ND; Cortellini, A; Kaseb, A; Rimassa, L; Chon, HJ; Pinato, DJ; Pinter, M A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma.
JHEP Rep. 2024; 6(2): 100982 Doi: 10.1016/j.jhepr.2023.100982 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dietz, J; Graf, C; Berg, CP; Port, K; Deterding, K; Buggisch, P; Peiffer, KH; Vermehren, J; Dultz, G; Geier, A; Reiter, FP; Bruns, T; Schattenberg, JM; Durmashkina, E; Gustot, T; Moreno, C; Trauth, J; Discher, T; Fischer, J; Berg, T; Kremer, AE; Müllhaupt, B; Zeuzem, S; Sarrazin, C, , European, HCV, Resistance, Study, Group Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.
JHEP Rep. 2024; 6(7):101072 Doi: 10.1016/j.jhepr.2024.101072 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Fitzinger, J; Rodriguez-Blanco, G; Herrmann, M; Borenich, A; Stauber, R; Aigner, E; Mangge, H Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease.
Nutrients. 2024; 16(2): Doi: 10.3390/nu16020250 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Sanyal, AJ; Bedossa, P; Fraessdorf, M; Neff, GW; Lawitz, E; Bugianesi, E; Anstee, QM; Hussain, SA; Newsome, PN; Ratziu, V; Hosseini-Tabatabaei, A; Schattenberg, JM; Noureddin, M; Alkhouri, N; Younes, R, , 1404-0043, Trial, Investigators A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
N Engl J Med. 2024; 391(4):311-319 Doi: 10.1056/NEJMoa2401755
PubMed FullText FullText_MUG

 

** Stauber, RE; Paar, M; Balazs, I; Horvath, A; Feldbacher, N; Posch, A; Rainer, F; Stadlbauer, V; Oettl, K Effect of albumin infusion on oxidative albumin modification and albumin binding capacity in chronic liver failure.
Basic Clin Pharmacol Toxicol. 2024; 134(3):375-384 Doi: 10.1111/bcpt.13973
Web of Science PubMed FullText FullText_MUG

 

** Stauber, RE; Rautou, PE; Stefanescu, H; Horhat, A; Thiele, M; Lackner, C, , SALVE, Histopathology, Group Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology.
JHEP Rep. 2024; 6(5): 101055 Doi: 10.1016/j.jhepr.2024.101055 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Scheiner, B; Kang, B; Balcar, L; Radu, P; Reiter, FP; Adzic, G; Guo, J; Gao, X; Yuan, X; Cheng, L; Gorgulho, J; Schultheiss, M; Ben Khaled, N; Sinner, F; D'Alessio, A; Pomej, K; Saborowski, A; Schwacha-Eipper, B; Zarka, V; Lampichler, K; Nishida, N; Lee, PC; Krall, A; Saeed, A; Himmelsbach, V; Tesini, G; Wietharn, B; Huang, YH; Vivaldi, C; Masi, G; Vogel, A; Schulze, K; Trauner, M; Stauber, RE; Kudo, M; Dekervel, J; Parikh, N; Dufour, JF; Prejac, J; Geier, A; Bengsch, B; von Felden, J; Venerito, M; Philipp, A; Finkelmeier, F; Ji, FP; Wang, HW; Rimassa, L; Pinato, DJ; Bouattour, M; Chon, HJ; Pinter, M Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy
J HEPATOL. 2024; 80: S69-S69.-EASL Congress; JUN 5-8, 2024; Milan, ITALY. [Oral Communication]
Web of Science

 

** Stauber, RE; Rainer, F; Stadlbauer, V; Avian, A; Scharnagl, H; Marsche, G A HDL-based prognostic model performs better than MELD in chronic liver failure
J HEPATOL. 2024; 80: S383-S383.-EASL Congress; JUN 5-8, 2024; Milan, ITALY. [Poster]
Web of Science

 

2023

Full paper/article (Journal)

** Buch, S; Innes, H; Lutz, PL; Nischalke, HD; Marquardt, JU; Fischer, J; Weiss, KH; Rosendahl, J; Marot, A; Krawczyk, M; Casper, M; Lammert, F; Eyer, F; Vogel, A; Marhenke, S; von, Felden, J; Sharma, R; Atkinson, SR; McQuillin, A; Nattermann, J; Schafmayer, C; Franke, A; Strassburg, C; Rietschel, M; Altmann, H; Sulk, S; Thangapandi, VR; Brosch, M; Lackner, C; Stauber, RE; Canbay, A; Link, A; Reiberger, T; Mandorfer, M; Semmler, G; Scheiner, B; Datz, C; Romeo, S; Ginanni, Corradini, S; Irving, WL; Morling, JR; Guha, IN; Barnes, E; Ansari, MA; Quistrebert, J; Valenti, L; Müller, SA; Morgan, MY; Dufour, JF; Trebicka, J; Berg, T; Deltenre, P; Mueller, S; Hampe, J; Stickel, F Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Gut. 2023; 72(2): 381-391. Doi: 10.1136/gutjnl-2022-327196 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hirschfield, GM; Shiffman, ML; Gulamhusein, A; Kowdley, KV; Vierling, JM; Levy, C; Kremer, AE; Zigmond, E; Andreone, P; Gordon, SC; Bowlus, CL; Lawitz, EJ; Aspinall, RJ; Pratt, DS; Raikhelson, K; Gonzalez-Huezo, MS; Heneghan, MA; Jeong, SH; Ladrón, de, Guevara, AL; Mayo, MJ; Dalekos, GN; Drenth, JPH; Janczewska, E; Leggett, BA; Nevens, F; Vargas, V; Zuckerman, E; Corpechot, C; Fassio, E; Hinrichsen, H; Invernizzi, P; Trivedi, PJ; Forman, L; Jones, DEJ; Ryder, SD; Swain, MG; Steinberg, A; Boudes, PF; Choi, YJ; McWherter, CA, , ENHANCE, Study, Group* Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology. 2023; 78(2): 397-415. Doi: 10.1097/HEP.0000000000000395 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Joerg, V; Scheiner, B; D, Alessio, A; Fulgenzi, CAM; Schönlein, M; Kocheise, L; Lohse, AW; Huber, S; Wege, H; Kaseb, A; Wang, Y; Mathew, A; Kuang, A; Muzaffar, M; Abugabal, YI; Chamseddine, S; Phen, S; Cheon, J; Lee, PC; Balcar, L; Krall, A; Ang, C; Wu, L; Saeed, A; Huang, YH; Bengsch, B; Rimassa, L; Weinmann, A; Stauber, R; Korolewicz, J; Pinter, M; Singal, AG; Chon, HJ; Pinato, DJ; Schulze, K; von, Felden, J Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.
Hepatol Commun. 2023; 7(11): Doi: 10.1097/HC9.0000000000000302 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Joerg, V; Scheiner, B; D'Alessio, A; Fulgenzi, CAM; Schönlein, M; Kocheise, L; Lohse, AW; Huber, S; Wege, H; Kaseb, A; Wang, YH; Mathew, A; Kuang, A; Muzaffar, M; Abugabal, YI; Chamseddine, S; Phen, S; Cheon, J; Lee, PC; Balcar, L; Krall, A; Ang, C; Wu, LD; Saeed, A; Huang, YH; Bengsch, B; Rimassa, L; Weinmann, A; Stauber, R; Korolewicz, J; Pinter, M; Singal, AG; Chon, HJ; Pinato, DJ; Schulze, K; von Felden, J Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study
HEPATOL COMMUN. 2023; 7(11): e0302 Doi: 10.1097/HC9.0000000000000302
Web of Science FullText FullText_MUG

 

** Mandorfer, M; Aigner, E; Cejna, M; Ferlitsch, A; Datz, C; Gräter, T; Graziadei, I; Gschwantler, M; Hametner-Schreil, S; Hofer, H; Jachs, M; Loizides, A; Maieron, A; Peck-Radosavljevic, M; Rainer, F; Scheiner, B; Semmler, G; Reider, L; Reiter, S; Schoder, M; Schöfl, R; Schwabl, P; Stadlbauer, V; Stauber, R; Tatscher, E; Trauner, M; Ziachehabi, A; Zoller, H; Fickert, P; Reiberger, T Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).
Wien Klin Wochenschr. 2023; 135(Suppl 3):493-523 Doi: 10.1007/s00508-023-02229-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mózes, FE; Lee, JA; Vali, Y; Alzoubi, O; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Holleboom, AG; van, Dijk, AM; Mak, AL; Boursier, J; de, Saint, Loup, M; Shima, T; Bugianesi, E; Gaia, S; Armandi, A; Shalimar; Lupșor-Platon, M; Wong, VW; Li, G; Wong, GL; Cobbold, J; Karlas, T; Wiegand, J; Sebastiani, G; Tsochatzis, E; Liguori, A; Yoneda, M; Nakajima, A; Hagström, H; Akbari, C; Hirooka, M; Chan, WK; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, M; Petta, S; Pennisi, G; Viganò, M; Ridolfo, S; Aithal, GP; Palaniyappan, N; Lee, DH; Ekstedt, M; Nasr, P; Cassinotto, C; de, Lédinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Fournier-Poizat, C; Geier, A; Martic, M; Tuthill, T; Anstee, QM; Harrison, SA; Bossuyt, PM; Pavlides, M, , LITMUS, investigators Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
Lancet Gastroenterol Hepatol. 2023; 8(8):704-713 Doi: 10.1016/S2468-1253(23)00141-3
Web of Science PubMed FullText FullText_MUG

 

** Paar, M; Fengler, VH; Reibnegger, G; Schnurr, K; Waterstradt, K; Schwaminger, SP; Stauber, RE; Oettl, K Determination of binding characteristics as a measure for effective albumin using different methods.
Biochim Biophys Acta Gen Subj. 2023; 1867(9): 130427 Doi: 10.1016/j.bbagen.2023.130427
Web of Science PubMed FullText FullText_MUG

 

** Pennisi, G; Enea, M; Falco, V; Aithal, GP; Palaniyappan, N; Yilmaz, Y; Boursier, J; Cassinotto, C; de, Lédinghen, V; Chan, WK; Mahadeva, S; Eddowes, P; Newsome, P; Karlas, T; Wiegand, J; Wong, VW; Schattenberg, JM; Labenz, C; Kim, W; Lee, MS; Lupsor-Platon, M; Cobbold, JFL; Fan, JG; Shen, F; Staufer, K; Trauner, M; Stauber, R; Nakajima, A; Yoneda, M; Bugianesi, E; Younes, R; Gaia, S; Zheng, MH; Cammà, C; Anstee, QM; Mózes, FE; Pavlides, M; Petta, S Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.
Hepatology. 2023; 78(1):195-211 Doi: 10.1097/HEP.0000000000000351
Web of Science PubMed FullText FullText_MUG

 

** Polaris Observatory Collaborators Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.
Lancet Gastroenterol Hepatol. 2023; 8(10): 879-907. Doi: 10.1016/S2468-1253(23)00197-8
Web of Science PubMed FullText FullText_MUG

 

** Qin, S; Chen, M; Cheng, AL; Kaseb, AO; Kudo, M; Lee, HC; Yopp, AC; Zhou, J; Wang, L; Wen, X; Heo, J; Tak, WY; Nakamura, S; Numata, K; Uguen, T; Hsiehchen, D; Cha, E; Hack, SP; Lian, Q; Ma, N; Spahn, JH; Wang, Y; Wu, C; Chow, PKH, , IMbrave050, investigators Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Lancet. 2023; Doi: 10.1016/S0140-6736(23)01796-8
Web of Science PubMed FullText FullText_MUG

 

** Simão, AL; Palma, CS; Izquierdo-Sanchez, L; Putignano, A; Carvalho-Gomes, A; Posch, A; Zanaga, P; Girleanu, I; Henrique, MM; Araújo, C; Degre, D; Gustot, T; Sahuco, I; Spagnolo, E; Carvalhana, S; Moura, M; Fernandes, DA; Banales, JM; Romero-Gomez, M; Trifan, A; Russo, FP; Stauber, R; Berenguer, M; Moreno, C; Gonçalves, J; Cortez-Pinto, H; Castro, RE Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.
JHEP Rep. 2023; 5(5):100697 Doi: 10.1016/j.jhepr.2023.100697 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Staufer, K; Huber, H; Zessner-Spitzenberg, J; Stauber, R; Finkenstedt, A; Bantel, H; Weiss, TS; Huber, M; Starlinger, P; Gruenberger, T; Reiberger, T; Sebens, S; McIntyre, G; Tabibiazar, R; Giaccia, A; Zoller, H; Trauner, M; Mikulits, W Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosis.
Cell Death Discov. 2023; 9(1):282 Doi: 10.1038/s41420-023-01551-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Staufer, K; Stauber, RE Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
Biomedicines. 2023; 11(8): Doi: 10.3390/biomedicines11082108 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Balcar, L; Scheiner, B; Fulgenzi, CAM; D'Alessio, A; Pomej, K; Cheon, J; Nishida, N; Lee, PC; Wu, L; Ang, CSP; Krall, A; Saeed, A; Stefanini, B; Cammarota, A; Pressiani, T; Mohamed, YI; Chamseddine, S; Wietharn, B; Parisi, A; Huang, YH; Phen, S; Vivaldi, C; Salani, F; Masi, G; Bettinger, D; Vogel, A; Von Felden, J; Schulze, K; Silletta, M; Trauner, M; Samson, A; Wege, H; Piscaglia, F; Galle, PR; Stauber, RE; Kudo, M; Singal, AG; Ulahannan, S; Parikh, ND; Cortellini, A; Kaseb, A; Rimassa, L; Chon, HJ; Pinato, DJ; Pinter, M SEX-RELATED DIFFERENCES IN EFFICACY AND SAFETY OF IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND META-ANALYSIS OF LANDMARK PHASE III TRIALS AND VALIDATION IN ROUTINE CLINICAL PRACTICE
HEPATOLOGY. 2023; 78: S1888-S1889.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

** Diaz, LA; Norero, B; Corsi, O; Ayares, G; Idalsoaga, F; García, S; Vázquez, V; Lacalle, L; Lazo, M; Ferreccio, C; Mendizabal, M; Piñero, F; Martinez, E; Ijeoma, I; Louvet, A; Piano, S; Cortez-Pinto, H; Wong, VWS; Kulkarni, A; Cotter, T; Brahmania, M; Roblero, JP; Dirchwolf, M; Pollarsky, F; George, J; Stauber, RE; Francque, S; Guerra, P; Oliveira, C; Araujo, R; Alvares-Da-Silva, M; Blaise, N; Abraldes, JG; Zheng, MH; Toro, L; Restrepo, JC; Ramirez, W; Grgurevic, I; Infante, M; Mbendi, C; Carrera, E; El Kassas, M; Mahmoud, A; Tesfaye, YG; Tadesse, SA; Akalu, TF; Desalegn, H; Allaire, M; Patrizia, C; Schattenberg, J; Aguyire, J; Micah, EA; Tachi, K; Cardona, KEM; Sanchez, A; Sánchez, M; Björnsson, ES; Iavarone, M; Okamoto, R; Some, F; Hellani, MF; Gonzalez, VEP; Chávez-Tapia, NC; Méndez-Sánchez, N; Mucumbi, SCM; Ugiagbe, RA; Akande, K; Nwoko, C; Ezenkwa, US; Okoye, IJ; Hamid, SS; Quezada, JL; Girala, M; Padilla, PM; Diaz-Ferrer, J; Tagle, M; Kukla, M; Odeghe, E; Wemimo, RM; Reis, D; Mozgovoi, S; Ismail, M; Koller, T; Spearman, W; Elhassan, M; Stal, P; Pazi, S; Ocanit, A; Masson, S; Dunn, W; Kamath, PS; Singal, A; Debes, J; Reig, M; Loomba, R; Bataller, R; Lazarus, J; Arrese, M; Arab, JP Sub-optimal global public health policies and strategies to combat hepatocellular carcinoma
J HEPATOL. 2023; 78: S865-S867. [Poster]
Web of Science

 

** Jörg, V; Scheiner, B; D'Alessio, A; Fulgenzi, C; Schoenlein, M; Kocheise, L; Lohse, AW; Huber, S; Wege, H; Kaseb, A; Wang, YH; Muzaffar, M; Abugabal, Y; Chamseddine, S; Phen, S; Cheon, J; Lee, PC; Balcar, L; Krall, A; Ang, C; Wu, L; Saeed, A; Huang, YH; Bengsch, B; Rimassa, L; Weinmann, A; Stauber, RE; Korolewicz, J; Pinter, M; Singal, A; Chon, HJ; Pinato, DJ; Schulze, K; von Felden, J Efficacy and tolerability of atezolizumab and bevacizumab in patients with hepatocellular carcinoma previously treated with systemic therapy: a global, observational study
J HEPATOL. 2023; 78: S582-S582. [Poster]
Web of Science

 

** Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, G; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Shalimar, D; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M COMPOSITE SCORES THAT INCLUDE LIVER STIFFNESS MEASUREMENT CAN PREDICT OUTCOMES IN PATIENTS WITH NAFLD
HEPATOLOGY. 2023; 78: S932-S935.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

** Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Dr Shalimar; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M LIVER STIFFNESS MEASUREMENT BASED COMPOSITE SCORES HAVE COMPARABLE PROGNOSTIC PERFORMANCE TO HISTOLOGICALLY ASSESSED FIBROSIS STAGE
HEPATOLOGY. 2023; 78: S995-S998.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

** Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Dr Shalimar; Hagström, SH; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M NASH SEVERITY ASSESSED BY THE NAFLD ACTIVITY SCORE (NAS) DOES NOT ADD PROGNOSTIC INFORMATION TO FIBROSIS STAGE IN PATIENTS WITH NAFLD
HEPATOLOGY. 2023; 78: S1018-S1020.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

** Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Shalimar; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M HISTOLOGICALLY ASSESSED FIBROSIS IS THE MAIN DETERMINANT OF PROGNOSIS IN PATIENTS IN NAFLD
HEPATOLOGY. 2023; 78: S971-S974.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

** Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Shalimar; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M CLASSIFICATION ACCORDING TO SEQUENTIALLY COMBINED NON-INVASIVE TESTS CARRIES PROGNOSTIC VALUE IN PATIENTS WITH NAFLD
HEPATOLOGY. 2023; 78: S928-S931.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

** Paar, M; Fengler, VH; Reibnegger, G; Schnurr, K; Waterstradt, K; Schwaminger, SP; Stauber, RE; Oettl, K EFFECTIVE ALBUMIN CONCENTRATION IN CHRONIC LIVER FAILURE IS DETERMINED MAINLY BY REVERSIBLE FACTORS: POSSIBLE THERAPEUTIC CONSEQUENCES
HEPATOLOGY. 2023; 78: S1965-S1966.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

** Pennisi, G; Enea, M; Falco, V; Aithal, GP; Palaniyappan, N; Yilmaz, Y; Boursier, J; Cassinotto, C; De Lédinghen, V; Chan, WK; Mahadeva, S; Eddowes, P; Newsome, P; Karlas, T; Wiegand, J; Wong, VWS; Schattenberg, JM; Labenz, C; Kim, W; Lee, MS; Lupsor-Platon, M; Cobbold, JFL; Fan, J; Shen, F; Staufer, K; Trauner, M; Stauber, R; Nakajima, A; Yoneda, M; Bugianesi, E; Younes, R; Gaia, S; Zheng, M; Cammà, C; Anstee, QM; Mózes, FE; Pavlides, M; Petta, S Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
DIGEST LIVER DIS. 2023; 55: S12-S13. Doi: 10.1016/j.dld.2023.01.022 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Scheiner, B; Sartoris, R; D'Alessio, A; Fulgenzi, C; Pomej, K; Balcar, L; Bouattour, M; Sidali, S; Himmelsbach, V; Finkelmeier, F; Schulze, K; von Felden, J; Hucke, F; Shmanko, K; Siebenhüner, A; Mertens, JC; De Dosso, S; Ebert, M; Teufel, A; Waldschmidt, DT; Radu, IP; Krall, A; Trauner, M; Dufour, JF; Wege, H; Weinmann, A; Trojan, J; Stauber, RE; Peck-Radosavljevic, M; Hsu, WF; Vogel, A; Ronot, M; Pinato, DJ; Pinter, M Validation of the CRAFITY score in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab
J HEPATOL. 2023; 78: S491-S492. [Poster]
Web of Science

 

2022

Full paper/article (Journal)

** Blach, S; Terrault, NA; Tacke, F; Gamkrelidze, I; Craxi, A; Tanaka, J; Waked, I; Dore, GJ; Abbas, Z; Abdallah, AR; Abdulla, M; Aghemo, A; Aho, I; Akarca, US; Alalwan, AM; Blome, MA; Al-Busafi, SA; Aleman, S; Alghamdi, AS; Al-Hamoudi, WK; Aljumah, AA; Al-Naamani, K; Al Serkal, YM; Altraif, IH; Anand, #### Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
LANCET GASTROENTEROL. 2022; 7(5): 396-415. Doi: 10.1016/S2468-1253(21)00472-6
Web of Science PubMed FullText FullText_MUG

 

** Douschan, P; Kovacs, G; Sassmann, T; Stadlbauer, V; Avian, A; Foris, V; Tatscher, E; Durchschein, F; Rainer, F; Spindelboeck, W; Wagner, M; Kniepeiss, D; Zollner, G; Bachmaier, G; Fickert, P; Olschewski, H; Stauber, RE Pulmonary vascular disease and exercise hemodynamics in chronic liver disease.
Respir Med. 2022; 202:106987 Doi: 10.1016/j.rmed.2022.106987
Web of Science PubMed FullText FullText_MUG

 

** Fandler-Höfler, S; Kneihsl, M; Stauber, RE; Bisping, E; Mangge, H; Wünsch, G; Haidegger, M; Fabisch, L; Hatab, I; Fickert, P; Werring, D; Enzinger, C; Gattringer, T Liver Fibrosis-4 index indicates atrial fibrillation in acute ischemic stroke.
Eur J Neurol. 2022; 29(8):2283-2288 Doi: 10.1111/ene.15377 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Haudum, CW; Kolesnik, E; Colantonio, C; Mursic, I; Url-Michitsch, M; Tomaschitz, A; Glantschnig, T; Hutz, B; Lind, A; Schweighofer, N; Reiter, C; Ablasser, K; Wallner, M; Tripolt, NJ; Pieske-Kraigher, E; Madl, T; Springer, A; Seidel, G; Wedrich, A; Zirlik, A; Krahn, T; Stauber, R; Pieske, B; Pieber, TR; Verheyen, N; Obermayer-Pietsch, B; Schmidt, A Cohort profile: 'Biomarkers of Personalised Medicine' (BioPersMed): a single-centre prospective observational cohort study in Graz/Austria to evaluate novel biomarkers in cardiovascular and metabolic diseases.
BMJ Open. 2022; 12(4):e058890 Doi: 10.1136/bmjopen-2021-058890 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mózes, FE; Lee, JA; Selvaraj, EA; Jayaswal, ANA; Trauner, M; Boursier, J; Fournier, C; Staufer, K; Stauber, RE; Bugianesi, E; Younes, R; Gaia, S; Lupșor-Platon, M; Petta, S; Shima, T; Okanoue, T; Mahadeva, S; Chan, WK; Eddowes, PJ; Hirschfield, GM; Newsome, PN; Wong, VW; de, Ledinghen, V; Fan, J; Shen, F; Cobbold, JF; Sumida, Y; Okajima, A; Schattenberg, JM; Labenz, C; Kim, W; Lee, MS; Wiegand, J; Karlas, T; Yılmaz, Y; Aithal, GP; Palaniyappan, N; Cassinotto, C; Aggarwal, S; Garg, H; Ooi, GJ; Nakajima, A; Yoneda, M; Ziol, M; Barget, N; Geier, A; Tuthill, T; Brosnan, MJ; Anstee, QM; Neubauer, S; Harrison, SA; Bossuyt, PM; Pavlides, M, , LITMUS, Investigators Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.
Gut. 2022; 71(5):1006-1019 Doi: 10.1136/gutjnl-2021-324243 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Panzer, M; Viveiros, A; Schaefer, B; Baumgartner, N; Seppi, K; Djamshidian, A; Todorov, T; Griffiths, WJH; Schott, E; Schuelke, M; Eurich, D; Stattermayer, AF; Bomford, A; Foskett, P; Vodopiutz, J; Stauber, R; Pertler, E; Morell, B; Tilg, H; Muller, T; Kiechl, S; Jimenez-Heredia, R; Weiss, KH; Hahn, SH; Janecke, A; Ferenci, P; Zoller, H Synonymous mutation in adenosine triphosphatase copper-transporting beta causes enhanced exon skipping in Wilson disease
HEPATOL COMMUN. 2022; Doi: 10.1002/hep4.1922 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ventura-Cots, M; Argemi, J; Jones, PD; Lackner, C; El Hag, M; Abraldes, JG; Alvarado, E; Clemente, A; Ravi, S; Alves, A; Alboraie, M; Altamirano, J; Barace, S; Bosques, F; Brown, R; Caballeria, J; Cabezas, J; Carvalhana, S; Cortez-Pinto, H; Costa, A; Degre, D; Fernandez-Carillo, C; Ganne-Carrie, N; Garcia-Tsao, G; Genesca, J; Koskinas, J; Lanthier, N; Louvet, A; Lozano, JJ; Lucey, MR; Masson, S; Mathurin, P; Mendez-Sanchez, N; Miquel, R; Moreno, C; Mounajjed, T; Odena, G; Kim, W; Sancho-Bru, P; Sands, RW; Szafranska, J; Verset, L; Schnabl, B; Sempoux, C; Shah, VJ; Shawcross, DL; Stauber, RE; Straub, BK; Verna, E; Tiniakos, D; Trepo, E; Vargas, V; Villanueva, C; Woosley, JT; Ziol, M; Mueller, S; Starkel, P; Bataller, R Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
GUT. 2022; Doi: 10.1136/gutjnl-2021-324295 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Ferenci, P; Mohr, I; Staettermayer, A; Stauber, RE; Panzer, M; Steindl-Munda, PE; Merle, U; Trauner, MH; Weiss, KH TETRAETHYLENTETRAMIN AS FIRST LINE TREATMENT OF WILSON DISEASE - LONG-TERM RESULTS
HEPATOLOGY. 2022; 76: S1121-S1122.-AASLD Annual Meeting; NOV 4-8, 2022; Washington, DC. [Poster]
Web of Science

 

** Madl, T; Kerbl-Knapp, J; Rainer, F; Douschan, P; Stadlbauer, V; Avian, A; Marsche, G; Claria, J; Stauber, RE A novel metabolomics-based prognostic model shows superior diagnostic accuracy than MELD in chronic liver failure
J HEPATOL. 2022; 77: S346-S346.-EASL Annual Meeting; JUN 22-26, 2022; London, UK. [Poster]
Web of Science

 

** Munda, P; Tulaeva, I; Stauber, RE; Gattringer, P; Trauner, M; Brunar, H; Valenta, R; Ferenci, P Induction of pre-s antobodies in HBeAg negative chronic hepatitis B patients by thereupatic vaccination with the pre-s based vaccine VVX001-interim analysis
J HEPATOL. 2022; 77: S854-S854.-EASL Annual Meeting; JUN 22-26, 2022; London, UK. [Poster]
Web of Science

 

** Simao, AL; Palma, CS; Izquierdo-Sanchez, L; Putignano, A; Carvalho-Gomes, A; Posch, A; Zanaga, P; Girleanu, I; Araujo, C; Delphine, D; Gustot, T; Sahuco, I; Spagnolo, E; Carvalhana, S; Moura, M; Henrique, MM; Fernandes, DAE; Marques, F; Banales, JM; Gomez, MR; Trifan, A; Russo, FP; Stauber, RE; Berenguer, M; Moreno, C; Goncalves, J; Cortez-Pinto, H; Castro, R Presence of cirrhosis in chronic liver disease patients associates with a lower immune response to COVID-19 vaccines-a multicenter european study
J HEPATOL. 2022; 77: S192-S192.-EASL Annual Meeting; JUN 22-26, 2022; [Poster]
Web of Science

 

** Staufer, K; Huber, H; Zessner-Spitzenberg, J; Stauber, RE; Finkenstedt, A; Bantel, H; Weiss, T; Huber, M; Starlinger, P; Grunberger, T; Reiberger, T; Sebens, S; McIntyre, G; Tabibiazar, R; Giaccia, A; Zoller, H; Trauner, M; Mikulits, W Large-scale multicenter study for the clinical utility of the non-invasive biomarkers Gas6 and soluble Axl in hepatocellular carcinoma, liver fibrosis and end-stage liver disease
J HEPATOL. 2022; 77: S470-S470.-EASL Annual Meeting; JUN 22-26, 2022; London, UK. [Poster]
Web of Science

 

Abstract (Proceedings)

** Paar, M; Fengler, VH; Reibnegger, G; Schnurr, K; Waterstradt, K; Stauber, RE; Boss, K; Kribben, A; Oettl, K Effective albumin: binding characteristics determined by different methods
ESAO Abstract Book 48th Annual Congress. 2022; 45(9):-48th Annual ESAO Congress; SEP 6-10, 2022; Krems, AUSTRIA. Doi: 10.1177/03913988221117047 [Oral Communication]
Web of Science FullText FullText_MUG

 

2021

Full paper/article (Journal)

** Dietz, J; Di Maio, VC; de Salazar, A; Merino, D; Vermehren, J; Paolucci, S; Kremer, AE; Lara, M; Pardo, MR; Zoller, H; Degasperi, E; Peiffer, KH; Sighinolfi, L; Téllez, F; Graf, C; Ghisetti, V; Schreiber, J; Fernández-Fuertes, E; Boglione, L; Muñoz-Medina, L; Stauber, R; Gennari, W; Figueruela, B; Santos, J; Lampertico, P; Zeuzem, S; Ceccherini-Silberstein, F; García, F; Sarrazin, C; HCV Virology Italian Resistance Network (VIRONET-C) collaborators; Spanish GEHEP-004 Collaborators; Members of the German HCV resistance study group Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy.
J Hepatol. 2021; 74(4):801-810 Doi: 10.1016/j.jhep.2020.11.017
Web of Science PubMed FullText FullText_MUG

 

** Fandler-Höfler, S; Stauber, RE; Kneihsl, M; Wünsch, G; Haidegger, M; Poltrum, B; Pichler, A; Deutschmann, H; Enzinger, C; Fickert, P; Gattringer, T Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke.
Ther Adv Neurol Disord. 2021; 14: 17562864211037239 Doi: 10.1177/17562864211037239 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Jachs, M; Binter, T; Schmidbauer, C; Hartl, L; Strasser, M; Laferl, H; Hametner-Schreil, S; Lindorfer, A; Dax, K; Stauber, RE; Kessler, HH; Bernhofer, S; Maieron, A; Loacker, L; Bota, S; Santonja, I; Munda, P; Mandorfer, M; Peck-Radosavljevic, M; Holzmann, H; Gschwantler, M; Zoller, H; Ferenci, P; Reiberger, T Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis.
United European Gastroenterol J. 2021; 9(10):1119-1127 Doi: 10.1002/ueg2.12163 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Lackner, C; Stauber, RE; Davies, S; Denk, H; Dienes, HP; Gnemmi, V; Guido, M; Miquel, R; Paradis, V; Schirmacher, P; Terracciano, L; Berghold, A; Pregartner, G; Binder, L; Douschan, P; Rainer, F; Sygulla, S; Jager, M; Rautou, PE; Bumbu, A; Horhat, A; Rusu, I; Stefanescu, H; Detlefsen, S; Krag, A; Thiele, M; Cortez-Pinto, H; Moreno, C; Gouw, ASH; Tiniakos, DG Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease.
J Hepatol. 2021; 75(4):810-819 Doi: 10.1016/j.jhep.2021.05.029
Web of Science PubMed FullText FullText_MUG

 

** Leber, B; Balázs, I; Horvath, A; Posch, A; Streit, A; Spindelböck, W; Feldbacher, N; Stiegler, P; Stauber, RE; Rechberger, GN; Kollroser, M; Sattler, W; Nusshold, C; Stadlbauer, V Direct acting antiviral therapy rescues neutrophil dysfunction and reduces hemolysis in hepatitis C infection.
Transl Res. 2021; 232:103-114 Doi: 10.1016/j.trsl.2020.12.005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Paar, M; Fengler, VH; Rosenberg, DJ; Krebs, A; Stauber, RE; Oettl, K; Hammel, M Albumin in patients with liver disease shows an altered conformation.
Commun Biol. 2021; 4(1): 731-731. Doi: 10.1038/s42003-021-02269-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stadlbauer, V; Negrean, I; Posch, A; Streit, A; Feldbacher, N; Stauber, RE; Horvath, A Fibroscan (R) probe selection for lean adults
JGH OPEN. 2021; Doi: 10.1002/jgh3.12579 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Trebicka, J; Fernandez, J; Papp, M; Caraceni, P; Laleman, W; Gambino, C; Giovo, I; Uschner, FE; Jansen, C; Jimenez, C; Mookerjee, R; Gustot, T; Albillos, A; Bañares, R; Jarcuska, P; Steib, C; Reiberger, T; Acevedo, J; Gatti, P; Shawcross, DL; Zeuzem, S; Zipprich, A; Piano, S; Berg, T; Bruns, T; Danielsen, KV; Coenraad, M; Merli, M; Stauber, R; Zoller, H; Ramos, JP; Solé, C; Soriano, G; de Gottardi, A; Gronbaek, H; Saliba, F; Trautwein, C; Kani, HT; Francque, S; Ryder, S; Nahon, P; Romero-Gomez, M; Van Vlierberghe, H; Francoz, C; Manns, M; Garcia-Lopez, E; Tufoni, M; Amoros, A; Pavesi, M; Sanchez, C; Praktiknjo, M; Curto, A; Pitarch, C; Putignano, A; Moreno, E; Bernal, W; Aguilar, F; Clària, J; Ponzo, P; Vitalis, Z; Zaccherini, G; Balogh, B; Gerbes, A; Vargas, V; Alessandria, C; Bernardi, M; Ginès, P; Moreau, R; Angeli, P; Jalan, R; Arroyo, V; PREDICT STUDY group of the EASL-CLIF CONSORTIUM PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
J Hepatol. 2021; 74(5):1097-1108 Doi: 10.1016/j.jhep.2020.11.019 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zhang, F; Wang, Y; Chen, G; Li, Z; Xing, X; Putz-Bankuti, C; Stauber, RE; Liu, X; Madl, T Growing Human Hepatocellular Tumors Undergo a Global Metabolic Reprogramming.
Cancers (Basel). 2021; 13(8): Doi: 10.3390/cancers13081980 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Dietz, J; Spengler, U; Müllhaupt, B; Schulze Zur Wiesch, J; Piecha, F; Mauss, S; Seegers, B; Hinrichsen, H; Antoni, C; Wietzke-Braun, P; Peiffer, KH; Berger, A; Matschenz, K; Buggisch, P; Backhus, J; Zizer, E; Boettler, T; Neumann-Haefelin, C; Semela, D; Stauber, R; Berg, T; Berg, C; Zeuzem, S; Vermehren, J; Sarrazin, C; European HCV Resistance Study Group Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.
Clin Gastroenterol Hepatol. 2021; 19(1):195-198 Doi: 10.1016/j.cgh.2019.10.051
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Fandler-Hofler, S; Stauber, R; Kneihsl, M; Wunsch, G; Haidegger, M; Poltrum, B; Pichler, A; Deutschmann, H; Enzinger, C; Fickert, P; Gattringer, T Liver fibrosis is associated with atrial fibrillation and worse outcome in large vessel occlusion stroke
EUR J NEUROL. 2021; 28: 151-151.-7th Congress of the European Academy of Neurology; June 19-22, 2021; Vienna, Austria. [Oral Communication]
Web of Science

 

** Mozes, F; Lee, J; Selvaraj, E; Jayaswal, A; Trauner, M; Boursier, J; Fournier, C; Staufer, K; Stauber, R; Bugianesi, E; Younes, R; Gaia, S; Lupsor-Platon, M; Petta, S; Shima, T; Okanoue, T; Mahadeva, S; Chan, WK; Eddowes, P; Newsome, PN; Wong, VWS; de Ledinghen, V; Fan, JG; Shen, F; Cobbold, J; Sumida, Y; Okajima, A; Schattenberg, J; Labenz, C; Kim, W; Lee, MS; Wiegand, J; Karlas, T; Yilmaz, Y; Aithal, G; Palaniyappan, N; Cassinotto, C; Aggarwal, S; Harshit, G; Ooi, G; Nakajima, A; Yoneda, M; Ziol, M; Barget, N; Geier, A; Tunill, T; Brosnan, MJ; Anstee, Q; Neubauer, S; Harrison, S; Bossuyt, P; Pavlides, M Individual patient data meta-analysis of the diagnostic performance of single and sequentially combined non-invasive tests in detecting advanced fibrosis
J HEPATOL. ILC 2021 Abstracts. 2021; 75: S259-S260.-The International Liver Congress; JUN 23-26, 2021; Virtuell. [Poster]
Web of Science

 

Comment

** Lackner, C; Stauber, RE; Tiniakos, D Reply to: "Prognostic value of histologic parameters in alcoholic hepatitis: A word of caution".
J Hepatol. 2021; 75(6):1510-1511 Doi: 10.1016/j.jhep.2021.09.005
Web of Science PubMed FullText FullText_MUG

 

** Stauber, RE; Scharnagl, H; Marsche, G Reply to: "Prognostic value of HDL-related biomarkers in patients with HBV-related ACLF".
J Hepatol. 2021; 75(1):245-246 Doi: 10.1016/j.jhep.2021.04.002
Web of Science PubMed FullText FullText_MUG

 

2020

Full paper/article (Journal)

** de Salazar, A; Dietz, J; di Maio, VC; Vermehren, J; Paolucci, S; Müllhaupt, B; Coppola, N; Cabezas, J; Stauber, RE; Puoti, M; Arenas Ruiz Tapiador, JI; Graf, C; Aragri, M; Jimenez, M; Callegaro, A; Pascasio Acevedo, JM; Macias Rodriguez, MA; Rosales Zabal, JM; Micheli, V; Garcia Del Toro, M; Téllez, F; García, F; Sarrazin, C; Ceccherini-Silberstein, F; Ceccherini-Silberstein, F Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen.
J ANTIMICROB CHEMOTH. 2020; 75(11): 3349-3358. Doi: 10.1093/jac/dkaa304
Web of Science PubMed FullText FullText_MUG

 

** Degré, D; Stauber, RE; Englebert, G; Sarocchi, F; Verset, L; Rainer, F; Spindelboeck, W; Njimi, H; Trépo, E; Gustot, T; Lackner, C; Deltenre, P; Moreno, C Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey's discriminant function <32.
J Hepatol. 2020; 72(4):636-642 Doi: 10.1016/j.jhep.2019.12.023 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fernández, J; Angeli, P; Trebicka, J; Merli, M; Gustot, T; Alessandria, C; Aagaard, NK; de Gottardi, A; Welzel, TM; Gerbes, A; Soriano, G; Vargas, V; Albillos, A; Salerno, F; Durand, F; Bañares, R; Stauber, R; Prado, V; Arteaga, M; Hernández-Tejero, M; Aziz, F; Morando, F; Jansen, C; Lattanzi, B; Moreno, C; Campion, D; Gronbaek, H; Garcia, R; Sánchez, C; García, E; Amorós, A; Pavesi, M; Clària, J; Moreau, R; Arroyo, V Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis.
Clin Gastroenterol Hepatol. 2020; 18(4):963-973 Doi: 10.1016/j.cgh.2019.07.055
Web of Science PubMed FullText FullText_MUG

 

** Horvath, A; Durdevic, M; Leber, B; di Vora, K; Rainer, F; Krones, E; Douschan, P; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis.
Nutrients. 2020; 12(6): Doi: 10.3390/nu12061874 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Jung, A; Korohoda, P; Krisper, P; Stadlbauer, V; Stauber, RE; Schneditz, D Bile acid kinetic modeling in end -stage liver support patients.
BIOCYBERN BIOMED ENG. 2020; 40(2): 764-773. Doi: 10.1016/j.bbe.2020.03.002
Web of Science FullText FullText_MUG

 

** Moreau, R; Clària, J; Aguilar, F; Fenaille, F; Lozano, JJ; Junot, C; Colsch, B; Caraceni, P; Trebicka, J; Pavesi, M; Alessandria, C; Nevens, F; Saliba, F; Welzel, TM; Albillos, A; Gustot, T; Fernández, J; Moreno, C; Baldassarre, M; Zaccherini, G; Piano, S; Montagnese, S; Vargas, V; Genescà, J; Solà, E; Bernal, W; Butin, N; Hautbergue, T; Cholet, S; Castelli, F; Jansen, C; Steib, C; Campion, D; Mookerjee, R; Rodríguez-Gandía, M; Soriano, G; Durand, F; Benten, D; Bañares, R; Stauber, RE; Gronbaek, H; Coenraad, MJ; Ginès, P; Gerbes, A; Jalan, R; Bernardi, M; Arroyo, V; Angeli, P; CANONIC Study Investigators of the EASL Clif Consortium; Grifols Chair; European Foundation for the Study of Chronic Liver Failure (EF Clif) Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
J Hepatol. 2020; 72(4):688-701 Doi: 10.1016/j.jhep.2019.11.009 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Paternostro, R; Pfeiffenberger, J; Ferenci, P; Stättermayer, AF; Stauber, RE; Wrba, F; Longerich, T; Lackner, K; Trauner, M; Ferlitsch, A; Reiberger, T; Weiss, KH Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease.
Liver Int. 2020; 40(4):894-904 Doi: 10.1111/liv.14368 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stickel, F; Lutz, P; Buch, S; Nischalke, HD; Silva, I; Rausch, V; Fischer, J; Weiss, KH; Gotthardt, D; Rosendahl, J; Marot, A; Elamly, M; Krawczyk, M; Casper, M; Lammert, F; Buckley, TWM; McQuillin, A; Spengler, U; Eyer, F; Vogel, A; Marhenke, S; von Felden, J; Wege, H; Sharma, R; Atkinson, S; Franke, A; Nehring, S; Moser, V; Schafmayer, C; Spahr, L; Lackner, C; Stauber, RE; Canbay, A; Link, A; Valenti, L; Grove, JI; Aithal, GP; Marquardt, JU; Fateen, W; Zopf, S; Dufour, JF; Trebicka, J; Datz, C; Deltenre, P; Mueller, S; Berg, T; Hampe, J; Morgan, MY Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers.
Hepatology. 2020; 72(1):88-102 Doi: 10.1002/hep.30996 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Trebicka, J; Fernandez, J; Papp, M; Caraceni, P; Laleman, W; Gambino, C; Giovo, I; Uschner, FE; Jimenez, C; Mookerjee, R; Gustot, T; Albillos, A; Bañares, R; Janicko, M; Steib, C; Reiberger, T; Acevedo, J; Gatti, P; Bernal, W; Zeuzem, S; Zipprich, A; Piano, S; Berg, T; Bruns, T; Bendtsen, F; Coenraad, M; Merli, M; Stauber, R; Zoller, H; Ramos, JP; Solè, C; Soriano, G; de Gottardi, A; Gronbaek, H; Saliba, F; Trautwein, C; Özdogan, OC; Francque, S; Ryder, S; Nahon, P; Romero-Gomez, M; Van Vlierberghe, H; Francoz, C; Manns, M; Garcia, E; Tufoni, M; Amoros, A; Pavesi, M; Sanchez, C; Curto, A; Pitarch, C; Putignano, A; Moreno, E; Shawcross, D; Aguilar, F; Clària, J; Ponzo, P; Jansen, C; Vitalis, Z; Zaccherini, G; Balogh, B; Vargas, V; Montagnese, S; Alessandria, C; Bernardi, M; Ginès, P; Jalan, R; Moreau, R; Angeli, P; Arroyo, V; PREDICT STUDY group of the EASL-CLIF Consortium The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
J Hepatol. 2020; 73(4):842-854 Doi: 10.1016/j.jhep.2020.06.013 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Trieb, M; Rainer, F; Stadlbauer, V; Douschan, P; Horvath, A; Binder, L; Trakaki, A; Knuplez, E; Scharnagl, H; Stojakovic, T; Heinemann, Á; Mandorfer, M; Paternostro, R; Reiberger, T; Pitarch, C; Amorós, A; Gerbes, A; Caraceni, P; Alessandria, C; Moreau, R; Clària, J; Marsche, G; Stauber, RE HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure.
J Hepatol. 2020; 73(1):113-120 Doi: 10.1016/j.jhep.2020.01.026 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Correspondence

** Degré, D; Stauber, RE; Deltenre, P; Lackner, C; Moreno, C Reply to: "Alcohol-related liver disease results in significant long-term mortality irrespective of the presence of steatohepatitis".
J Hepatol. 2020; 73(2):460-460 Doi: 10.1016/j.jhep.2020.03.037 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Müller, H; Kniepeiss, D; Stauber, R; Schrem, H; Rauter, M; Krause, R; Schemmer, P Recovery from COVID-19 following hepatitis C, human immunodeficiency virus infection, and liver transplantation.
Am J Transplant. 2020; 20(11):3255-3256 Doi: 10.1111/ajt.16107 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Correction

** Moreau, R; Clària, J; Aguilar, F; Fenaille, F; Lozano, JJ; Junot, C; Colsch, B; Caraceni, P; Trebicka, J; Pavesi, M; Alessandria, C; Nevens, F; Saliba, F; Welzel, TM; Albillos, A; Gustot, T; Fernández, J; Moreno, C; Baldassarre, M; Zaccherini, G; Piano, S; Montagnese, S; Vargas, V; Genescà, J; Solà, E; Bernal, W; Butin, N; Hautbergue, T; Cholet, S; Castelli, F; Jansen, C; Steib, C; Campion, D; Mookerjee, R; Rodríguez-Gandía, M; Soriano, G; Durand, F; Benten, D; Bañares, R; Stauber, RE; Gronbaek, H; Coenraad, MJ; Ginès, P; Gerbes, A; Jalan, R; Bernardi, M; Arroyo, V; Angeli, P; CANONIC Study Investigators of the EASL Clif Consortium; Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif) Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701].
J Hepatol. 2020; 72(6):1218-1220 Doi: 10.1016/j.jhep.2020.03.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Altekruse, A; Kovacs, G; Sassmann, T; Foris, V; Avian, A; Stadlbauer, V; Stauber, R; Olschewski, H; Douschan, P Pulmonary exercise hemodynamics in patients with liver cirrhosis - a stress echocardiography study.
EUR RESPIR J. 2020; 56: Doi: 10.1183/13993003.congress-2020.1513 [Poster]
Web of Science FullText FullText_MUG

 

** Sourij, C; Stauber, R; Aziz, F; Kojzar, H; Obermayer, A; Pferschy, P; Tripolt, N; Aberer, F; Sourij, H NAFLD in Patients with Diabetes mellitus and Lipid Metabolism Disorders: Data from the Graz Diabetes Registry for Biomarker Research GIRO.
WIEN KLIN WOCHENSCHR. 2020; 132: S344-S345. [Poster]
Web of Science

 

2019

Full paper/article (Journal)

** Clària, J; Moreau, R; Fenaille, F; Amorós, A; Junot, C; Gronbaek, H; Coenraad, MJ; Pruvost, A; Ghettas, A; Chu-Van, E; López-Vicario, C; Oettl, K; Caraceni, P; Alessandria, C; Trebicka, J; Pavesi, M; Deulofeu, C; Albillos, A; Gustot, T; Welzel, TM; Fernández, J; Stauber, RE; Saliba, F; Butin, N; Colsch, B; Moreno, C; Durand, F; Nevens, F; Bañares, R; Benten, D; Ginès, P; Gerbes, A; Jalan, R; Angeli, P; Bernardi, M; Arroyo, V; CANONIC Study Investigators of the EASL Clif Consortium, Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif) Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.
Hepatology. 2019; 69(4): 1686-1701. Doi: 10.1002/hep.30363 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ferenci, P; Pfeiffenberger, J; Stättermayer, AF; Stauber, RE; Willheim, C; Weiss, KH; Munda-Steindl, P; Trauner, M; Schilsky, M; Zoller, H HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson's Disease.
JHEP Rep. 2019; 1(1): 2-8. Doi: 10.1016/j.jhepr.2019.02.007 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ferenci, P; Stremmel, W; Członkowska, A; Szalay, F; Viveiros, A; Stättermayer, AF; Bruha, R; Houwen, R; Pop, TL; Stauber, R; Gschwantler, M; Pfeiffenberger, J; Yurdaydin, C; Aigner, E; Steindl-Munda, P; Dienes, HP; Zoller, H; Weiss, KH Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease.
Hepatology. 2019; 69(4):1464-1476 Doi: 10.1002/hep.30280 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Grabner, GF; Fawzy, N; Pribasnig, MA; Trieb, M; Taschler, U; Holzer, M; Schweiger, M; Wolinski, H; Kolb, D; Horvath, A; Breinbauer, R; Rülicke, T; Rabl, R; Lass, A; Stadlbauer, V; Hutter-Paier, B; Stauber, RE; Fickert, P; Zechner, R; Marsche, G; Eichmann, TO; Zimmermann, R Metabolic disease and ABHD6 alter the circulating bis(monoacylglycerol)phosphate profile in mice and humans.
J Lipid Res. 2019; 60(5):1020-1031 Doi: 10.1194/jlr.M093351 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gschwantler, M; Bamberger, T; Graziadei, I; Maieron, A; Katalinic, N; Stauber, R Burden of disease in patients with chronic hepatitis C in the Austrian REAL study.
Wien Klin Wochenschr. 2019; 131(1-2):8-16 Doi: 10.1007/s00508-018-1404-2
Web of Science PubMed FullText FullText_MUG

 

** Staufer, K; Halilbasic, E; Spindelboeck, W; Eilenberg, M; Prager, G; Stadlbauer, V; Posch, A; Munda, P; Marculescu, R; Obermayer-Pietsch, B; Stift, J; Lackner, C; Trauner, M; Stauber, RE Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease
UNITED EUR GASTROENT. 2019; UNSP 2050640619865133 Doi: 10.1177/2050640619865133 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Trebicka, J; Amoros, A; Pitarch, C; Titos, E; Alcaraz-Quiles, J; Schierwagen, R; Deulofeu, C; Fernandez-Gomez, J; Piano, S; Caraceni, P; Oettl, K; Sola, E; Laleman, W; McNaughtan, J; Mookerjee, RP; Coenraad, MJ; Welzel, T; Steib, C; Garcia, R; Gustot, T; Rodriguez Gandia, MA; Bañares, R; Albillos, A; Zeuzem, S; Vargas, V; Saliba, F; Nevens, F; Alessandria, C; de Gottardi, A; Zoller, H; Ginès, P; Sauerbruch, T; Gerbes, A; Stauber, RE; Bernardi, M; Angeli, P; Pavesi, M; Moreau, R; Clària, J; Jalan, R; Arroyo, V Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
Front Immunol. 2019; 10: 476-476. Doi: 10.3389/fimmu.2019.00476 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Dietz, J; de Salazar, A; Vermehren, J; Merino, D; zur Wiesch, JS; Lara, M; Pardo, MJR; Di Maio, VC; Paolucci, S; Degasperi, E; Zoller, H; Ruiz-Tapiador, JIA; Stauber, RE; Figueruela, B; Buti, M; Lampertico, P; Zeuzem, S; Silberstein, FC; Garcia, FG; Sarrazin, C Clinical and virological characteristics of patients with chronic hepatitis C and failure to voxilaprevir/velpatasvir/sofosbuvir treatment
J HEPATOL. 2019; 70: E219-E220.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA. Doi: 10.1016/S0618-8278(19)30409-8 [Poster]
Web of Science FullText FullText_MUG

 

** Dietz, J; Vermehren, J; Peiffer, KH; Wietzke-Braun, P; Muellhaupt, B; Schattenberg, J; Antoni, C; Hametner, S; Mauss, S; Heinzow, H; Graf, C; Port, K; Rockstroh, JK; Zoller, H; Zizer, E; Herrmann, A; Zur Wiesch, JS; Mueller, T; Stauber, RE; Kremer, A; Berg, C; Zeuzem, S; Sarrazin, C CLINICAL AND VIROLOGICAL CHARACTERISTICS AND RETREATMENT OF HCV-INFECTED PATIENTS WITH FAILURE TO MULTIPLE SUBSEQUENT DAA THERAPIES
HEPATOLOGY. 2019; 70: 937A-938A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

** Garcia, FG; Dietz, J; Di Maio, VC; Vermehren, J; De Salazar, A; Paolucci, S; Mullhaupt, B; Coppola, N; Cabezas, J; Stauber, RE; Puoti, M; Ruiz-Tapiador, JIA; Aragri, M; Jimenez, M; Callegaro, A; Acevedo, JMP; Rodriguez, MAM; Zabal, JMR; Micheli, V; Gomez, N; Tellez, F; Sarrazin, C; Silberstein, FC CLINICAL AND VIROLOGICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS C AND FAILURE TO A GLECAPREVIR AND PIBRENTASVIR (G/P) TREATMENT IN REAL WORLD
HEPATOLOGY. 2019; 70: 998A-999A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

** Horvath, A; Durdevic, M; Leber, B; di Vora, K; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, R; Fickert, P; Stiegler, P; Stadlbauer, V Changes in the intestinal microbiome during probiotic intervention in cirrhosis
J HEPATOL. 2019; 70: E648-E648.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA. Doi: 10.1016/S0618-8278(19)31290-3 [Poster]
Web of Science FullText FullText_MUG

 

** Komarova, I; Leber, B; Horvath, A; Posch, A; Streit, A; Spindelbock, W; Stiegler, P; Stauber, RE; Stadlbauer, V Improvement of neutrophil function in hepatitis C patients under direct acting anti-viral treatment is associated with hemolysis parameters
J HEPATOL. Journal of Hepatology. 2019; 70(1):E226-E226.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA. Doi: 10.1016/S0618-8278(19)30422-0 [Poster]
Web of Science FullText FullText_MUG

 

** Paternostro, R; Pfeiffenberger, J; Ferenci, P; Stattermayer, A; Wrba, F; Longerich, T; Lackner, C; Stauber, RE; Trauner, MH; Ferlitsch, A; Weiss, KH LONG TERM DISEASE MONITORING USING TRANSIENT ELASTOGRAPHY IN PATIENTS WITH BIOPSY-PROVEN WILSON DISEASE
HEPATOLOGY. 2019; 70: 1179A-1180A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

** Stauber, RE; Kaferbock, P; Spindelbock, W; Douschan, P; Rainer, F; Lackner, C Quantitative fibrosis assessment independently predicts outcome in alcoholic liver disease
J HEPATOL. 2019; 70: E286-E286.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA. Doi: 10.1016/S0618-8278(19)30547-X [Poster]
Web of Science FullText FullText_MUG

 

** Stauber, RE; Marculescu, R; Obermayer-Pietsch, B; Eilenberg, M; Lackner, C; Cales, P; Trauner, MH; Staufer, K FibroMeter(VCTE) SHOWS SUPERIOR DIAGNOSTIC ACCURACY FOR NONINVASIVE DIAGNOSIS OF FIBROSIS STAGE IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD).
HEPATOLOGY. 2019; 70: 1059A-1059A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

** Ventura-Cots, M; Argemi, J; Jones, PD; Lackner, K; Abraldes, JG; Alves, A; Alboraie, MA; Altamirano, J; Bosques, FJ; Brown, RS; Caballeria, J; Cabezas, J; Cortez-Pinto, H; Costa, A; Degre, D; El Hag, M; Fernandez-Carrillo, C; Ganne, N; Garcia-Tsao, G; Genesca, J; Koskinas, J; Lanthier, NGG; Louvet, A; Lozano, JJ; Lucey, MR; Masson, S; Mathurin, P; Mendez-Sanchez, N; Miquel, R; Moreno, C; Mounajjed, T; Odena, G; Sancho-Bru, P; Sempoux, C; Straub, BK; Stauber, RE; Tiniakos, D; Blasco, VMV; Verna, E; Verset, L; Kim, W; Woosley, J; Ziol, M; Mueller, S; Starkel, P; Shah, V; Bataller, R MOLECULAR PROFILING OF HUMAN ALCOHOLIC HEPATITIS VS EARLY ALCOHOLIC STEATOHEPATITIS REVEALS PROFOUND UP-REGULATION OF EPITHELIAL-TO-MESENCHYMAL TRANSITION PATHWAY
HEPATOLOGY. 2019; 70: 820A-822A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

2018

Full paper/article (Journal)

** Alcaraz-Quiles, J; Casulleras, M; Oettl, K; Titos, E; Flores-Costa, R; Duran-Güell, M; López-Vicario, C; Pavesi, M; Stauber, RE; Arroyo, V; Clària, J Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen-Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis.
Hepatology. 2018; 68(5):1937-1952 Doi: 10.1002/hep.30135 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Beinhardt, S; Al-Zoairy, R; Kozbial, K; Stättermayer, AF; Maieron, A; Stauber, R; Strasser, M; Zoller, H; Graziadei, I; Rasoul-Rockenschaub, S; Trauner, M; Ferenci, P; Hofer, H Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation.
Liver Int. 2018; 38(7):1188-1197 Doi: 10.1111/liv.13652 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gschwantler, M; Laferl, H; Vogel, W; Korak, W; Moser, S; Hofer, H; Bauer, B; Schleicher, M; Bognar, B; Bischof, M; Stauber, R; Maieron, A; Ferenci, P; Austrian Hepatitis Study Group Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope study.
Wien Klin Wochenschr. 2018; 130(1-2):54-61 Doi: 10.1007/s00508-017-1263-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kozbial, K; Moser, S; Al-Zoairy, R; Schwarzer, R; Datz, C; Stauber, R; Laferl, H; Strasser, M; Beinhardt, S; Stättermayer, AF; Gschwantler, M; Zoller, H; Maieron, A; Graziadei, I; Trauner, M; Steindl-Munda, P; Hofer, H; Ferenci, P Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.
Liver Int. 2018; 38(6):1028-1035 Doi: 10.1111/liv.13629 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pollheimer, MJ; Racedo, S; Mikels-Vigdal, A; Marshall, D; Bowlus, C; Lackner, C; Madl, T; Karlsen, TH; Hov, JR; Lyman, SK; Adamkewicz, J; Smith, V; Moreau, E; Zollner, G; Eide, TJ; Stojakovic, T; Scharnagl, H; Gruber, HJ; Stauber, RE; Trauner, M; Fickert, P Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
J Hepatol. 2018; 69(2):368-377 Doi: 10.1016/j.jhep.2018.04.009
Web of Science PubMed FullText FullText_MUG

 

** Rainer, F; Horvath, A; Sandahl, TD; Leber, B; Schmerboeck, B; Blesl, A; Groselj-Strele, A; Stauber, RE; Fickert, P; Stiegler, P; Møller, HJ; Grønbaek, H; Stadlbauer, V Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.
Aliment Pharmacol Ther. 2018; 47(5):657-664 Doi: 10.1111/apt.14474 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Alcaraz-Quiles, J; Casulleras, M; Oettl, K; Titos, E; Flores-Costa, R; Duran-Guell, M; Lopez-Vicario, C; Pavesi, M; Stauber, RE; Arroyo, V; Claria, J Oxidized albumin triggers a cytokine/eicosanoid storm in leukocytes through p38 MAP kinase: role in systemic inflammation in decompensated cirrhosis
EUR J CLIN INVEST. 2018; 48: 78-78.-52th Annual Scientific Meeting of the European Society for Clinical Investigation; MAY 30 - JUN 1; Barcelona, SPAIN. [Poster]
Web of Science

 

** Claria, J; Moreau, R; Fenaille, F; Amoros, A; Junot, C; Gronbaek, H; Coenraad, M; Oettl, K; Caraceni, P; Alessandria, C; Trebicka, J; Pavesi, M; Gomez, CD; Albillos, A; Gustot, T; Welzel, T; Fernandez, J; Stauber, RE; Saliba, F; Butin, N; Colsch, B; Moreno, C; Durand, F; Nevens, F; Banares, R; Benten, D; Gines, P; Gerbes, A; Jalan, R; Angeli, P; Bernardi, M; Arroyo, V The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality
J HEPATOL. 2018; 68: S120-S121.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. [Poster]
Web of Science

 

** Ferenci, P; Pfeiffenberger, J; Stattermayer, A; Stauber, RE; Willheim, C; Weiss, KH; Trauner, MH; Zoller, H Is the HSD17B13 Variant a Genetic Modifier of Wilson Disease?
HEPATOLOGY. 2018; 68: 721A-721A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 09-13, 2018; San Francisco, CA. [Poster]
Web of Science

 

** Horvath, A; Rainer, F; Leber, B; Schmerboeck, B; Spindelboeck, W; Stauber, R; Stiegler, P; Stadlbauer, V ACELLULAR GROWTH RETARDATION ABILITY (AGRA) PREDICTS THE OCCURRENCE OF SEVERE BACTERIAL INFECTIONS IN CIRRHOSIS.
TRANSPL INT. 2018; 31: 8-9. [Poster]
Web of Science

 

** Komarova, I; Horvath, A; Krones, E; Leber, B; Schmerboeck, B; Durchschein, F; Zollner, G; Stauber,RE; Spindelböck, W; Douschan, P; Stiegler, P; Kniepeiss, D; Stojakovic, T; Fauler, G; Stadlbauer, V Changes of bile acids profile in different etiologies of liver cirrhosis and its association with neutrophil response
JOURNAL OF HEPATOLOGY. 2018; 68(SUPP.1):S473-S473.-The International Liver Congress; APR 11–15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)31193-0 [Poster]
Web of Science FullText FullText_MUG

 

** Kozbial, K; Al-Zoairy, R; Schaefer, B; Gschwantler, M; Stauber, RE; Hametner, S; Maieron, A; Laferl, H; Strasser, M; Hayat-Khayyati, A; Datz, C; Kramer, L; Graziadei, I; Stattermayer, A; Beinhardt, S; Munda, P; Zoller, H; Trauner, M; Hofer, H; Ferenci, P Real world experience of retreatment of chronic hepatitis C patients who failed IFN-free DAA therapy
J HEPATOL. 2018; 68: S279-S280.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)30776-1 [Poster]
Web of Science FullText FullText_MUG

 

** Lackner, K; Binder, L; Rainer, F; Stauber, RE Morphometrical quantification of fibrosis correlates with clinical cirrhosis stage and predicts long-term survival in patients with alcoholic liver disease
J HEPATOL. 2018; 68: S815-S815.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)31903-2 [Poster]
Web of Science FullText FullText_MUG

 

** Leber, B; Horvath, A; Schmerboeck, B; Posch, A; Streit, A; Spindelbock, W; Stiegler, P; Stauber, RE; Stadlbauer, V Direct acting anti-viral therapy rescues neutrophil dysfunction in hepatitis C infection by reduction of heamolysis
J HEPATOL. 2018; 68: S326-S327.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)30873-0 [Poster]
Web of Science FullText FullText_MUG

 

** Paternostro, R; Pfeiffenberger, J; Stattermayer, A; Stauber, RE; Trauner, MH; Ferenci, P; Ferlitsch, A; Weiss, KH Transient Elastography, APRI and FIB-4 Scores for Staging of Fibrosis and Cirrhosis in Wilson Disease
HEPATOLOGY. 2018; 68: 725A-726A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 09-13, 2018; San Francisco, CA. [Poster]
Web of Science

 

** Pollheimer, M; Racedo, S; Mikels-Vigdal, A; Bowlus, C; Lackner, C; Karlsen, TH; Hov, JR; Lyman, SK; Adamkewicz, J; Smith, V; Moreau, E; Eide, TJ; Stojakovic, T; Stauber, RE; Trauner, M; Fickert, P Lysyl oxidase-like protein 2 in cholangiopathies
VIRCHOWS ARCH. 2018; 473: S6-S7.-30th European Congress of Pathology; 08-12.09, 2018 ; Bilbao. [Oral Communication]
Web of Science

 

** Quiles, JA; Casulleras, M; Oettl, K; Titos, E; Flores-Costa, R; Lopez-Vicario, C; Duran-Guell, M; Pavesi, M; Stauber, RE; Arroyo, V; Claria, J Oxidized albumin present in patients with decompensated cirrhosis triggers the inflammatory response in peripheral leukocytes through the p38 MAP kinase pathway
J HEPATOL. 2018; 68: S10-S10.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)30237-X [Oral Communication]
Web of Science FullText FullText_MUG

 

** Rainer, F; Horvath, A; Bashir, M; Leber, B; Schmerboeck, B; Blesl, A; Madl, T; Klymiuk, I; Groselj-Strele, A; Durdevic, M; Gronbaek, H; Moller, HJ; Freedber, DE; Abrams, JA; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V Loss of colonization resistance in cirrhosis facilitates proton pump inhibitor-associated oralization of the colonic microbiome
J HEPATOL. 2018; 68: S700-S700.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)31663-5 [Poster]
Web of Science FullText FullText_MUG

 

** Sassmann, T; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Revelant, F; Stadlbauer, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H; Douschan, P Diastolic dysfunction and cardiopulmonary exercise capacity in patients with advanced liver disease-results from a prospective cross-sectional cohort
WIEN KLIN WOCHENSCHR. 2018; 130(19-20):627-627.-ÖGP Jahrestagung; OKT 18-20, 2018; Linz, Austria. [Poster]
Web of Science

 

** Sassmann, T; Kovacs, G; Stauber, RE; Revelant, F; Foris, V; Pfeiffer, S; Gruber, F; Stadlbauer, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H; Douschan, P; Impact of diastolic dysfunction on exercise capacity in patients with liver cirrhosis
European Respiratory Journal. 2018; 52(sup 62):-ERS International Congress; SEP 15 - 19, 2018; Paris, France. Doi: 10.1183/13993003.congress-2018.PA2486 [Poster]
Web of Science FullText FullText_MUG

 

** Stauber, RE; Staufer, K; Stift, J; Marculescu, R; Obermayer-Pietsch, B; Trauner, M; Lackner, K Enhanced liver fibrosis (ELF) score accurately detects advanced fibrosis in nonalcoholic fatty liver disease (NAFLD)
J HEPATOL. 2018; 68: S563-S563.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)31383-7 [Poster]
Web of Science FullText FullText_MUG

 

** Staufer, K; Marculescu, R; Obermayer-Pietsch, B; Stift, J; Lackner, K; Trauner, MH; Stauber, RE Evaluation and Comparison of Four Noninvasive Tests for Detection of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD)
HEPATOLOGY. 2018; 68: 1308A-1309A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 09-13, 2018; San Francisco, CA. [Poster]
Web of Science

 

2017

Full paper/article (Journal)

** Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Douschan, P; Rainer, F; Stauber, R; Haybaeck, J; Denk, H; Lackner, C Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.
Liver Int. 2017; 37(4):600-610 Doi: 10.1111/liv.13325
Web of Science PubMed FullText FullText_MUG

 

** Dengler, M; Staufer, K; Huber, H; Stauber, R; Bantel, H; Weiss, KH; Starlinger, P; Pock, H; Klöters-Plachky, P; Gotthardt, DN; Rauch, P; Lackner, C; Stift, J; Brostjan, C; Gruenberger, T; Kumada, T; Toyoda, H; Tada, T; Weiss, TS; Trauner, M; Mikulits, W Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Oncotarget. 2017; 8(28):46234-46248 Doi: 10.18632/oncotarget.17598 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ganten, TM; Stauber, RE; Schott, E; Malfertheiner, P; Buder, R; Galle, PR; Göhler, T; Walther, M; Koschny, R; Gerken, G Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study.
Clin Cancer Res. 2017; 23(19):5720-5728 Doi: 10.1158/1078-0432.CCR-16-0919 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kerbert, AJ; Schaapman, JJ; van der Reijden, JJ; Amorós Navarro, À; McCormick, A; van Hoek, B; Arroyo, V; Ginès, P; Jalan, R; Vargas, V; Stauber, R; Verspaget, HW; Coenraad, MJ; CANONIC Study Investigators of the EASL-CLIF Consortium Short article: Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis.
Eur J Gastroenterol Hepatol. 2017; 29(5):535-538 Doi: 10.1097/MEG.0000000000000834
Web of Science PubMed FullText FullText_MUG

 

** Lackner, C; Spindelboeck, W; Haybaeck, J; Douschan, P; Rainer, F; Terracciano, L; Haas, J; Berghold, A; Bataller, R; Stauber, RE Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.
J Hepatol. 2017; 66(3):610-618 Doi: 10.1016/j.jhep.2016.11.011
Web of Science PubMed FullText FullText_MUG

 

** Nagy, BM; Nagaraj, C; Egemnazarov, B; Kwapiszewska, G; Stauber, RE; Avian, A; Olschewski, H; Olschewski, A Lack of ABCG2 Leads to Biventricular Dysfunction and Remodeling in Response to Hypoxia.
Front Physiol. 2017; 8(8):98-98 Doi: 10.3389/fphys.2017.00098 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Reiberger, T; Püspök, A; Schoder, M; Baumann-Durchschein, F; Bucsics, T; Datz, C; Dolak, W; Ferlitsch, A; Finkenstedt, A; Graziadei, I; Hametner, S; Karnel, F; Krones, E; Maieron, A; Mandorfer, M; Peck-Radosavljevic, M; Rainer, F; Schwabl, P; Stadlbauer, V; Stauber, R; Tilg, H; Trauner, M; Zoller, H; Schöfl, R; Fickert, P Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).
Wien Klin Wochenschr. 2017; 129(Suppl 3): 135-158. Doi: 10.1007/s00508-017-1262-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Richtig, G; Aigelsreiter, A; Schwarzenbacher, D; Ress, AL; Adiprasito, JB; Stiegelbauer, V; Hoefler, G; Schauer, S; Kiesslich, T; Kornprat, P; Winder, T; Eisner, F; Gerger, A; Stoeger, H; Stauber, R; Lackner, C; Pichler, M SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
PLoS One. 2017; 12(11):e0187814-e0187814 Doi: 10.1371/journal.pone.0187814 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stauber, RE; Fauler, G; Rainer, F; Leber, B; Posch, A; Streit, A; Spindelboeck, W; Stadlbauer, V; Kessler, HH; Mangge, H Anti-HCV treatment with ombitasvir/paritaprevir/ritonavir ± dasabuvir is associated with increased bile acid levels and pruritus.
Wien Klin Wochenschr. 2017; 129(21-22):848-851 Doi: 10.1007/s00508-017-1268-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Staufer, K; Dengler, M; Huber, H; Marculescu, R; Stauber, R; Lackner, C; Dienes, HP; Kivaranovic, D; Schachner, C; Zeitlinger, M; Wulkersdorfer, B; Rauch, P; Prager, G; Trauner, M; Mikulits, W The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis.
Cell Death Dis. 2017; 8(10):e3135-e3135 Doi: 10.1038/cddis.2017.554 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Talakić, E; Schaffellner, S; Kniepeiss, D; Mueller, H; Stauber, R; Quehenberger, F; Schoellnast, H CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?
Eur Radiol. 2017; 27(10):4173-4180 Doi: 10.1007/s00330-017-4788-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Wimmer, T; Steiner, J; Talakic, E; Stauber, R; Quehenberger, F; Portugaller, RH; Schoellnast, H Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.
J Comput Assist Tomogr. 2017; 41(5):708-712 Doi: 10.1097/RCT.0000000000000592
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Kozbial, K; Aberle, SW; Susser, S; Al-Zoairy, R; Moser, S; Stättermayer, AF; Maieron, A; Gschwantler, M; Stauber, R; Graziadei, I; Zoller, H; Beinhardt, S; Holzmann, H; Munda-Steindl, P; Hofer, H; Sarrazin, C; Ferenci, P Letter: retreatment of patients with chronic hepatitis C who have failed interferon-free combination therapy with direct acting anti-virals.
Aliment Pharmacol Ther. 2017; 45(2):373-375 Doi: 10.1111/apt.13887 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schaffellner, S; Stadlbauer, V; Sereinigg, M; Mìller, H; Högenauer, C; Fickert, P; Krumnikl, J; Lackner, C; Kniepeiss, D; Stauber, RE Niacin-Associated Acute Hepatotoxicity Leading to Emergency Liver Transplantation.
Am J Gastroenterol. 2017; 112(8): 1345-1346. Doi: 10.1038/ajg.2017.171 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Alcaraz-Quiles, J; Casulleras, M; Oettl, K; Flores-Costa, R; Duran-Guell, M; Lopez-Vicario, C; Titos, E; Stauber, RE; Arroyo, V; Claria, J Oxidized plasma albumin present in patients with decompensated cirrhosis triggers the inflammatory response in innate immune cells
HEPATOLOGY. 2017; 66: 282A-282A.-68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; OCT 20-24, 2017; Washington, DC. [Poster]
Web of Science

 

** Dengler, M; Staufer, K; Huber, H; Stauber, R; Bantel, H; Weiss, KH; Starlinger, P; Pock, H; Kloters-Plachky, P; Gotthardt, DN; Rauch, P; Lackner, C; Stift, J; Brostjan, C; Gruenberger, T; Kumada, T; Toyoda, H; Tada, T; Weiss, TS; Trauner, M; Mikulits, W Soluble Axl identifies patients at higher risk for hepatocellular carcinoma development: results from a large scale multicenter analysis
J HEPATOL. 2017; 66(1):S626-S626.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31697-5 [Poster]
Web of Science FullText FullText_MUG

 

** Douschan, P; Kovacs, G; Stadlbauer, V; Kniepeiss, D; Krones, E; Durchschein, F; Rainer, F; Spindelboeck, W; Wagner, M; Zollner, G; Avian, A; Fickert, P; Olschewski, A; Olschewski, H; Stauber, RE Exercise capacity and exercise hemodynamics in the screening for pulmonary vascular disease (PVD) in patients with portal hypertension - results from a prospective cross-sectional study
J HEPATOL. 2017; 66(1):S568-S569.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31556-8 [Poster]
Web of Science FullText FullText_MUG

 

** Douschan, P; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Sassmann, T; Revelant, F; Stadlbauer, V; Kniepeiss, D; Fickert, P; Avian, A; Olschewski, A; Olschewski, H Impact of chronic liver disease on pulmonary hemodynamics and exercise tolerance - results from a prospective cross-sectional study
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):768-769. [Poster]
Web of Science

 

** Douschan, P; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Stadlbauer-Kollner, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H Exercise Hemodynamics In The Screening For Pulmonary Vascular Disease In Patients With Portal Hypertension - Results From A Prospective Cross-Sectional Study
AM J RESP CRIT CARE. 2017; 195: -International Conference of the American-Thoracic-Society (ATS); MAY 19-24, 2017; Washington, USA. [Oral Communication]
Web of Science

 

** Horvath, A; Bashir, M; Schmerboeck, B; Rainer, F; Krones, E; Baumann-Durchschein, F; Douschan, P; Spindelboeck, W; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Leber, B; Stadlbauer, V Intestinal colonisation by Veillonella spp. is predictive for mortality in stable cirrhosis and could be partially reduced by a multispecies probiotic in a randomized placebo controlled trial
J HEPATOL. 2017; 66(1):S128-S128.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)30524-X [Poster]
Web of Science FullText FullText_MUG

 

** Leber, B; Horvath, A; Schmerbock, B; Tawdrous, M; Streit, A; Posch, A; Fickert, P; Spindelbock, W; Stiegler, P; Stauber, RE; Stadlbauer, V Direct acting antivirals improve neutrophil phagocytic capacity in chronic hepatitis C
J HEPATOL. 2017; 66(1):S293-S293.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)30902-9 [Poster]
Web of Science FullText FullText_MUG

 

** Rainer, F; Horvath, A; Sandahl, TD; Leber, B; Schmerboeck, B; Blesl, A; Krones, E; Baumann-Durchschein, F; Douschan, P; Spindelboeck, W; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Moller, HJ; Gronbaek, H; Stadlbauer, V Macrophage activation markers sCD163 and mannose receptor predict survival and correlate with markers of gut permeability in patients with liver cirrhosis
J HEPATOL. 2017; 66(1):S368-S369.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31080-2 [Poster]
Web of Science FullText FullText_MUG

 

** Stadlbauer, V; Schmerbock, B; Leber, B; Kipperer, M; Stiegler, P; Posch, A; Streit, A; Spindelbock, W; Fickert, P; Stauber, R Drop of FGF19 levels in patients with HCC development following DAA therapy for chronic hepatitis C
J HEPATOL. 2017; 66(1):S710-S711.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31903-7 [Poster]
Web of Science FullText FullText_MUG

 

** Stauber, RE; Spindelboeck, W; Rainer, F; Douschan, P; Lackner, C Prognostic Value of Liver Histology in "Low-Risk" Alcoholic Liver Disease (Maddrey Score < 32)
HEPATOLOGY. 2017; 66: 710A-711A.-68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; OCT 20-24, 2017; Washington, DC. [Poster]
Web of Science

 

** Stauber, RE; Spindelboeck, W; Rainer, F; Douschan, P; Lackner, C Clinical criteria are of limited value for diagnosis of alcoholic steatohepatitis
J HEPATOL. 2017; 66(1):S116-S116.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)30494-4 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Stauber, RE; Spindelboeck, W; Rainer, F; Douschan, P; Lackner, C PROGNOSTIC VALUE OF LIVER HISTOLOGY IN "LOW-RISK" ALCOHOLIC LIVER DISEASE (MADDREY SCORE < 32)
ALCOHOL ALCOHOLISM. 2017; 52: [Poster]
Web of Science

 

** Vermehren, J; Dietz, J; Susser, S; Schott, E; Schattenberg, JM; Zizer, E; Wiesch, JSZ; Antoni, C; Wietzke-Braun, P; Niederau, C; Mauss, S; Rockstroh, JK; Mullhaupt, B; Stauber, RE; Zeuzem, S; Sarrazin, C Failure to multiple Interferon-free direct antiviral therapies: could chronic hepatitis C become incurable?
HEPATOLOGY. 2017; 66: 859A-859A.-68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; OCT 20-24, 2017; Washington, DC. [Poster]
Web of Science

 

Comment

** Lackner, C; Berghold, A; Bataller, R; Stauber, RE Reply to: "Effect of abstinence on the prognosis of patients with alcoholic liver disease: A word of caution".
J Hepatol. 2017; 66(6):1330-1331 Doi: 10.1016/j.jhep.2017.02.028
Web of Science PubMed FullText FullText_MUG

 

2016

Full paper/article (Journal)

** Beinhardt, S; Al Zoairy, R; Ferenci, P; Kozbial, K; Freissmuth, C; Stern, R; Stättermayer, AF; Stauber, R; Strasser, M; Zoller, H; Watschinger, B; Schmidt, A; Trauner, M; Hofer, H; Maieron, A DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting.
Transpl Int. 2016; 29(9):999-1007 Doi: 10.1111/tri.12799 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Clària, J; Stauber, RE; Coenraad, MJ; Moreau, R; Jalan, R; Pavesi, M; Amorós, À; Titos, E; Alcaraz-Quiles, J; Oettl, K; Morales-Ruiz, M; Angeli, P; Domenicali, M; Alessandria, C; Gerbes, A; Wendon, J; Nevens, F; Trebicka, J; Laleman, W; Saliba, F; Welzel, TM; Albillos, A; Gustot, T; Benten, D; Durand, F; Ginès, P; Bernardi, M; Arroyo, V; CANONIC Study Investigators of the EASL-CLIF Consortium and the European Foundation for the Study of Chronic Liver Failure (EF-CLIF) Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.
Hepatology. 2016; 64(4):1249-1264 Doi: 10.1002/hep.28740 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fabian, E; Schiller, D; Graninger, W; Langner, C; Frei, J; Schoellnast, H; Alibegovic, V; Stauber, R; Schoefl, R; Krejs, GJ Clinical-Pathological Conference Series from the Medical University of Graz : Case No 159: 52-year-old patient with psoriasis and arthralgia of the finger joints.
Wien Klin Wochenschr. 2016; 128(21-22):846-853 Doi: 10.1007/s00508-016-1010-0 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fontana, RJ; Brown, RS; Moreno-Zamora, A; Prieto, M; Joshi, S; Londoño, MC; Herzer, K; Chacko, KR; Stauber, RE; Knop, V; Jafri, SM; Castells, L; Ferenci, P; Torti, C; Durand, CM; Loiacono, L; Lionetti, R; Bahirwani, R; Weiland, O; Mubarak, A; ElSharkawy, AM; Stadler, B; Montalbano, M; Berg, C; Pellicelli, AM; Stenmark, S; Vekeman, F; Ionescu-Ittu, R; Emond, B; Reddy, KR Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
Liver Transpl. 2016; 22(4):446-458 Doi: 10.1002/lt.24416 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Horvath, A; Leber, B; Schmerboeck, B; Tawdrous, M; Zettel, G; Hartl, A; Madl, T; Stryeck, S; Fuchs, D; Lemesch, S; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Rainer, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis.
Aliment Pharmacol Ther. 2016; 44(9):926-935 Doi: 10.1111/apt.13788 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pilz, S; Putz-Bankuti, C; Gaksch, M; Spindelboeck, W; Haselberger, M; Rainer, F; Posch, A; Kreuzer, P; Stojakovic, T; Stadlbauer, V; Obermayer-Pietsch, B; Stauber, RE Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations in Cirrhotic Patients: A Randomized Controlled Trial.
Nutrients. 2016; 8(5): Doi: 10.3390/nu8050278 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rosón, B; Corbella, X; Perney, P; Santos, A; Stauber, R; Lember, M; Arutyunov, A; Ruza, I; Vaclavik, J; García, L; Pujol, R; Stauber, R; Vogel, W; Vaclavik, J; Gajdová, J; Smrzova, A; Liberdová, A; Cibickova, L; Plasek, J; Svarcova, T; Salupere, R; Lember, M; Rosón, B; Guillem, MN; Fernández-Sola, J; Zapatero, A; Monte, R; Puerta, RB; Gamallo, R; Durán, C; Perney, P; Ouakli, A; Oziol, E; Bastide, D; Tourneaire, P; Allard, G; Cros, H; Piala, JM; Quere, I; Condouret, S; Ruža, I; Funka, K; Zarina, L; Barata, J; Gonsalves, O; Santos, A; Oliveira, N; Yakushin, S; Petrovicheva, L; Sleptsov, A; Arutyunov, A; Mitkhat, G; Marusenko, I; ALCHIMIE Study Group Prevalence, Clinical Characteristics, and Risk Factors for Non-recording of Alcohol Use in Hospitals across Europe: The ALCHIMIE Study.
Alcohol Alcohol. 2016; 51(4):457-464 Doi: 10.1093/alcalc/agv142 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Spindelboeck, W; Horvath, A; Tawdrous, M; Schmerböck, B; Zettel, G; Posch, A; Streit, A; Jurse, P; Lemesch, S; Horn, M; Wuensch, G; Stiegler, P; Stauber, RE; Leber, B; Stadlbauer, V Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes.
PLoS One. 2016; 11(3):e0150299-e0150299 Doi: 10.1371/journal.pone.0150299 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Trieb, M; Horvath, A; Birner-Gruenberger, R; Spindelboeck, W; Stadlbauer, V; Taschler, U; Curcic, S; Stauber, RE; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G Liver disease alters high-density lipoprotein composition, metabolism and function.
Biochim Biophys Acta. 2016; 1861(7):630-638 Doi: 10.1016/j.bbalip.2016.04.013 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Kozbial, K; Moser, S; Schwarzer, R; Laferl, H; Al-Zoairy, R; Stauber, R; Stättermayer, AF; Beinhardt, S; Graziadei, I; Freissmuth, C; Maieron, A; Gschwantler, M; Strasser, M; Peck-Radosalvjevic, M; Trauner, M; Hofer, H; Ferenci, P Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment.
J Hepatol. 2016; 65(4):856-858 Doi: 10.1016/j.jhep.2016.06.009 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stern, R; Hametner, S; Ramona, AZ; Moser, S; Karpi, A; Laferl, H; Stauber, RE; Zoller, HM; Maieron, A; Vogel, W; Graziadei, I; Gschwantler, M; Kozbial, K; Freissmuth, C; Hofer, H; Ferenci, P Interferon/Ribavirin-Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C.
Am J Gastroenterol. 2016; 111(5):744-745 Doi: 10.1038/ajg.2016.39
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Amouzadeh-Ghadikolai, O; Baranyi, A; Meinitzer, A; Breitenecker, RJ; Stauber, R; Rothenhausler, HB New insights in the kynurenine pathway of interferon-alpha-induced depression
EUR NEUROPSYCHOPHARM. 2016; 26: S390-S391.-29th Congress of the European-College-of-Neuropsychopharmacology (ECNP); SEP 17-20, 2016; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Beinhardt, S; Al-Zoairy, R; Freissmuth, C; Kozbial, K; Stern, R; Stattermayer, AF; Zoller, H; Maieron, A; Stauber, R; Staufer, K; Strasser, M; Vogel, W; Peck-Radosaljevic, M; Trauner, M; Ferenci, P; Hofer, H; SAFETY AND EFFICACY OF IFNANDRBV-FREE DAA-BASED REGIMENS IN HCV-RECURRENCE AFTER ORTHOTOPIC LIVER TRANSPLANTATION.
J HEPATOL. 2016; 64: S818-S818. Doi: 10.1016/S0168-8278(16)01599-3 [Poster]
Web of Science FullText FullText_MUG

 

** Grgic-Mustafic, R; Kahn, J; Podbregar, M; Holobar, A; Stauber, R; Fickert, P; Stadlbauer-Kollner, V; Nwoha, B; Muller, H; Kniepeiss, D A NEW METHOD FOR THE DETERMINATION AND MONITORING OF THE AMMONIA IN THE EXHALED AIR
TRANSPL INT. .. 2016; 29: 18-18. [Poster]
Web of Science

 

** Gschwantler, M; Ferenci, P; Bauer, BJ; Laferl, H; Bamberger, T; Stauber, RE; Graziadei, I; Hettinger, J; Teskey, A; Maieron, A Burden of disease in patients with chronic hepatitis C in the Austrian REAL Study
HEPATOLOGY. 2016; 63(1 SUPP):466A-467A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA. [Poster]
Web of Science

 

** Horvath, A; Leber, B; Fuchs, D; Schmerboeck, B; Tawdrous, M; Yueksel, O; Sherzay, K; Hartl, A; Lemesch, S; Spindelboeck, W; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Stadlbauer, V; MULTISPECIES PROBIOTIC MAINTAINS HEALTH RELATED QUALITY OF LIFE IN CIRRHOSIS BETTER THAN PLACEBO.
J HEPATOL. 2016; 64: S249-S249.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(16)00262-2 [Poster]
Web of Science FullText FullText_MUG

 

** Kozbial, K; Moser, S; Schwarzer, R; Al Zoairy, R; Stauber, RE; Laferl, H; Maieron, A; Zoller, HM; Beinhardt, S; Staattermayer, A; Stern, R; Steindl-Munda, PE; Strasser, MP; Peck-Radosavljevic, M; Graziadei, I; Trauner, MH; Hofer, H; Ferenci, P Does successful viral eradication translate into beneficial long-term clinical outcome of patients with advanced liver disease due to hepatitis C after DAA therapy?
HEPATOLOGY. 2016; 63(1 SUPP):447A-447A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA. [Poster]
Web of Science

 

** Lackner, C; Spindelboeck, W; Rainer, F; Haybaeck, J; Stauber, RE; HISTOLOGICAL ACTIVITY AND FIBROSIS PREDICT LONG-TERM SURVIVAL IN PATIENTS WITH COMPENSATED ALCOHOLIC LIVER DISEASE.
J HEPATOL. 2016; 64: S229-S229.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(16)00212-9 [Poster]
Web of Science FullText FullText_MUG

 

** Nagy, BM; Nagaraj, C; Egemnazarov, B; Kwapiszewska, G; Stauber, R; Avian, A; Olschewski, A; Olschewski, H Lack Of Abcg2 Leads To Biventricular Dysfunction And Remodelling In Response To Hypoxia
AM J RESP CRIT CARE. 2016; 193: -International Conference of the American-Thoracic-Society (ATS); MAY 13-18, 2016; San Francisco, CA. [Poster]
Web of Science

 

** Schaffellner, S; Stauber, R; Sereinigg, M; Muller, H; Fickert, P; Hogenauer, C; Krumnikl, J; Lackner, C; Stadlbauer, V; Kniepeiss, D THE DOSE MAKES THE POISON: ACUTE LIVER FAILURE AFTER VITAMIN B3 OVERDOSAGE
TRANSPL INT. .. 2016; 29: 11-11. [Poster]
Web of Science

 

** Stauber, RE; Haas, J; Wagner, D; Kniepeiss, D; Stadlbauer, V; Ferlitsch, A; Fuhrmann, V; THE ALBICC MODEL: A NEW PROGNOSTIC TOOL FOR PREDICTION OF SHORT-TERM SURVIVAL IN PATIENTS WITH END-STAGE LIVER DISEASE.
J HEPATOL. 2016; 64: S284-S284.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(16)00346-9 [Poster]
Web of Science FullText FullText_MUG

 

** Yang, JD; Mara, K; Harmsen, WS; Therneau, TM; Peck, M; Stauber, R; Degos, F; Blanc, JF; Leroy, V; Trinchet, JC; Duvoux, C; Assenat, E; Klinker, H; Schott, E; Colombo, M; Izzo, F; Marinho, RT; Pascual, S; Coll, S; Pena, AM; Stal, P; Haglund, U; Johnson, P; Evans, J; Meyer, T; Suddle, A; Fenwick, S; Castel, H; Schwartz, M; Gores, GJ; Roberts, LR; VALIDATION OF MESIAH SCORE SYSTEM IN PATIENTS WITH HEPATOCELLULAR CARCINOMA.
J HEPATOL. JOURNAL OF HEPATOLOGY64: S330-S331. AMSTERDAM: ELSEVIER SCIENCE BV; ( Presented at: EASL International Liver Congress, Barcelona, SPAIN, APR 13-17, 2016)
Web of Science

 

Comment

** Toplak, H; Stauber, R; Sourij, H EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects.
Diabetologia. 2016; 59(6):1148-1149 Doi: 10.1007/s00125-016-3941-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Full paper/article (Journal)

** Baranyi, A; Meinitzer, A; Breitenecker, RJ; Amouzadeh-Ghadikolai, O; Stauber, R; Rothenhäusler, HB Quinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis.
PLoS One. 2015; 10(9):e0137022-e0137022 Doi: 10.1371/journal.pone.0137022 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gustot, T; Fernandez, J; Garcia, E; Morando, F; Caraceni, P; Alessandria, C; Laleman, W; Trebicka, J; Elkrief, L; Hopf, C; Solís-Munoz, P; Saliba, F; Zeuzem, S; Albillos, A; Benten, D; Montero-Alvarez, JL; Chivas, MT; Concepción, M; Córdoba, J; McCormick, A; Stauber, R; Vogel, W; de Gottardi, A; Welzel, TM; Domenicali, M; Risso, A; Wendon, J; Deulofeu, C; Angeli, P; Durand, F; Pavesi, M; Gerbes, A; Jalan, R; Moreau, R; Ginés, P; Bernardi, M; Arroyo, V; CANONIC Study Investigators of the EASL-CLIF Consortium Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.
Hepatology. 2015; 62(1):243-252 Doi: 10.1002/hep.27849 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Krones, E; Fickert, P; Zitta, S; Neunherz, S; Artinger, K; Reibnegger, G; Durchschein, F; Wagner, D; Stojakovic, T; Stadlbauer, V; Fauler, G; Stauber, R; Zollner, G; Kniepeiss, D; Rosenkranz, AR The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis.
BMC Nephrol. 2015; 16(4):196-196 Doi: 10.1186/s12882-015-0188-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mangge, H; Baumgartner, BG; Zelzer, S; Prüller, F; Schnedl, WJ; Reininghaus, EZ; Haybaeck, J; Lackner, C; Stauber, R; Aigner, E; Weghuber, D Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages.
Aliment Pharmacol Ther. 2015; 42(1):99-105 Doi: 10.1111/apt.13232 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pilz, S; Putz-Bankuti, C; Meinitzer, A; März, W; Kienreich, K; Stojakovic, T; Pieber, TR; Stauber, RE Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease.
Amino Acids. 2015; 47(9):1817-1826 Doi: 10.1007/s00726-015-2000-7
Web of Science PubMed FullText FullText_MUG

 

** Stättermayer, AF; Traussnigg, S; Dienes, HP; Aigner, E; Stauber, R; Lackner, K; Hofer, H; Stift, J; Wrba, F; Stadlmayr, A; Datz, C; Strasser, M; Maieron, A; Trauner, M; Ferenci, P Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutations.
J Hepatol. 2015; 63(1):156-163 Doi: 10.1016/j.jhep.2015.01.034
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Beinhardt, S; Al Zoairy, R; Freissmuth, C; Kozbial, K; Hametner, S; Stern, R; Stauber, RE; Maieron, A; Staufer, K; Strasser, MP; Zoller, HM; Graziadei, I; Vogel, W; Peck-Radosavljevic, M; Trauner, M; Ferenci, P; Hofer, H Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria
HEPATOLOGY. . 2015; 62: 746A-747A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

** Beinhardt, S; Freissmuth, C; Al-Zoairy, R; Kozbial, K; Hametner, S; Stern, R; Stauber, R; Maieron, A; Staufer, K; Strasser, M; Zoller, H; Graziadei, I; Vogel, W; Peck-Radosavljevic, M; Trauner, M; Ferenci, P; Hofer, H EFFICACY AND SAFETY OF IFN-FREE ANTIVIRAL THERAPY IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION: REAL-LIFE EXPERIENCE FROM AUSTRIA
J HEPATOL. 2015; 62: S282-S283.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)30192-6 [Poster]
Web of Science FullText FullText_MUG

 

** Beinhardt, S; Kozbial, K; Schmidt, A; Freissmuth, C; Mandorfer, M; Strassl, R; al Zoairy, R; Stauber, R; Strasser, M; Sunder-Plassmann, G; Trauner, M; Peck-Radosavljevic, M; Vogel, W; Hofer, H; Ferenci, P REAL LIFE EXPERIENCE WITH INTERFERON/RIBAVIRIN-FREE ANTIVIRAL TREATMENT IN RENAL TRANSPLANT RECIPIENTS AND ENDSTAGE RENAL DISEASE-PATIENTS ON DIALYSIS INFECTED WITH HEPATITIS C VIRUS
J HEPATOL. 2015; 62: S667-S667.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31073-4 [Poster]
Web of Science FullText FullText_MUG

 

** Beinhardt, S; Mandorfer, M; Payer, BA; Stattermayer, AF; Datz, C; Maieron, A; Huber, F; Dulic-Lakovic, E; Stauber, R; Fischer, G; Gschwantler, M; Ferenci, P; Hofer, H USEFULNESS OF INTERFERON LAMBDA4-, HLA CLASS II-POLYMORPHISM AND KILLER-IMMUNGLOBULIN-LIKE RECEPTOR-2DL3:C1/C1 TO PREDICT SPONTANEOUS CLEARANCE OF ACUTE HEPATITIS C VIRUS INFECTION
J HEPATOL. 2015; 62: S602-S603.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)30943-0 [Poster]
Web of Science FullText FullText_MUG

 

** Binder, L; Rainer, F; Haybaeck, J; Xu, S; Spindelboeck, W; Wee, A; Stauber, R; Lackner, C MORPHOMETRICAL QUANTIFICATION OF FIBROSIS CORRELATES WITH CLINICAL CIRRHOSIS STAGE AND PREDICTS LONG-TERM SURVIVAL IN PATIENTS WITH ALCOHOLIC CIRRHOSIS
J HEPATOL. 2015; 62: S758-S758.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31286-1 [Poster]
Web of Science FullText FullText_MUG

 

** Horvath, A; Leber, B; Krones, E; Zollner, G; Durchschein, F; Spindelboeck, W; Lemesch, S; Douschan, P; Fauler, G; Stojakovic, T; Fickert, P; Stauber, R; Stiegler, P; Stadlbauer, V SERUM BILE ACIDS IN CIRRHOSIS DEPEND ON AETIOLOGY.
J HEPATOL. 2015; 62(S2):S344-S344.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)30336-6 [Poster]
Web of Science FullText FullText_MUG

 

** Horvath, A; Leber, B; Schmerboeck, B; Tawdrous, M; Hartl, A; Lemesch, S; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Spindelboeck, W; Oettl, K; Payerl, D; Stadlbauer, V Probiotic supplementation improves liver function but fails to restore neutrophil phagocytosis in stable cirrhosis. A randomized, double-blind, placebo-controlled study
HEPATOLOGY. . 2015; 62: 1216A-1216A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

** Kerbert, AJ; Schaapman, J; van der Reijden, J; Alex, A; McCormick, A; van Hoek, B; Arroyo, V; Gines, P; Jalan, R; Vargas, V; Stauber, RE; Verspaget, HW; Coenraad, M Impact of genetic variation of the AVP1a receptor on the presence of circulatory failure in patients with acute decompensation of liver cirrhosis or acute-on-chronic liver failure
HEPATOLOGY. . 2015; 62: 1217A-1217A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

** Kozbial, K; Freissmuth, C; Strassl, R; Al-Zoairy, R; Maieron, A; Stauber, R; Gschwantler, M; Strasser, M; Laferl, H; Bamberger, T; Moser, S; Eder, M; Beinhardt, S; Staettermayer, AF; Mandorfer, M; Ferlitsch, A; Zoller, H; Knoflach, P; Staufer, K; Peck-Radosavljevic, M; Munda, P; Vogel, W; Ferenci, P; Hofer, H VIRAL KINETICS DURING INTERFERON-FREE SOFOSBUVIR CONTAINING TREATMENT REGIMENS IN A REAL-LIFE COHORT OF CHRONIC HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE
J HEPATOL. 2015; 62: S625-S625.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)30986-7 [Poster]
Web of Science FullText FullText_MUG

 

** Lackner, C; Binder, L; Rainer, F; Stauber, RE MORPHOMETRICAL QUANTIFICATION OF FIBROSIS CORRELATES WITH CLINICAL CIRRHOSIS STAGE AND PREDICTS LONG-TERM SURVIVAL IN PATIENTS WITH ALCOHOLIC LIVER DISEASE
ALCOHOL ALCOHOLISM. 2015; 50: -ESBRA 2015 meeting; SEP 12-15, 2015; Valencia, Spanien. [Oral Communication]
Web of Science

 

** Stauber, R; Stadlbauer, V; Spindelboeck, W; Rainer, F; Posch, A; Streit, A; Jakoby, E; Kniepeiss, D; Muller, H INTERFERON-FREE ANTI-HCV THERAPY AFTER ORGAN TRANSPLANTATION
TRANSPL INT. 2015; 28: 11-11. [Oral Communication]
Web of Science

 

** Staufer, K; Stauber, R; Theek, C; von Darl, M; Traussnigg, S; Kienbacher, C; Lackner, C; Steindl-Munda, P; Schulz-Knappe, P; Trauner, M MINIMALLY INVASIVE DIAGNOSIS OF NAFLD AND DISCRIMINATION BETWEEN NAFL AND NASH BY AUTOANTIBODY SIGNATURES
J HEPATOL. 2015; 62: S746-S746.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31258-7 [Poster]
Web of Science FullText FullText_MUG

 

** Stern, R; Kozbial, K; Freissmuth, C; Hametner, S; Al Zoairy, R; Moser, S; Karpi, A; Laferl, H; Stauber, RE; Zoller, HM; Maieron, A; Vogel, W; Graziadei, I; Gschwantler, M; Hofer, H; Ferenci, P Safety and Efficacy of Interferon/Ribavirin-Free Therapy in Septuagenerians and Octogenerians with Chronic Hepatitis C
HEPATOLOGY. . 2015; 62: 1128A-1129A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

2014

Full paper/article (Journal)

** Baranyi, A; Meinitzer, A; Putz-Bankuti, C; Stauber, R; Kapfhammer, HP; Rothenhäusler, HB Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.
Psychosom Med. 2014; 76(3):197-207 Doi: 10.1097/PSY.0000000000000042
Web of Science PubMed FullText FullText_MUG

 

** Beinhardt, S; Leiss, W; Stättermayer, AF; Graziadei, I; Zoller, H; Stauber, R; Maieron, A; Datz, C; Steindl-Munda, P; Hofer, H; Vogel, W; Trauner, M; Ferenci, P Long-term outcomes of patients with Wilson disease in a large Austrian cohort.
Clin Gastroenterol Hepatol. 2014; 12(4):683-689 Doi: 10.1016/j.cgh.2013.09.025
Web of Science PubMed FullText FullText_MUG

 

** Jalan, R; Saliba, F; Pavesi, M; Amoros, A; Moreau, R; Ginès, P; Levesque, E; Durand, F; Angeli, P; Caraceni, P; Hopf, C; Alessandria, C; Rodriguez, E; Solis-Muñoz, P; Laleman, W; Trebicka, J; Zeuzem, S; Gustot, T; Mookerjee, R; Elkrief, L; Soriano, G; Cordoba, J; Morando, F; Gerbes, A; Agarwal, B; Samuel, D; Bernardi, M; Arroyo, V; CANONIC study investigators of the EASL-CLIF Consortium Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.
J Hepatol. 2014; 61(5): 1038-1047. Doi: 10.1016/j.jhep.2014.06.012 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Razavi, H; Waked, I; Sarrazin, C; Myers, RP; Idilman, R; Calinas, F; Vogel, W; Mendes Correa, MC; Hézode, C; Lázaro, P; Akarca, U; Aleman, S; Balık, I; Berg, T; Bihl, F; Bilodeau, M; Blasco, AJ; Brandão Mello, CE; Bruggmann, P; Buti, M; Calleja, JL; Cheinquer, H; Christensen, PB; Clausen, M; Coelho, HS; Cramp, ME; Dore, GJ; Doss, W; Duberg, AS; El-Sayed, MH; Ergör, G; Esmat, G; Falconer, K; Félix, J; Ferraz, ML; Ferreira, PR; Frankova, S; García-Samaniego, J; Gerstoft, J; Giria, JA; Gonçales, FL; Gower, E; Gschwantler, M; Guimarães Pessôa, M; Hindman, SJ; Hofer, H; Husa, P; Kåberg, M; Kaita, KD; Kautz, A; Kaymakoglu, S; Krajden, M; Krarup, H; Laleman, W; Lavanchy, D; Marinho, RT; Marotta, P; Mauss, S; Moreno, C; Murphy, K; Negro, F; Nemecek, V; Örmeci, N; Øvrehus, AL; Parkes, J; Pasini, K; Peltekian, KM; Ramji, A; Reis, N; Roberts, SK; Rosenberg, WM; Roudot-Thoraval, F; Ryder, SD; Sarmento-Castro, R; Semela, D; Sherman, M; Shiha, GE; Sievert, W; Sperl, J; Stärkel, P; Stauber, RE; Thompson, AJ; Urbanek, P; Van Damme, P; van Thiel, I; Van Vlierberghe, H; Vandijck, D; Wedemeyer, H; Weis, N; Wiegand, J; Yosry, A; Zekry, A; Cornberg, M; Müllhaupt, B; Estes, C The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.
J Viral Hepat. 2014; 21 Suppl 1(41):34-59 Doi: 10.1111/jvh.12248 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stättermayer, AF; Strassl, R; Maieron, A; Rutter, K; Stauber, R; Strasser, M; Beinhardt, S; Datz, C; Scherzer, TM; Steindl-Munda, P; Gschwantler, M; Trauner, M; Hofer, H; Ferenci, P Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
Aliment Pharmacol Ther. 2014; 39(1):104-111 Doi: 10.1111/apt.12547 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stauber, RE; Spindelboeck, W; Haas, J; Putz-Bankuti, C; Stadlbauer, V; Lackner, C; Oettl, K Human nonmercaptalbumin-2: a novel prognostic marker in chronic liver failure.
Ther Apher Dial. 2014; 18(1):74-78 Doi: 10.1111/1744-9987.12024
Web of Science PubMed FullText FullText_MUG

 

** Wedemeyer, H; Duberg, AS; Buti, M; Rosenberg, WM; Frankova, S; Esmat, G; Örmeci, N; Van Vlierberghe, H; Gschwantler, M; Akarca, U; Aleman, S; Balık, I; Berg, T; Bihl, F; Bilodeau, M; Blasco, AJ; Brandão Mello, CE; Bruggmann, P; Calinas, F; Calleja, JL; Cheinquer, H; Christensen, PB; Clausen, M; Coelho, HS; Cornberg, M; Cramp, ME; Dore, GJ; Doss, W; El-Sayed, MH; Ergör, G; Estes, C; Falconer, K; Félix, J; Ferraz, ML; Ferreira, PR; García-Samaniego, J; Gerstoft, J; Giria, JA; Gonçales, FL; Guimarães Pessôa, M; Hézode, C; Hindman, SJ; Hofer, H; Husa, P; Idilman, R; Kåberg, M; Kaita, KD; Kautz, A; Kaymakoglu, S; Krajden, M; Krarup, H; Laleman, W; Lavanchy, D; Lázaro, P; Marinho, RT; Marotta, P; Mauss, S; Mendes Correa, MC; Moreno, C; Müllhaupt, B; Myers, RP; Nemecek, V; Øvrehus, AL; Parkes, J; Peltekian, KM; Ramji, A; Razavi, H; Reis, N; Roberts, SK; Roudot-Thoraval, F; Ryder, SD; Sarmento-Castro, R; Sarrazin, C; Semela, D; Sherman, M; Shiha, GE; Sperl, J; Stärkel, P; Stauber, RE; Thompson, AJ; Urbanek, P; Van Damme, P; van Thiel, I; Vandijck, D; Vogel, W; Waked, I; Weis, N; Wiegand, J; Yosry, A; Zekry, A; Negro, F; Sievert, W; Gower, E Strategies to manage hepatitis C virus (HCV) disease burden.
J Viral Hepat. 2014; 21 Suppl 1(41):60-89 Doi: 10.1111/jvh.12249 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Bruggmann, P; Berg, T; Øvrehus, AL; Moreno, C; Brandão Mello, CE; Roudot-Thoraval, F; Marinho, RT; Sherman, M; Ryder, SD; Sperl, J; Akarca, U; Balık, I; Bihl, F; Bilodeau, M; Blasco, AJ; Buti, M; Calinas, F; Calleja, JL; Cheinquer, H; Christensen, PB; Clausen, M; Coelho, HS; Cornberg, M; Cramp, ME; Dore, GJ; Doss, W; Duberg, AS; El-Sayed, MH; Ergör, G; Esmat, G; Estes, C; Falconer, K; Félix, J; Ferraz, ML; Ferreira, PR; Frankova, S; García-Samaniego, J; Gerstoft, J; Giria, JA; Gonçales, FL; Gower, E; Gschwantler, M; Guimarães Pessôa, M; Hézode, C; Hofer, H; Husa, P; Idilman, R; Kåberg, M; Kaita, KD; Kautz, A; Kaymakoglu, S; Krajden, M; Krarup, H; Laleman, W; Lavanchy, D; Lázaro, P; Marotta, P; Mauss, S; Mendes Correa, MC; Müllhaupt, B; Myers, RP; Negro, F; Nemecek, V; Örmeci, N; Parkes, J; Peltekian, KM; Ramji, A; Razavi, H; Reis, N; Roberts, SK; Rosenberg, WM; Sarmento-Castro, R; Sarrazin, C; Semela, D; Shiha, GE; Sievert, W; Stärkel, P; Stauber, RE; Thompson, AJ; Urbanek, P; van Thiel, I; Van Vlierberghe, H; Vandijck, D; Vogel, W; Waked, I; Wedemeyer, H; Weis, N; Wiegand, J; Yosry, A; Zekry, A; Van Damme, P; Aleman, S; Hindman, SJ Historical epidemiology of hepatitis C virus (HCV) in selected countries.
J Viral Hepat. 2014; 21 Suppl 1(41):5-33 Doi: 10.1111/jvh.12247 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Douschan, P; Kovacs, G; Foris, V; Stauber, R; Olschewski, A; Olschewski, H Performance on cardiopulmonary exercise testing in patients with compensated liver cirrhosis
WIEN KLIN WOCHENSCHR. 2014; 126(19-20):684-684.-ÖGP Jahrestagung; Salzburg, Austria. [Poster]
Web of Science

 

** Ganten, TM; Stauber, R; Schott, E; Malfertheiner, P; Buder, R; Galle, PR; Gohler, T; Bernard, I; Gerken, G Final analysis of overall survival per subgroups of HCC patients in the prospective, non-interventional INSIGHT study treated with sorafenib
ONCOL RES TREAT. 2014; 37: 123-123. [Poster]
Web of Science

 

** Horvath, A; Leber, B; Lemesch, S; Suppan, O; Yuksel, O; Sherzay, K; Zettel, G; Tawdrous, M; Spindelboeck, W; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Fickert, P; Stauber, R; Stiegler, P; Stadlbauer, V LISTING FOR LIVER TRANSPLANT: NO IMPACT ON THE QUALITY OF LIFE
TRANSPL INT. 2014; 27: 20-21. [Poster]
Web of Science

 

** Kozbial, K; Strassl, RP; Al Zoairy, R; Maieron, A; Stauber, RE; Strasser, MP; Laferl, H; Bamberger, T; Staettermayer, A; Zoller, HM; Knoflach, P; Staufer, K; Peck-Radosavljevic, M; Steindl-Munda, PE; Vogel, W; Ferenci, P; Hofer, H Early Viral Kinetics during Interferon-free Sofosbuvir containing Treatment Regimen in a Real-life Cohort of Chronic Hepatitis C Patients
HEPATOLOGY. 2014; 60: 701A-702A.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA. [Poster]
Web of Science

 

** Nelson, DR; Reddy, KR; Di Bisceglie, AM; Ferenci, P; Crawford, DH; Stauber, RE; Yakovlev, AA; de Ledinghen, V; Hinrichsen, H; Bernstein, DE; de Knegt, RJ; Hassanein, T; Norris, S; Xiong, JYJ; McGovern, BH; Agarwal, K ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients with History of Depression or Bipolar Disorder: Pooled Analysis of Efficacy and Safety in Phase 3 Trials
HEPATOLOGY. 2014; 60: 1159A-1160A.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA. [Poster]
Web of Science

 

** Stattermayer, A; Zoller, HM; Weiss, KH; Szalay, F; Bruha, R; Houwen, R; Stauber, RE; Steindl-Munda, PE; Hofer, H; Stremmel, W; Ferenci, P Patients with Wilson disease without detectable ATP7B mutations
HEPATOLOGY. 2014; 60: 428A-428A.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA. [Poster]
Web of Science

 

** Stauber, R; Stadlbauer, V; Spindelboeck, W; Posch, A; Streit, A; Kniepeiss, D; Iberer, F FIRST EXPERIENCES WITH SOFOSBUVIR-BASED INTERFERON FREE TREATMENT OF HCV-INFECTION BEFORE OR AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2014; 27: 15-15. [Oral Communication]
Web of Science

 

2013

Full paper/article (Journal)

** Baranyi, A; Meinitzer, A; Stepan, A; Putz-Bankuti, C; Breitenecker, RJ; Stauber, R; Kapfhammer, HP; Rothenhäusler, HB A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection.
Psychother Psychosom. 2013; 82(5):332-340 Doi: 10.1159/000348587
Web of Science PubMed FullText FullText_MUG

 

** Beinhardt, S; Payer, BA; Datz, C; Strasser, M; Maieron, A; Dorn, L; Grilnberger-Franz, E; Dulic-Lakovic, E; Stauber, R; Laferl, H; Aberle, JH; Holzmann, H; Krall, C; Vogel, W; Ferenci, P; Hofer, H A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection.
J Hepatol. 2013; 59(5):972-977 Doi: 10.1016/j.jhep.2013.06.028
Web of Science PubMed FullText FullText_MUG

 

** El-Heliebi, A; Kroneis, T; Zöhrer, E; Haybaeck, J; Fischereder, K; Kampel-Kettner, K; Zigeuner, R; Pock, H; Riedl, R; Stauber, R; Geigl, JB; Huppertz, B; Sedlmayr, P; Lackner, C Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?
J Transl Med. 2013; 11(10):214-214 Doi: 10.1186/1479-5876-11-214 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Jahn, S; Zollner, G; Lackner, C; Stauber, RE Severe toxic hepatitis associated with dronedarone.
Curr Drug Saf. 2013; 8(3):201-202 Doi: 10.2174/15748863113089990031 (- Case Report)
PubMed FullText FullText_MUG

 

** Leitner, E; Kessler, HH; Spindelboeck, W; Hoenigl, M; Putz-Bankuti, C; Stadlbauer-Köllner, V; Krause, R; Grisold, AJ; Feierl, G; Stauber, RE Comparison of two molecular assays with conventional blood culture for diagnosis of sepsis.
J Microbiol Methods. 2013; 92(3):253-255 Doi: 10.1016/j.mimet.2012.12.012
Web of Science PubMed FullText FullText_MUG

 

** Moreau, R; Jalan, R; Gines, P; Pavesi, M; Angeli, P; Cordoba, J; Durand, F; Gustot, T; Saliba, F; Domenicali, M; Gerbes, A; Wendon, J; Alessandria, C; Laleman, W; Zeuzem, S; Trebicka, J; Bernardi, M; Arroyo, V; CANONIC Study Investigators of the EASL–CLIF Consortium Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
Gastroenterology. 2013; 144(7): 1437.e1- 1437.e9 Doi: 10.1053/j.gastro.2013.02.042
Web of Science PubMed FullText FullText_MUG

 

** Oettl, K; Birner-Gruenberger, R; Spindelboeck, W; Stueger, HP; Dorn, L; Stadlbauer, V; Putz-Bankuti, C; Krisper, P; Graziadei, I; Vogel, W; Lackner, C; Stauber, RE Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival.
J Hepatol. 2013; 59(5):978-983 Doi: 10.1016/j.jhep.2013.06.013
Web of Science PubMed FullText FullText_MUG

 

** Peck-Radosavljevic, M; Angermayr, B; Datz, C; Ferlitsch, A; Ferlitsch, M; Fuhrmann, V; Häfner, M; Kramer, L; Maieron, A; Payer, B; Reiberger, T; Stauber, R; Steininger, R; Trauner, M; Thurnher, S; Ulbrich, G; Vogel, W; Zoller, H; Graziadei, I; Austrian Society of Gastroenterology and Hepatology Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).
Wien Klin Wochenschr. 2013; 125(7-8):200-219 Doi: 10.1007/s00508-013-0337-z
Web of Science PubMed FullText FullText_MUG

 

** Putz-Bankuti, C; Kessler, HH; Valentin, T; Leitner, E; Talakic, E; Schoellnast, H; Fickert, P; Krejs, GJ; Stauber, RE Pleuro-Pulmonary Nocardiosis as Opportunistic Infection in a Patient with Chronic Hepatitis C under Combination Treatment with Pegylated Interferon, Ribavirin, and Boceprevir.
Case Reports Hepatol. 2013; 2013:529041 Doi: 10.1155/2013/529041 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Scherzer, TM; Stättermayer, AF; Stauber, R; Maieron, A; Strasser, M; Laferl, H; Schwarzer, R; Datz, C; Rutter, K; Beinhardt, S; Steindl-Munda, P; Hofer, H; Ferenci, P Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients.
J Hepatol. 2013; 59(5):964-971 Doi: 10.1016/j.jhep.2013.06.030
Web of Science PubMed FullText FullText_MUG

 

** Weiss, KH; Thurik, F; Gotthardt, DN; Schäfer, M; Teufel, U; Wiegand, F; Merle, U; Ferenci-Foerster, D; Maieron, A; Stauber, R; Zoller, H; Schmidt, HH; Reuner, U; Hefter, H; Trocello, JM; Houwen, RH; Ferenci, P; Stremmel, W; EUROWILSON Consortium Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Clin Gastroenterol Hepatol. 2013; 11(8):1028-35.e1-1028-35.e2 Doi: 10.1016/j.cgh.2013.03.012
Web of Science PubMed FullText FullText_MUG

 

** Wolf, P; Gruber-Wackernagel, A; Rinner, B; Griesbacher, A; Eberhard, K; Groselj-Strele, A; Mayer, G; Stauber, RE; Byrne, SN Phototherapeutic hardening modulates systemic cytokine levels in patients with polymorphic light eruption.
Photochem Photobiol Sci. 2013; 12(1):166-173 Doi: 10.1039/c2pp25187f
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** A, Horvath; B, Leber; S, Lemesch; P, Stiegler; R, Stauber; P, Fickert; G, Zollner; W, Spindelboeck; E, Krones; F, Durchschein; P, Douschan; V, Stadlbauer INCREASED GUT PERMEABILITY, ELEVATED ENDOTOXIN RELATED PROTEINS AND NEUTROPHIL DYSFUNCTION IN LIVER CIRRHOSIS.
Journal of Hepatology. 2013; 58(S1):S104--48th Annual meeting of the European Association for the Study of the Liver ; 24 April 2013 - 28 April 2013; Amsterdam. Doi: 10.1016/S0168-8278(13)60246-9 [Poster]
Web of Science FullText FullText_MUG

 

** Baranyi, A; Meinitzer, A; Stepan, A; Putz-Bankuti, C; Stauber, R; Kapfhammer, HP; Rothenhausler, HB A BIOPSYCHOSOCIAL MODEL OF INTERFERON-alpha-INDUCED DEPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
EUR PSYCHIAT. 2013; 28: [Poster]
Web of Science

 

** Beinhardt, S; Payer, BA; Datz, C; Strasser, M; Maieron, A; Dorn, L; Huber, F; Dulic-Lakovic, E; Stauber, R; Laferl, H; Aberle, JH; Holzmann, H; Krall, C; Vogel, W; Ferenci, P; Hofer, H A DIAGNOSTIC SCORE FOR THE PREDICTION OF SPONTANEOUS RESOLUTION OF ACUTE HEPATITIS C VIRUS INFECTION
J HEPATOL. . 2013; 58: S181-S181.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

** Beinhardt, S; Payer, BA; Datz, C; Strasser, M; Maieron, A; Dorn, L; Huber, F; Dulic-Lakovic, E; Stauber, R; Laferl, H; Aberle, JH; Holzmann, H; Vogel, W; Fischer, G; Ferenci, P; Hofer, H KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DL3 AND ITS HLA-C LIGANDS DO NOT PREDICT SPONTANEOUS RESOLUTION IN PATIENTS WITH ACUTE HEPATITIS C
J HEPATOL. . 2013; 58: S181-S182.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

** Koschny, R; Schott, E; Galle, PR; Gohler, T; Malfertheiner, P; Stauber, R; Buder, R; Bernard, I; Gerken, G Overall survival of specific HCC patient subgroups in prospective, non-interventional INSIGHT study treated with sorafenib
EUR J CANCER. 2013; 49: S623-S623.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

** Lackner, C; Spindelboeck, W; Haybaeck, J; Terracciano, L; Matejka, J; Douschan, P; Stauber, R A CLINICAL-BIOCHEMICAL-HISTOLOGICAL (CBH) MODEL IMPROVES LONG-TERM MORTALITY PREDICTION IN MALE AND FEMALE PATIENTS WITH ALCOHOLIC LIVER DISEASE
J HEPATOL. . 2013; 58: S220-S220.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)60540-1 [Poster]
Web of Science FullText FullText_MUG

 

** Lackner, C; Spindelboeck, W; Haybaeck, J; Terracciano, L; Matejka, J; Douschan, P; Stauber, R; IS THERE A ROLE FOR HISTOLOGY IN THE PREDICTION OF LONG-TERMMORTALITY IN ALD?.
ALCOHOL ALCOHOLISM. . 2013; 48: 9-9. [Poster]
Web of Science

 

** Leber, B; Tripolt, N; Lemesch, S; Horvath, A; Stojakovic, T; Fauler, G; Stauber, R; Fickert, P; Sourij, H; Stadlbauer, V INCREASED GUT PERMEABILITY IN METABOLIC SYNDROME IS NOT ASSOCIATED WITH CHANGES IN BILE ACID PROFILE.
J HEPATOL. 2013; 58(S1):S549-S550.-48th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 24-28, 2013; Amsterdam, THE NETHERLANDS. Doi: 10.1016/S0168-8278(13)61366-5 [Poster]
Web of Science FullText FullText_MUG

 

** Nguyen-Tat, M; Ganten, TM; Schott, E; Gohler, T; Malfertheiner, P; Stauber, R; Buder, R; Bernard, I; Gerken, G Overall survival of specific HCC patients subgroups in prospective, non-interventional INSIGHT study treated with sorafenib
ONKOLOGIE. 2013; 36: 121-122. [Poster]
Web of Science

 

** Pavesi, M; Jalan, R; Amoros, A; Moreau, R; Gines, P; Durand, F; Angeli, P; Caraceni, P; Rodriguez, E; Agarwarl, B; Hopf, C; Alessandria, C; Solis-Munoz, P; Laleman, W; Trebicka, J; Saliba, F; Zeuzem, S; Albillos, A; Gustot, T; Mookerjee, R; Elkrief, L; Benten, D; Montero, JL; Catalina, MV; Concepcion, M; Cordoba, J; McCormick, A; Stauber, R; Vogel, W; De Gottardi, A; Peck-Radosavljevic, M; van Vlierberghe, H; Sperl, J; Groenbaek, H; Mortensen, C; Coenraad, MJ; Morando, F; Domenicali, M; Gerbes, A; Risso, A; Garcia, E; Deulofeu, C; Bernardi, M; Arroyo, V THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF)
J HEPATOL. . 2013; 58: S568-S569.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)61413-0 [Poster]
Web of Science FullText FullText_MUG

 

** Rutter, K; Ferlitsch, A; Maieron, A; Stattermayer, AF; Graziadei, I; Dulic, M; Gschwantler, M; Stauber, R; Hofer, H; Peck-Radosavljevic, M; Vogel, W; Trauner, M; Ferenci, P SAFETY OF TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR IN HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE - PREDICTIVE FACTORS FOR SEPSIS
J HEPATOL. . 2013; 58: S30-S30.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)60067-7 [Poster]
Web of Science FullText FullText_MUG

 

** Scherzer, TM; Laferl, H; Maieron, A; Schwarzer, R; Strasser, M; Stauber, R; Datz, C; Staettermayer, AF; Beinhardt, S; Rutter, K; Trattner, H; Hofer, H; Munda, P; Ferenci, P INFLUENCE OF GENDER, AGE AND ITPA POLYMORPHISM (rs6051702, rs1127354, rs7270101) ON THROMBOCYTOPENIA IN HCV GENOTYPE 1 AND 4 PATIENTS ON ANTIVIRAL THERAPY
J HEPATOL. . 2013; 58: S370-S370.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)60901-0 [Poster]
Web of Science FullText FullText_MUG

 

** Stauber, RE; Spindelboeck, W; Putz-Bankuti, C; Pock, H; Stojakovic, T; Obermayer-Pietsch, B ENHANCED LIVER FIBROSIS (ELF) SCORE IS RELATED TO LIVER DYSFUNCTION AND PREDICTS MORTALITY IN CIRRHOSIS.
J HEPATOL. 2013; 58(S1):S297-S297.-48th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 24-28, 2013; Amsterdam, THE NETHERLANDS. Doi: 10.1016/S0168-8278(13)60734-5 [Poster]
Web of Science FullText FullText_MUG

 

2012

Full paper/article (Journal)

** Baranyi, A; Meinitzer, A; Stepan, A; Matejka, J; Stauber, R; Kapfhammer, HP; Rothenhäusler, HB Interferon α therapy in patients with chronic hepatitis C infection: biopsychosocial consequences].
Nervenarzt. 2012; 83(9):1169-1177 Doi: 10.1007/s00115-011-3302-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Beinhardt, S; Aberle, JH; Strasser, M; Dulic-Lakovic, E; Maieron, A; Kreil, A; Rutter, K; Staettermayer, AF; Datz, C; Scherzer, TM; Strassl, R; Bischof, M; Stauber, R; Bodlaj, G; Laferl, H; Holzmann, H; Steindl-Munda, P; Ferenci, P; Hofer, H Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.
Gastroenterology. 2012; 142(1):78-85 Doi: 10.1053/j.gastro.2011.09.039
Web of Science PubMed FullText FullText_MUG

 

** Krones, E; Stauber, R; Vieth, M; Langner, C Hypertrophic gastric folds caused by metastatic prostate adenocarcinoma.
Endoscopy. 2012; 44 Suppl 2 UCTN(3):E47-E48 Doi: 10.1055/s-0031-1291524 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Leber, B; Tripolt, NJ; Blattl, D; Eder, M; Wascher, TC; Pieber, TR; Stauber, R; Sourij, H; Oettl, K; Stadlbauer, V The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study.
Eur J Clin Nutr. 2012; 66(10):1110-1115 Doi: 10.1038/ejcn.2012.103 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Peck-Radosavljevic, M; Sieghart, W; Kölblinger, C; Reiter, M; Schindl, M; Ulbrich, G; Steininger, R; Müller, C; Stauber, R; Schöniger-Hekele, M; Gschwendtner, M; Plank, C; Funovics, M; Graziadei, I; Lammer, J; Gruenberger, T; Gastl, G; Karnel, F; Austrian Association of Gastroenterology,Hepatology (GGH); Austrian Society of Interventional Radiology (GIR); Austrian Society of Hematology and Oncology (GHO); Austrian Society for Surgical Oncology (ASSO) Austrian Joint GGH-GIR-GHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma.
Wien Klin Wochenschr. 2012; 124(3-4):104-110 Doi: 10.1007/s00508-011-0056-2
Web of Science PubMed FullText FullText_MUG

 

** Pinter, M; Hucke, F; Graziadei, I; Vogel, W; Maieron, A; Königsberg, R; Stauber, R; Grünberger, B; Müller, C; Kölblinger, C; Peck-Radosavljevic, M; Sieghart, W Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
Radiology. 2012; 263(2):590-599 Doi: 10.1148/radiol.12111550 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Putz-Bankuti, C; Kessler, HH; Schilcher, G; Schneditz, D; Konrad, PM; Rosenkranz, AR; Stauber, RE Increase of HCV RNA concentration during hemodialysis treatment in patients with chronic hepatitis C.
J Clin Virol. 2012; 54(2):110-114 Doi: 10.1016/j.jcv.2012.02.009
Web of Science PubMed FullText FullText_MUG

 

** Putz-Bankuti, C; Pilz, S; Stojakovic, T; Scharnagl, H; Pieber, TR; Trauner, M; Obermayer-Pietsch, B; Stauber, RE Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease.
Liver Int. 2012; 32(5):845-851 Doi: 10.1111/j.1478-3231.2011.02735.x
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Peck-Radosavljevic, M; Stauber, RE; BCLC - now also an internationally acclaimed prognostic system?.
Liver Int. 2012; 32(7):1037-1038 Doi: 10.1111/j.1478-3231.2012.02840.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Beinhardt, S; Leiss, W; Graziadei, I; Stauber, RE; Maieron, A; Datz, C; Vogel, W; Ferenci, P Long-term outcome of a large patient cohort with Wilson disease in Austria
HEPATOLOGY. 2012; 56: 827A-827A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

 

** Beinhardt, S; Payer, BA; Datz, C; Strasser, MP; Maieron, A; Dorn, L; Huber, F; Dulic-Lakovic, E; Stauber, RE; Laferl, H; Aberle, JH; Holzmann, H; Krall, C; Vogel, W; Ferenci, P; Hofer, H A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection
HEPATOLOGY. 2012; 56: 677A-678A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

 

** Ganten, T; Schott, E; Galle, P; Gohler, T; Malfertheiner, P; Stauber, R; Buder, R; Achilles, K; Gerken, G; INTERIM ANALYSIS OF OVERALL SURVIVAL PER SUBGROUPS IN THE PROSPECTIVE, NON-INTERVENTIONAL INSIGHT STUDY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB.
ANN ONCOL. 2012; 23: 255-256.-37th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 28-OCT 02, 2012; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Jalan, R; Moreau, R; Gines, P; Pavesi, M; Angeli, P; Caraceni, P; Hopf, C; Alessandria, C; Solis-Munoz, P; Laleman, W; Trebicka, J; Saliba, F; Zeuzem, S; Albillos, A; Gustot, T; Baenas, MY; Elkrief, L; Benten, D; Montero, JL; Catalina, MV; Concepcion, M; Cordoba, J; McCormick, A; Stauber, RE; Vogel, W; De Gottardi, A; Peck-Radosavljevic, M; van Vlierberghe, H; Frankova, S; Karlsen, S; Mortensen, CO; Coenraad, M; Morando, F; Gerbes, AL; Risso, A; Garcia, E; Deulofeu, C; Bernardi, M; Arroyo, V Acute-on Chronic Liver Failure (ACLF): A distinct clinical syndrome
HEPATOLOGY. 2012; 56: 249A-249A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Oral Communication]
Web of Science

 

** Malfertheiner, P; Ganten, TM; Schott, E; Galle, PR; Gohler, T; Stauber, R; Buder, R; Achilles, K; Gerken, G; Interim analysis of overall survival per subgroups in the prospective, non-interventional INSIGHT study in patients with hepatocellular carcinoma treated with Sorafenib.
ONKOLOGIE. 2012; 35: 162-162. [Poster]
Web of Science

 

** Moreau, R; Gines, P; Jalan, R; Pavesi, M; Durand, F; Angeli, P; Caraceni, P; Pereira, G; Hopf, C; Alessandria, C; Solis, P; Laleman, W; Trebicka, J; Saliba, F; Zeuzem, S; Albillos, A; Gustot, T; Yago, M; Elkrief, L; Benten, D; Montero, JL; Chiva, T; Concepcion, M; Cordoba, J; McCormick, A; Stauber, RE; Vogel, W; De Gottardi, A; Morando, F; Domenicali, M; Gerbes, AL; Risso, A; Garcia, E; Deulofeu, C; Bernardi, M; Arroyo, V DIAGNOSIS, PREVALENCE, AND PROGNOSIS OF ACUTE-ON-CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE EASL-CHRONIC LIVER FAILURE (CLIF) CONSORTIUM CANONIC STUDY
J HEPATOL. 2012; 56: S552-S553.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(12)61415-9 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Scherzer, TM; Laferl, H; Maieron, A; Schwarzer, R; Strasser, MP; Stauber, RE; Datz, C; Stattermayer, A; Beinhardt, S; Rutter, K; Steindl-Munda, PE; Hofer, H; Ferenci, P Effect of gender and ITPA polymorphism (rs6051702) on anemia in chronic HCV genotype 1 and 4 patients treated with peg-interferon alpha 2a and ribavirin
HEPATOLOGY. 2012; 56: 1027A-1027A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

 

** Stauber, RE; Spindelböck, W; Putz-Bankuti, C; Pock, H; Stojakovic, T; Obermayer-Pietsch, B The ELF test – a new prognostic marker in cirrhosis.
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):571-572.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 20-22, 2012; Graz, AUSTRIA. [Poster]
Web of Science

 

** Stauber, RE; Spindelboeck, W; Birner-Gruenberger, R; Putz-Bankuti, C; Stadlbauer, V; Lackner, C; Oettl, K Human nonmercaptalbumin-2 (HNA2): a novel prognostic marker in chronic liver failure
HEPATOLOGY. 2012; 56: 975A-975A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

 

2011

Full paper/article (Journal)

** Mookerjee, RP; Lackner, C; Stauber, R; Stadlbauer, V; Deheragoda, M; Aigelsreiter, A; Jalan, R The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis.
J Hepatol. 2011; 55(5):1103-1111 Doi: 10.1016/j.jhep.2011.02.021
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Pinter, M; Sieghart, W; Hucke, F; Graziadei, I; Vogel, W; Maieron, A; Königsberg, R; Weissmann, A; Kornek, G; Matejka, J; Stauber, R; Buder, R; Grünberger, B; Schöniger-Hekele, M; Müller, C; Peck-Radosavljevic, M Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib.
Aliment Pharmacol Ther. 2011; 34(8): 949-959. Doi: 10.1111/j.1365-2036.2011.04823.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scherzer, TM; Stättermayer, AF; Strasser, M; Laferl, H; Maieron, A; Stauber, R; Datz, C; Dulic-Lakovic, E; Steindl-Munda, P; Hofer, H; Ferenci, P Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin.
HEPATOLOGY. 2011; 54(5): 1518-1526. Doi: 10.1002/hep.24546 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stättermayer, AF; Stauber, R; Hofer, H; Rutter, K; Beinhardt, S; Scherzer, TM; Zinober, K; Datz, C; Maieron, A; Dulic-Lakovic, E; Kessler, HH; Steindl-Munda, P; Strasser, M; Krall, C; Ferenci, P Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C.
Clin Gastroenterol Hepatol. 2011; 9(4): 344-350. Doi: 10.1016/j.cgh.2010.07.019
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Amrein, K; Ribitsch, W; Otto, R; Worm, HC; Stauber, RE Severe lactic acidosis reversed by thiamine within 24 hours.
Crit Care. 2011; 15(6):457-457 Doi: 10.1186/cc10495 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Review

** Krisper, P; Stadlbauer, V; Stauber, RE Clearing of toxic substances: are there differences between the available liver support devices?
Liver Int. 2011; 31 Suppl 3: 5-8. Doi: 10.1111/j.1478-3231.2011.02588.x
PubMed FullText FullText_MUG

 

Abstract (Journal)

** Ganten, TM; Schott, E; Gohler, T; Wiest, R; Malfertheiner, P; Stauber, R; Buder, R; Achilles, K; Gerken, G First interim results from a non-interventional study in hepatocellular carcinoma patients treated with sorafenib - the INSIGHT study
ONKOLOGIE. 2011; 34: 215-215. [Oral Communication]
Web of Science

 

** Gruber-Wackernagel, A; Rinner, B; Griesbacher, A; Groselj-Strele A; Hofer, A; Legat, FJ; Stauber, R; Byrne, SN; Wolf, P Phototherapeutic hardening modulates systemic baseline cytokine levels in PLE patients
Journal of Investigative Dermatology. 2011; 131(2):S105-S105.-41st Annual ESDR Meeting; SEP 7-9; 2011; Barcelona, Spain. [Poster]
Web of Science

 

** Pinter, M; Hucke, F; Graziadei, I; Maieron, A; Konigsberg, R; Stauber, RE; Gruenberger, B; Muller, C; Koelblinger, C; Peck-Radosavljevic, M; Sieghart, W TRANSARTERIAL (CHEMO-)EMBOLIZATION VERSUS SORAFENIB IN PATIENTS WITH ADVANCED STAGE HEPATOCELLULAR CARCINOMA
HEPATOLOGY. 2011; 54: 1388A-1388A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA. [Poster]
Web of Science

 

** Scherzer, TM; Stauber, R; Staettermayer, AF; Zinober, K; Maieron, A; Strasser, M; Laferl, H; Rutter, K; Beinhardt, S; Datz, C; Steindl-Munda, P; Hofer, H; Ferenci, P EFFECTS OF SNP RS6051702 POLYMORPHISM ON ANEMIA AND TREATMENT OUTCOME IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS
J HEPATOL. 2011; 54: S192-S193.-46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); 2011; Berlin, GERMANY. Doi: 10.1016/S0168-8278(11)60473-X [Poster]
Web of Science FullText FullText_MUG

 

** Sieghart, W; Pinter, M; Graziadei, I; Hucke, F; Rasoul-Rockenschaub, S; Stauber, R; Wagner, D; Vogel, W; Peck-Radosavljevic, M OUTCOME OF PATIENTS WITH CHILD-PUGH C LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION
J HEPATOL. 2011; 54: S265-S265.-46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); 2011; Berlin, GERMANY. Doi: 10.1016/S0168-8278(11)60658-2 [Poster]
Web of Science FullText FullText_MUG

 

** Stauber, RE; Scherzer, T; Putz-Bankuti, C; Matejka, J; Spindelboeck, W; Zinober, K; Bernhardt, S; Wehr, E; Stojakovic, T; Kessler, HH; Ferenci, P; Obermayer-Pietsch, B BASELINE VITAMIN D LEVELS DO NOT INFLUENCE SVR IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 OR 4 INFECTION UNDERGOING PEGINTERFERON/RIBAVIRIN TREATMENT.
J HEPATOL. 2011; 54: S468-S469.-46th Annual Meeting of the European Association for the Study of the Liver (EASL); MAR 30-APR 3, 2011; Berlin, GERMANY. Doi: 10.1016/S0168-8278(11)61188-4 [Poster]
Web of Science FullText FullText_MUG

 

** Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Pock, H; Stauber, RE Alpha-fetoprotein and des-gamma-carboxy prothrombin as serum markers for hepatocellular carcinoma.
Clin Chem Lab Med 2011; 49: S275-S275.-IFCC WorldLab and EuroMedLab; MAY 15-19, 2011; Berlin, GERMANY. [Poster]
Web of Science

 

** Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Pock, H; Stauber, RE EVALUATION OF FOUR DIFFERENT TUMOR MARKERS FOR HEPATOCELLULAR CARCINOMA
J HEPATOL. 2011; 54: S401-S401. [Poster]
Web of Science

 

** Weiss, KH; Schots, M; Gotthardt, DN; Ferenci-Foerster, D; Maieron, A; Stauber, R; Reuner, U; Houwen, RHJ; Stremmel, W; Ferenci, P EFFICACY AND SAFETY OF D-PENICILLAMINE AND TRIENTINE FOR THE TREATMENT OF WILSON DISEASE
J HEPATOL. 2011; 54: S1-S1. Doi: 10.1016/S0168-8278(11)00096-1 [Oral Communication]
Web of Science FullText FullText_MUG

 

2010

Full paper/article (Journal)

** Ferenci, P; Laferl, H; Scherzer, TM; Maieron, A; Hofer, H; Stauber, R; Gschwantler, M; Brunner, H; Wenisch, C; Bischof, M; Strasser, M; Datz, C; Vogel, W; Löschenberger, K; Steindl-Munda, P; Austrian Hepatitis Study Group Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response.
Gastroenterology. 2010; 138(2): 503-512. Doi: 10.1053/j.gastro.2009.10.058
Web of Science PubMed FullText FullText_MUG

 

** Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Scheidl, S; Hesse, C; Troester, N; Salmhofer, W; Stauber, R; Fürst, F; Thonhofer, R; Ofner-Kopeinig, P; Gruenig, E; Olschewski, H Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization.
Chest. 2010; 138(2):270-278 Doi: 10.1378/chest.09-2099 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krisper, P; Tiran, B; Fliser, D; Haditsch, B; Stadlbauer, V; Otto, R; Ernst, T; Kretschmer, U; Stauber, RE; Haller, H; Holzer, H; Manns, MP; Rifai, K Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with prometheus.
Artif Organs. 2010; 34(1): 84-88. Doi: 10.1111/j.1525-1594.2009.00793.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Peck-Radosavljevic, M; Deutsch, J; Ferenci, P; Graziadei, I; Hofer, H; Holzmann, H; Huber, WD; Laferl, H; Maieron, A; Stauber, R; Vogel, W 4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009.
Wien Klin Wochenschr. 2010; 122(9-10):280-302 Doi: 10.1007/s00508-009-1298-0
Web of Science PubMed FullText FullText_MUG

 

** Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
Atherosclerosis. 2010; 209(1): 178-183. Doi: 10.1016/j.atherosclerosis.2009.08.052
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Review

** Stauber, RE; Olschewski, H Portopulmonary hypertension: short review
EUR J GASTROENTEROL HEPATOL. 2010; 22(4): 385-390. Doi: 10.1097/MEG.0b013e3283337130
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Putz-Bankuti, C; Stojakovic, T; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, R Reduction of serum leptin levels during antiviral treatment with peginterferon and ribavirin in patients with chronic hepatitis C
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A10-A10.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 29-OCT 2; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Scherzer, TM; Stattermayer, A; Kessler, HH; Gschwantler, M; Strasser, MP; Laferl, H; Maieron, A; Stauber, RE; Datz, C; Rutter, K; Beinhardt, S; Steindl-Munda, PE; Hofer, H; Ferenci, P IMPACT OF IL28B POLYMORPHISM ON TREATMENT DURATION IN HCV GENOTYPE 1 AND 4 PATIENTS
HEPATOLOGY. 2010; 52(4): 923
Web of Science

 

** Scherzer, TM; Stauber, RE; Maieron, A; Laferl, H; Gschwantler, M; Beinhardt, S; Rutter, K; Stattermayer, A; Steindl-Munda, PE; Hofer, H; Ferenci, P UNDETECTABLE HCV RNA AFTER SILIBININ IV TREATMENT IS ASSOCIATED WITH HIGH ON TREATMENT RESPONSE RATES IN HCV NULLRESPONDERS
HEPATOLOGY. 2010; 52(4):835- [Poster]
Web of Science

 

** Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; Marz, W; Wascher, TC; Trauner, M LOW-DOSE ATORVASTATIN IMPROVES DYSLIPIDEMIA AND VASCULAR FUNCTION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AFTER ONE YEAR OF TREATMENT.
J HEPATOL. 2010; 52: S431-S432.-45th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 14-18, 2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)61118-X [Poster]
Web of Science FullText FullText_MUG

 

** Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE EFFECTS OF ANTIVIRAL TREATMENT ON SERUM LEPTIN LEVELS AND LIPID PROFILE IN PATIENTS WITH CHRONIC HEPATITIS C
ATHEROSCLER SUPPL. 2010; 11(2): MS456-78th Congress of the European Atherosclerosis Society; JUN 20-23, 2010; Hamburg, GERMANY. Doi: 10.1016/S1567-5688(10)70957-0
Web of Science FullText FullText_MUG

 

Comment

** Møller, S; Stauber, RE Does local sympathetic atrophy contribute to splanchnic vasodilation in portal hypertension?
Liver Int. 2010; 30(4): 499-501. Doi: 10.1111/j.1478-3231.2010.02206.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Full paper/article (Journal)

** Heinemann, A; Schuligoi, R; Lippe, IT; Stauber, RE Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
Pharmacology. 2009; 83(1): 26-32. Doi: 10.1159/000167877
Web of Science PubMed FullText FullText_MUG

 

** Klade, CS; Kubitschke, A; Stauber, RE; Meyer, MF; Zinke, S; Wiegand, J; Zauner, W; Aslan, N; Lehmann, M; Cornberg, M; Manns, MP; Reisner, P; Wedemeyer, H Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.
Vaccine. 2009; 27(23): 3099-3108. Doi: 10.1016/j.vaccine.2009.02.088
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Oettl, K; Stadlbauer, V; Krisper, P; Stauber, RE Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure.
Ther Apher Dial. 2009; 13(5): 431-436. Doi: 10.1111/j.1744-9987.2009.00762.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Rothenhäusler, HB; Scherr, M; Putz-Bankuti, C; Kapper, A; Stepan, A; Baranyi, A; Haas-Krammer, A; Haas, B; Stauber, R The relationship between emotional distress, cognitive performance and health - related quality of life in patients with hepatitis C prior to antiviral treatment.
Fortschr Neurol Psychiatr. 2009; 77(8): 457-463. Doi: 10.1055/s-0028-1109574
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stauber, RE; Wagner, D; Stadlbauer, V; Palma, S; Gurakuqi, G; Kniepeiss, D; Iberer, F; Smolle, KH; Haas, J; Trauner, M Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
Liver Int. 2009; 29(10):1516-1520 Doi: 10.1111/j.1478-3231.2009.02104.x
Web of Science PubMed FullText FullText_MUG

 

** Wedemeyer, H; Schuller, E; Schlaphoff, V; Stauber, RE; Wiegand, J; Schiefke, I; Firbas, C; Jilma, B; Thursz, M; Zeuzem, S; Hofmann, WP; Hinrichsen, H; Tauber, E; Manns, MP; Klade, CS Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
Vaccine. 2009; 27(37): 5142-5151. Doi: 10.1016/j.vaccine.2009.06.027
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Gries, A; Putz-Bankuti, C; Stauber, RE; Haditsch, B; Stojakovic, T Beta2-glycoprotein-I plasma levels in liver cirrhosis.
Clin Chim Acta. 2009; 403(1-2): 257-258. Doi: 10.1016/j.cca.2009.03.001
Web of Science PubMed FullText FullText_MUG

 

Review

** Raggam, RB; Rossmann, AM; Salzer, HJ; Stauber, RE; Kessler, HH Health care worker-to-patient transmission of hepatitis C virus in the health care setting: Many questions and few answers.
J Clin Virol. 2009; 45(4): 272-275. Doi: 10.1016/j.jcv.2009.04.015
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Maieron, A; Metz-Gercek, S; Scherzer, TM; Laferl, H; Fischer, G; Bischof, M; Steindl-Munda, PE; Stauber, RE; Ziachehabi, A; Hofer, H; Gschwantler, M; Vogel, W; Ferenci, P SHORTENING OF TREATMENT DURATION IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 2 AND 3-IMPACT OF RIBAVIRIN DOSE - RESULTS OF A RANDOMIZED MULTICENTRE TRIAL
HEPATOLOGY. 2009; 50(4):1578- [Poster]
Web of Science

 

** Oettl, K; Brtnik, M; Payerl, D; Stadlbauer, V; Stauber, RE Oxidative modification and high levels of bilirubin impair binding properties of albumin in Advanced Liver Disease
FREE RADICAL RES. 2009; 43: 43-43.-SFRR-Europe Meeting 2009; AUG 26-29, 2009; Rome, ITALY. [Oral Communication]
Web of Science

 

** Rybczynski, M; Leber, B; Smolle, KH; Stauber, R; Stadlbauer, V Innate immune dysfunction in sepsis and acute-on-chronic liver failure
WIEN KLIN WOCHENSCHR. 2009; 121(1-2):A9-A9.-Wiener Intensivmedizinische Tage; FEB 11-14, 2009; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

** Scherzer, TM; Beinhardt, S; Rutter, K; Stattermayer, A; Maieron, A; Stauber, R; Gschwantler, M; Steindl-Munda, P; Hofer, H; Ferenci, P Silibinin as the treatment of chronic hepatitis C with peginterferon/ribavirin non-responders - The search for optimal therapy schemes
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A25-A26. [Poster]
Web of Science

 

** Scherzer, TM; Beinhardt, S; Rutter, K; Stattermayer, A; Maieron, A; Stauber, RE; Gschwantler, M; Kerschner, H; Steindl-Munda, PE; Hofer, H; Ferenci, P SILIBININ FOR TREATMENT OF NONRESPONDERS TO PEGINTERFERON/RIBAVIRIN - SEARCH FOR THE OPTIMAL DOSING SCHEDULE
HEPATOLOGY. 2009; 50(4):847- [Poster]
Web of Science

 

** Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, M; Wagner, M; Sourij, H; Stauber, RE; Marz, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A26-A26.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

2008

Full paper/article (Journal)

** Dahaba, AA; Worm, HC; Zhu, SM; Bao, FP; Salah, A; Zakaria, S; Bornemann, H; Stadlbauer, V; Rehak, PH; Metzler, H; Stauber, RE Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy: a multicentre, observer blinded, validation study.
Gut. 2008; 57(1): 77-83. Doi: 10.1136/gut.2007.129130 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ferenci, P; Brunner, H; Laferl, H; Scherzer, TM; Maieron, A; Strasser, M; Fischer, G; Hofer, H; Bischof, M; Stauber, R; Gschwantler, M; Steindl-Munda, P; Staufer, K; Löschenberger, K; Austrian Hepatitis Study Group A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.
Hepatology. 2008; 47(6): 1816-1823. Doi: 10.1002/hep.22262 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ferenci, P; Laferl, H; Scherzer, TM; Gschwantler, M; Maieron, A; Brunner, H; Stauber, R; Bischof, M; Bauer, B; Datz, C; Löschenberger, K; Formann, E; Staufer, K; Steindl-Munda, P; Austrian Hepatitis Study Group Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response.
Gastroenterology. 2008; 135(2):451-458 Doi: 10.1053/j.gastro.2008.04.015
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gurakuqi, GC; Stadlbauer, V; Portugaller, HR; Högenauer, C; Trauner, M; Stauber, RE Fatal hemobilia resulting from an iatrogenic arteriobiliary fistula as a rare complication of transjugular liver biopsy.
Eur J Gastroenterol Hepatol. 2008; 20(1):83-86 Doi: 10.1097/MEG.0b013e3282748f32 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Oettl, K; Stadlbauer, V; Petter, F; Greilberger, J; Putz-Bankuti, C; Hallström, S; Lackner, C; Stauber, RE Oxidative damage of albumin in advanced liver disease.
Biochim Biophys Acta. 2008; 1782(7-8):469-473 Doi: 10.1016/j.bbadis.2008.04.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Raggam, RB; Wagner, J; Michelin, BD; Putz-Bankuti, C; Lackner, A; Bozic, M; Stauber, RE; Santner, BI; Marth, E; Kessler, HH Reliable detection and quantitation of viral nucleic acids in oral fluid: Liquid phase-based sample collection in conjunction with automated and standardized molecular assays.
J Med Virol. 2008; 80(9): 1684-1688. Doi: 10.1002/jmv.21245
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schneditz, D; Bachler, I; Stadlbauer, V; Stauber, RE Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements.
Int J Clin Pract. 2008; 62(12): 1851-1857. Doi: 10.1111/j.1742-1241.2007.01517.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Stadlbauer, V; Weiss, S; Payer, F; Stauber, RE Herbal does not at all mean innocuous: the sixth case of hepatotoxicity associated with morinda citrifolia (noni).
Am J Gastroenterol. 2008; 103(9): 2406-2407. Doi: 10.1111/j.1572-0241.2008.02010_8.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Review

** Stauber, RE; Kessler, HH Drugs in development for hepatitis C.
Drugs. 2008; 68(10): 1347-1359. Doi: 10.2165/00003495-200868100-00002
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Duller, D; Haas, J; Stadlbauer, V; Kniepeiss, D; Palma, S; Gurakuqi, G; Gallent, HR; Iberer, E; Stauber, RE The LB model: A new prognostic tool for prediction of short term survival in patients with end stage liver disease
J HEPATOL. 2008; 48: S81-S81.-EASL - Meeting of the European Society for Liver Disease; APR 23-26; Milan, ITALY. Doi: 10.1016/S0168-8278(08)60194-4 [Poster]
Web of Science FullText FullText_MUG

 

** Duller, D; Haas J., Stadlbauer V., Palma St., Gallent H., Kniepeiss D., Smolle KH., Stauber RE The LB Model: a New Prognostic Tool for Prediction of Short Term Survival in Patients with End-Stage Liver Disease
Liver Transplantation Supplement of the Meeting of the International Society of Liver Transplantation2008; 14(S1):S201-S202.-ILTS – Meeting of the international liver transplant society 2008; JUL 12-14; Paris, France. [Poster]
Web of Science

 

** Ferenci, P; Laferl, H; Scherzer, TM; Gschwantler, M; Maieron, A; Brunner, H; Stauber, RE; Bischol, M; Bauer, B; Datz, C; Loschenberger, K; Formann, E; Hofer, H; Steindl-Munda, PE RESPONSE-GUIDED THERAPY WITH PEGINTERFERON ALFA-2A (40KD) PLUS RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 OR 4: PROSPECTIVE RANDOMIZED STUDY OF EXTENDED THERAPY IN PATIENTS WITHOUT A RAPID VIROLOGICAL RESPONSE
HEPATOLOGY. 2008; 48(4):116--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA. [Oral Communication]
Web of Science

 

** Madl, C; Kitzberger, R; Warszawska, J; Holzinger, U; Hammer, J; Stauber, R; Firlinger, F; Lenz, K Effect of intravenous esomeprazole versus ranitidine on gastric pH in critically ill patients - a prospective, randomized, double-blind, multicenter study
WIEN KLIN WOCHENSCHR. 2008; 120(1-2):A8-A8.-WIT 2008; FEB 6-9, 2008; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Brodmann, M; Aberer, E; Gruenig, E; Olschewski, H Stress Doppler echocardiography for screening of patients at risk for pulmonary arterial hypertension.
CIRCULATION. 2008; 118(12):E294-E294.- World Congress of Cardiology; MAY 18-21, 2008; Buenos Aires, ARGENTINA. [Poster]
Web of Science

 

** Stange, J; Goetze, A; Klammt, S; Strube, S; Gruenert, J; Stauber, R; Emmerich, J; Mitzner, S; Koball, S; Hickstein, H; Liebe, S; Schmidt, RH BED SIDE REDUCTION OF INDUSTRIAL CONSERVATIVE AND VASODILATOR CAPRYLATE FROM ALBUMIN MAY IMPROVE ITS THERAPEUTIC EFFECT ON COMPLICATIONS OF PORTAL HYPERTENSION-A CONTROLLED STUDY
HEPATOLOGY. 2008; 48(4):1697--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA. [Poster]
Web of Science

 

2007

Full paper/article (Journal)

** Domej, W; Mitterhammer, H; Stauber, R; Kaufmann, P; Smolle, KH Successful outcome after intravenous gasoline injection.
J Med Toxicol. 2007; 3(4): 173-177. Doi: 10.1007/BF03160935 (- Case Report) [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Stadlbauer, V; Krisper, P; Beuers, U; Haditsch, B; Schneditz, D; Jung, A; Putz-Bankuti, C; Holzer, H; Trauner, M; Stauber, RE Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.
ASAIO J. 2007; 53(2): 187-193. Doi: 10.1097/01.mat.0000249852.71634.6c [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stadlbauer, V; Tauss, J; Portugaller, HR; Stiegler, P; Iberer, F; Stauber, RE Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction.
Metab Brain Dis. 2007; 22(1): 45-50. Doi: 10.1007/s11011-006-9032-3 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Stadlbauer, V; Gurakuqi, G; Stauber, RE; März, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid.
Hepatology. 2007; 46(3):776-784 Doi: 10.1002/hep.21741 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Review

** Krisper, P; Stauber, RE Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS?
NAT CLIN PRACT NEPHROL. 2007; 3(5): 267-276. Doi: 10.1038/ncpneph0466
Web of Science PubMed FullText FullText_MUG

 

** Oettl, K; Stauber, RE Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.
Br J Pharmacol. 2007; 151(5): 580-590. Doi: 10.1038/sj.bjp.0707251 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stauber, RE; Lackner, C Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.
World J Gastroenterol. 2007; 13(32): 4287-4294. Doi: 10.3748/wjg.v13.i32.4287 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Ferenci, P; Laferl, H; Scherzer, TM; Brunner, H; Maieron, A; Gschwantler, M; Stauber, RE; Hubmann, R; Staufer, K; Datz, C; Bischof, M; Hofer, H; Loschenberger, K; Steindl-Munda, PE Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin treatment in patients with genotypes 1 or 4
HEPATOLOGY. 2007; 46(4):814A-815A. [Poster]
Web of Science

 

** Haditsch, B; Krisper, P; Stauber, R; Mekaroonkamol, P; Holzer, H; Schneditz, D Measurement of indocyanine green concentration and elimination in the extracorporeal circulation during hemodialysis and extracorpotreal liver support therapy.
NEPHROL DIALYSIS TRANSPLANT. 2007; 22: 122-122.-XLIV ERA-EDTA Congress; JUN 21-24, 2007; Barcelona, SPAIN. [Poster]
Web of Science

 

** Madl, C; Kitzberger, Z; Warszawska, J; Holzinger, U; Hammer, J; Stauber, R; Firlinger, F; Lenz, K Effect of intravenous esomeprazole versus ranitidine on gastric pH in critically ill patients - A prospective, randomized, double-blind, multicenter study
CRIT CARE MED. 2007; 35(12):A11-A11. [Poster]
Web of Science

 

** Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Fruhwald, F; Aberer, E; Gruenig, E; Olschewski, H Screening of patients at risk for pulmonary arterial hypertension: role of exercise stress echocardiography.
Eur Heart J 2007; 28(Supp):183-183.-Congress of the European Society of Cardiology; SEP 1-5, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Vogel, W; Brunner, H; Maieron, A; Graziadei, I; Rosenbeiger, M; Jilek, K; Stauber, RE; Wolkersdorfer, D Peginterferon alfa-2b and ribavirin treatment of patients with chronic hepatitis C and normal versus elevated aminotransferase levels final results of a prospective open trial
HEPATOLOGY. 2007; 46(4):385A-385A. [Poster]
Web of Science

 

** Wedemeyer, H; Tauber, E; Schuller, E; Wiegand, J; Schiefke, I; Hofmann, WP; Zeuzem, S; Hinrichsen, H; Thursz, MR; Jilma, B; Stauber, RE; Manns, MP; Klade, CS Differential pattern of HCV-specific T cell responses distinguishes SVR and relapse patients receiving standard antiviral therapy plus therapeutic IC41 vaccination
HEPATOLOGY. 2007; 46(4):851A-851A. [Poster]
Web of Science

 

2006

Full paper/article (Journal)

** Donnerer, J; Grahovac, M; Stelzl, E; Kessler, HH; Bankuti, C; Stadlbauer, V; Stauber, RE Ribavirin levels and haemoglobin decline in early virological responders and non-responders to hepatitis C virus combination therapy.
PHARMACOLOGY. 2006; 76(3): 136-140. Doi: 10.1159/000090942
Web of Science PubMed FullText FullText_MUG

 

** Ferenci, P; Formann, E; Laferl, H; Gschwantler, M; Hackl, F; Brunner, H; Hubmann, R; Datz, C; Stauber, R; Steindl-Munda, P; Kessler, HH; Klingler, A; Gangl, A; Austrian Hepatitis Study Group Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection.
J HEPATOL. 2006; 44(2): 275-282. Doi: 10.1016/j.jhep.2005.09.015
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Jung, A; Krisper, P; Haditsch, B; Stauber, RE; Trauner, M; Holzer, H; Schneditz, D Bilirubin kinetic modeling for quantification of extracorporeal liver support.
Blood Purif. 2006; 24(4):413-422 Doi: 10.1159/000094575
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Putz-Bankuti, C; Datz, C; März, W; Lackner, C; Stauber, RE; Trauner, M; Toplak, H; Stojakovic, T; Krejs, GJ Clinical-pathological conference series from the Medical University of Graz : case no. 131: elevated transaminases in a 30-year-old male.
Wien Klin Wochenschr. 2006; 118(23-24):769-775 Doi: 10.1007/s00508-006-0718-7 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stadlbauer, V; Krisper, P; Aigner, R; Haditsch, B; Jung, A; Lackner, C; Stauber, RE Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure.
Crit Care. 2006; 10(6):R169-R169 Doi: 10.1186/cc5119 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Review

** Stauber, RE; Stadlbauer, V Novel approaches for therapy of chronic hepatitis C.
J CLIN VIROL. 2006; 36(2): 87-94. Doi: 10.1016/j.jcv.2006.02.003
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Ferenci, P; Brunner, H; Laferl, H; Bergholz, U; Rosenbeiger, M; Stauber, R; Maieron, A; Fischer, G; Bischof, M; Steindl-Munda, P Further reduction of ribavirin dose in HCV genotype 2/3 patients receiving peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)): Interim results of a randomised controlled trial
J HEPATOL. 44: S37-S37.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80083-8 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Ferenci, P; Scherzer, T; Laferl, H; Staufer, K; Maieron, A; Gschwantler, M; Brunner, H; Hubmann, R; Datz, C; Bischof, M; Stauber, R; Kessler, H; Steindl-Munda, P High SVR rate, with 24 weeks of peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 patients with a week-4 virological response
J CLIN VIROL. 36: S50-S50. Doi: 10.1016/S1386-6532(06)80153-8 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Ferenci, R; Bergholz, U; Laferl, H; Scherzer, TM; Maieron, A; Gschwantler, M; Brunner, H; Hubmann, RR; Datz, C; Bischof, M; Stauber, R; Steindl-Munda, R 24 week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 'superresponders'
J HEPATOL. 44: S6-S6.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

** Graziadei, IW; Nilica, B; Stadlbauer, V; Stauber, R; Trauner, M; Mueller, C; Vogel, W Imatinib treatment for patients with advanced stage hepatocellular carcinoma: A multicenter phase II trial
HEPATOLOGY. 2006; 44(4):503A-504A. [Poster]
Web of Science

 

** Oettl, K; Greilberger, J; Stadlbauer, V; Petter, F; Lackner, C; Putz-Bankuti, C; Stauber, R Redox state of serum albumin and carbonyl content of plasma proteins in advanced liver disease
FREE RADICAL RES. 40: S151-S151.-13 th Biennal Congress, Society for Free Radical Research-International; AUG 15-19, 2006; Davos, Switzerland. [Poster]
Web of Science

 

** Oettl, K; Stadlbauer, V; Petter, F; Greilberger, J; Putz-Bankuti, C; Lackner, K; Stauber, R Redox state of human serum albumin in liver disease
FEBS Journal. 273(1):164-164.-31 st FEBS Congress, Molecules in Health and Disease; JUN 24-29, 2006; Istanbul, Turkey. [Poster]
Web of Science

 

** Stauber, RE; Oettl, K; Stadlbauer, V; Greilberger, J; Krisper, P; Lackner, C Redox state of albumin and carbonyl content of proteins are altered in acute-on-chronic liver failure
HEPATOLOGY. 44(4):364A-365A.-57th Annual meeting of the AASLD; OCT 27-31, 2006; Boston, USA. [Poster]
Web of Science

 

** Stauber, RE; Stadlbauer, V; Struber, G; Kaufmann, P Evaluation of four prognostic scores in patients with acute-on-chronic liver failure
J HEPATOL. 44: S69-S70.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80166-2 [Poster]
Web of Science FullText FullText_MUG

 

** Vogel, W; Brunner, H; Rosenbeiger, M; Graziadei, I; Maieron, A; Jilek, K; Stauber, R; Wolkersdorfer, D; Ulmer, H Treatment comparison of patients with chronic hepatitis C and elevated ALT vs patients with persistently normal ALT - Preliminary results of a prospective open trial
J HEPATOL. 44: S228-S228.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80615-X [Poster]
Web of Science FullText FullText_MUG

 

** Vogel, W; Brunner, H; Rosenbeiger, M; Graziadei, IW; Maieron, A; Jilek, K; Stauber, R Treatment comparison of chronic hepatitis C patients with normal and elevated transaminses: Viral load is predictive of ETR - Preliminary results of a prospective trial
GASTROENTEROLOGY. 2006; 130(4):A843-A843. [Poster]
Web of Science

 

Comment

** Lackner, C; Struber, G; Bankuti, C; Bauer, B; Stauber, RE Noninvasive diagnosis of cirrhosis in chronic hepatitis C based on standard laboratory tests.
Hepatology. 2006; 43(2):378-379 Doi: 10.1002/hep.21037 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Full paper/article (Journal)

** Ferenci, P; Steindl-Munda, P; Vogel, W; Jessner, W; Gschwantler, M; Stauber, R; Datz, C; Hackl, F; Wrba, F; Bauer, P; Lorenz, O Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease.
CLIN GASTROENTEROL HEPATOL. 2005; 3(8): 811-818. Doi: 10.1053/S1542-3565(05)00181-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Fritz, E; Hammer, HF; Lipp, RW; Högenauer, C; Stauber, R; Hammer, J Effects of lactulose and polyethylene glycol on colonic transit.
ALIMENT PHARMACOL THERAPEUT. 2005; 21(3): 259-268. Doi: 10.1111/j.1365-2036.2005.02244.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krisper, P; Haditsch, B; Stauber, R; Jung, A; Stadlbauer, V; Trauner, M; Holzer, H; Schneditz, D In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation.
J Hepatol. 2005; 43(3):451-457 Doi: 10.1016/j.jhep.2005.02.038
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Lackner, C; Struber, G; Liegl, B; Leibl, S; Ofner, P; Bankuti, C; Bauer, B; Stauber, RE Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Hepatology. 2005; 41(6):1376-1382 Doi: 10.1002/hep.20717 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schneditz, D; Mekaroonkamol, P; Haditsch, B; Stauber, R Measurement of indocyanine green dye concentration in the extracorporeal circulation.
ASAIO J. 2005; 51(4): 376-378. Doi: 10.1097/01.mat.0000169030.37228.82 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stadlbauer, V; Fickert, P; Lackner, C; Schmerlaib, J; Krisper, P; Trauner, M; Stauber, RE Hepatotoxicity of NONI juice: report of two cases.
World J Gastroenterol. 2005; 11(30):4758-4760 Doi: 10.3748/wjg.v11.i30.4758 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Ferenci, P; Bergholz, U; Laferl, H; Gurguta, C; Maieron, A; Gschwantler, M; Brunner, H; Hubmann, R; Datz, C; Bischof, M; Stauber, R; Steindl-Munda, P Is shorter treatment with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) possible in HCV genotype 1 'super-responders'? preliminary results of a prospective randomized clinical trial
HEPATOLOGY 2005 42: -.
Web of Science

 

** Ferenci, P; Brunner, H; Laferl, H; Czizek, U; Rosenbeiger, M; Stauber, R; Maieron, A; Fischer, G; Steindl-Munda, P Interim analysis of a randomized, controlled study comparing the efficacy of 40KD peg-interferon alfa2a in combination with 800mg or 400 mg ribavirin/day in chronic hepatitis C, genotype 2/3
GASTROENTEROLOGY. 2005; 128(4): A684-A684.
Web of Science

 

** Krisper, P; Stadlbauer, V; Haditsch, B; Holzer, H; Trauner, M; Stauber, RE; Schneditz, D The bilirubin/albumin ratio does not influence the clearance of conjugated bilirubin in extracorporeal liver support (ELS)
NEPHROL DIALYSIS TRANSPLANT. 2005; 20: V117-V117.-42nd Annual Meeting of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA); JUN 04-07, 2005; Istanbul, TURKEY.
Web of Science

 

2004

Full paper/article (Journal)

** Formann, E; Stauber, R; Denk, DM; Jessner, W; Zollner, G; Munda-Steindl, P; Gangl, A; Ferenci, P Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin.
AMER J GASTROENTEROL. 2004; 99(5): 873-877. Doi: 10.1111/j.1572-0241.2004.30372.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stadlbauer, V; Schaffellner, S; Kniepeiss, D; Jakoby, E; Stauber, R; Iberer, F; Tscheliessnigg, KH Experiences in liver transplantation for hepatocellular carcinoma.
Transplant Proc. 2004; 36(1):195-198 Doi: 10.1016/j.transproceed.2003.11.009
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stauber, RE; Hofer, H; Hackl, F; Schütze, K; Datz, C; Hegenbarth, K; Jessner, W; Steindl-Munda, P; Peter, F; Austrian Hepatitis Study Group Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine.
WIEN KLIN WOCHENSCHR. 2004; 116(15-16): 530-535. Doi: 10.1007/BF03217706
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Stauber, RE; Krisper, P; Zollner, G; Iberer, F; Beuers, U; Trauner, M Extracorporeal albumin dialysis in a patient with primary sclerosing cholangitis: effect on pruritus and bile acid profile.
Int J Artif Organs. 2004; 27(4):342-344 Doi: 10.1177/039139880402700411 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Ferenci, P; Formann, E; Gschwantler, M; Laferl, H; Brunner, H; Hackl, F; Hubmann, R; Stauber, R; Gangl, A Prospective evaluation of the 24 hour interferon (IFN) induced decline in hepatitis C virus genotype 1 load to predict sustained virologic response (SVR) to peginterferon-alfa2a/ribavirin combination therapy with or without amantadine
J HEPATOL 2004 40: 141-141. Doi: 10.1016/S0168-8278(04)90476-X
Web of Science FullText FullText_MUG

 

** Ferenci, P; Formann, E; Laferl, H; Gschwantler, M; Hackl, F; Brunner, H; Datz, C; Stauber, R; Munda, P; Gangl, A Randomized, controlled, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) (Pegasys (R)) plus ribavirin (Copegus (R)) and amantadine (AMA) or placebo in patients with chronic hepatitis C genotype 1 infection.
HEPATOLOGY 2004 40: 396A-396A.
Web of Science

 

** Klade, CS; Otava, O; Vytvytska, O; Zauner, W; Buschle, M; Stauber, R; Wedemeyer, H A comprehensive analysis of the T-cell response against conserved regions of HCV genotypes 1, 2 and 3
HEPATOLOGY 2004 40: 695A-695A.
Web of Science

 

** Krisper, P; Stauber, R; Haditsch, B; Trauner, M; Holzer, H; Schneditz, D Mars versus prometheus: Comparison of reduction ratios (RR) as a measure of treatment dose in two different liver detoxification devices
J HEPATOL. 2004; 40: 69-70.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90216-4
Web of Science FullText FullText_MUG

 

** Krisper, P; Stauber, R; Haditsch, B; Trauner, M; Holzer, H; Schneditz, D MARS versus Prometheus: Comparison of clearances as a measure of efficiency in two different liver detoxification devices
GASTROENTEROLOGY. 2004; 126: A706 -A706 .
Web of Science

 

** Vogel, W; Brunner, H; Lin, W; Stauber, R; Gschwantler, M; Stadler, B; Ulmer, H Two-weeks induction therapy with pegylated interferon decreases early viral load without improving sustained virological response rate in patients with chronic hepatitis C - Prospective, randomized, open label phase III clinical trial
GASTROENTEROLOGY. 2004; 126(4): A694-A694.
Web of Science

 

2003

Full paper/article (Journal)

** Jessner, W; Stauber, R; Hackl, F; Datz, C; Watkins-Riedel, T; Hofer, H; Gangl, A; Kessler, H; Ferenci, P Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection.
J Viral Hepat. 2003; 10(1):37-42 Doi: 10.1046%2Fj.1365-2893.2003.00396.x
Web of Science PubMed FullText FullText_MUG

 

** Kessler, HH; Stelzl, E; Marth, E; Stauber, RE Detection of mutations in the hepatitis B virus polymerase gene.
Clin Chem. 2003; 49(6 Pt 1):989-992 Doi: 10.1373%2F49.6.989 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Steindl-Munda, P; Ferenci, P; Brunner, H; Nachbaur, K; Datz, C; Gschwantler, M; Hofer, H; Stauber, R; Hackl, F; Jessner, W; Rosenbeiger, M; Gangl, A; Vogel, W; Austrian Hepatitis Study Group Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.
Liver Int. 2003; 23(4):269-275 Doi: 10.1034%2Fj.1600-0676.2003.00838.x
Web of Science PubMed FullText FullText_MUG

 

** Wagner, M; Kaufmann, P; Fickert, P; Trauner, M; Lackner, C; Stauber, RE Successful conservative management of acute hepatic failure following exertional heatstroke.
Eur J Gastroenterol Hepatol. 2003; 15(10):1135-1139 Doi: 10.1097/01.meg.0000085465.12407.32 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Kniepeiss, D; Iberer, F; Grasser, B; Schaffellner, S; Stadlbauer, V; Stauber, R; Tscheliessnigg, KH Simultaneous coronary artery bypass grafting and orthotopic liver transplantation.
Transpl Int. 2003; 16(3):207-209 Doi: 10.1007/s00147-002-0513-y (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Ferenci, P; Michael, G; Laferl, H; Brunner, H; Jessner, W; Hackl, F; Formann, E; Stauber, R; Hubmann, R Prospective evaluation of the 24 hour interferon-induced decline in hepatitis C virus genotype I load to predict response to peginterferon-alfa2a/ribavirin combination therapy
GASTROENTEROLOGY. 2003; 124(4): A767-A767. Doi: 10.1016/S0016-5085(03)83876-3
Web of Science FullText FullText_MUG

 

2002

Full paper/article (Journal)

** Kessler, HH; Clarici, AM; Stelzl, E; Mühlbauer, G; Daghofer, E; Santner, BI; Marth, E; Stauber, RE Fully automated detection of hepatitis C virus RNA in serum and whole-blood samples.
Clin Diagn Lab Immunol. 2002; 9(6):1385-1388 Doi: 10.1128/CDLI.9.6.1385-1388.2002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Hegenbarth, K; Fickert, P; Aschauer, M; Horina, JH; Stauber, RE; Trauner, M Successful management of acute portal vein thrombosis by low molecular weight heparin and oral anticoagulation.
Am J Gastroenterol. 2002; 97(6):1567-1568 Doi: 10.1111/j.1572-0241.2002.05750.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Ferenci, P; Jessner, W; Hackl, F; Gschwantier, M; Brunner, H; Hellmich, B; Laferi, H; Stauber, R; Hubmann, R; Datz, C Prediction of early virologic response to treatment with 40KD pegylated (PEG)-interferon (IFN) alfa2a/ribavirin in patients with chronic hepatitis C (genotype 1)
GASTROENTEROLOGY. 2002; 122(4): 81
Web of Science

 

** Jessner, W; Hackl, F; Stauber, R; Datz, C; Kessler, H; Ferenci, P Treatment with 40 kd pegylated (PEG)-interferon (IFN) alfa2a may overcome primary IFN-resistance in patients with chronic hepatitis C (genotype 1)
J HEPATOL 2002 36: 17-17. Doi: 10.1016/S0168-8278(02)80045-9
Web of Science FullText FullText_MUG

 

** Vogel, W; Brunner, H; Lin, W; Stauber, R; Ptacek-Wegerer, K; Gschwantler, M; Stadler, B Measurement of viral interferon sensitivity in patients with chronic Hepatitis C. Prospective, randomised, open label phase III clinical trial
J HEPATOL 2002 36: 135-136. Doi: 10.1016/S0168-8278(02)80486-X
Web of Science FullText FullText_MUG

 

2001

Full paper/article (Journal)

** Ferenci, P; Brunner, H; Nachbaur, K; Datz, C; Gschwantler, M; Hofer, H; Stauber, R; Hackl, F; Jessner, W; Rosenbeiger, M; Munda-Steindl, P; Hegenbarth, K; Gangl, A; Vogel, W; Australian Hepatitis Study Group Combination of interferon induction therapy and ribavirin in chronic hepatitis C.
Hepatology. 2001; 34(5):1006-1011 Doi: 10.1053/jhep.2001.28706 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ferenci, P; Stauber, R; Steindl-Munda, P; Gschwantler, M; Fickert, P; Datz, C; Müller, C; Hackl, F; Rainer, W; Watkins-Riedel, T; Lin, W; Krejs, GJ; Gangl, A; Austrian Hepatitis Study Group Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study Group.
Eur J Gastroenterol Hepatol. 2001; 13(6):699-705 Doi: 10.1097/00042737-200106000-00014
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Grasser, B; Iberer, F; Schaffellner, S; Kniepeiss, D; Stauber, R; Koshsorur, G; Rehak, P; Tscheliessnigg, KH Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.
Transplant Proc. 2001; 33(3):2154-2156 Doi: 10.1016%2FS0041-1345%2801%2901925-X
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kessler, HH; Stelzl, E; Raggam, RB; Haas, J; Kirchmeir, F; Hegenbarth, K; Daghofer, E; Santner, BI; Marth, E; Stauber, RE Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples.
J Clin Microbiol. 2001; 39(5):1788-1790 Doi: 10.1128/JCM.39.5.1788-1790.2001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zollner, G; Fickert, P; Zenz, R; Fuchsbichler, A; Stumptner, C; Kenner, L; Ferenci, P; Stauber, RE; Krejs, GJ; Denk, H; Zatloukal, K; Trauner, M Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
Hepatology. 2001; 33(3):633-646 Doi: 10.1053/jhep.2001.22646 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Hegenbarth, K; Maurer, U; Kroisel, PM; Fickert, P; Trauner, M; Stauber, RE No evidence for mutagenic effects of ribavirin: report of two normal pregnancies.
Am J Gastroenterol. 2001; 96(7):2286-2287 Doi: 10.1111/j.1572-0241.2001.03997.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Ferenci, P; Stauber, R; Hackl, F; Jessner, W; Hegenbarth, K; Munda-Steindl, P; Kessler, H Viral kinetics on treatment with pegylated (PEG 40 kd) interferon (IFN) alfa2a in patients infected with HCV subtype 1
JOURNAL OF HEPATOLOGY. 34: 131-132.
Web of Science

 

** Jessner, W; Stauber, R; Hackl, F; Munda-Steindl, P; Kessler, H; Ferenci, P Effect of pegylated (PEG 40kd) interferon (IFN)alpha-2a on early virus elimination in patients infected with HCV subtype 1
GASTROENTEROLOGY 2001 120: A29-A29.
Web of Science

 

** Stauber, R; Munda-Steindl, P; Hackl, F; Schuutze, K; Datz, C; Hofer, H; Hegenbarth, K; Jessner, W; Ferenci, P Induction treatment of chronic hepatitis C with daily interferon plus ribavirin plus amantadine is effective in non-responders to interferon plus ribavirin
J HEPATOL. 2001; 34: 134-135.
Web of Science

 

** Steindl-Munda, PE; Jessner, W; Vogel, W; Datz, C; Brunner, H; Stauber, R; Ferenci, P High dose interferon induction therapy does not improve response to combination therapy in relapsers and nonresponders to previous interferon monotherapy
J HEPATOL. 2001; 34: 166-166.
Web of Science

 

** Vogel, W; Brunner, H; Stauber, R; Lin, W; Gschwantler, M; Stadler, B Measurement of viral interferon sensitivity in patients with chronic hepatitis C prospective, randomised, open label phase III clinical trial.
HEPATOLOGY 2001 34: 337A-337A.
Web of Science

 

2000

Full paper/article (Journal)

** Fickert, P; Trauner, M; Hausegger, K; Tauss, J; Lackner, H; Krejs, GJ; Stauber, RE Intra-hepatic haematoma complicating transjugular intra-hepatic portosystemic shunt for Budd-Chiari syndrome associated with anti-phospholipid antibodies, aplastic anaemia and chronic hepatitis C.
Eur J Gastroenterol Hepatol. 2000; 12(7):813-816 Doi: 10.1097/00042737-200012070-00017 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Kessler, HH; Preininger, S; Stelzl, E; Daghofer, E; Santner, BI; Marth, E; Lackner, H; Stauber, RE Identification of different states of hepatitis B virus infection with a quantitative PCR assay.
Clin Diagn Lab Immunol. 2000; 7(2):298-300 Doi: 10.1128%2FCDLI.7.2.298-300.2000 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kessler, HH; Stelzl, E; Daghofer, E; Santner, BI; Marth, E; Lackner, H; Stauber, RE Semiautomated quantification of hepatitis B virus DNA in a routine diagnostic laboratory.
Clin Diagn Lab Immunol. 2000; 7(5):853-855 Doi: 10.1128/CDLI.7.5.853-855.2000 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Lipp, RW; Schnedl, WJ; Stauber, R; Ranner, G; Leb, G; Krejs, GJ Scintigraphic long-term follow-up of a patient with metastatic glucagonoma.
Am J Gastroenterol. 2000; 95(7):1818-1820 Doi: 10.1111/j.1572-0241.2000.02164.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Review

** Trauner, M; Fickert, P; Stauber, RE Hepatocellular bile salt transport: lessons from cholestasis.
Can J Gastroenterol. 2000; 14 Suppl D(3):99D-104 Doi: 10.1155/2000/870929
PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Ferenci, P; Berr, F; Caca, K; Firneisz, G; Szalai, F; Datz, C; Stauber, R; Vogel, W; Polli, C Phenotypic-genotypic correlations of common mutations in European patients with Wilson disease.
HEPATOLOGY 2000 32: 1023-1023.
Web of Science

 

** Ferenci, P; Stauber, R; Hackl, F; Schuetze, K; Bauer, B; Datz, C Treatment with amantadine plus ribavirin plus interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy.
GASTROENTEROLOGY 2000 118: A1437-A1437.
Web of Science

 

** Stauber, R; Hackl, F; Schutze, K; Bauer, B; Datz, C; Hubmann, R; Ferenci, P Successful triple combination treatment of patients with chronic hepatitis C not responding to interferon plus ribavirin
J HEPATOL. 2000; 32: 184-184. Doi: 10.1016/S0168-8278(00)81032-6
Web of Science FullText FullText_MUG

 

** Stauber, RE; Hegenbarth, KS; Hackl, F; Hofer, H; Munda-Steindl, P; Ferenci, P Triple combination treatment of chronic hepatitis C is effective in nonresponders to interferon plus ribavirin.
HEPATOLOGY 2000 32: 558A-558A.
Web of Science

 

** Stauber, RE; Hegenbarth, KS; Maurer, U; Kroisel, PM; Fickert, P; Trauner, M No evidence for teratogenic effects of ribavirin: Report of two cases.
HEPATOLOGY 2000 32: 1639-1639.
Web of Science

 

** Stauber, RE; Hegenbarth, KS; Tiran, A; Höfler, G; Zatloukal, K; Stenzel, HC Phenotypic screening for hemochromatosis in 4000 Austrian military recruits.
HEPATOLOGY 2000 32: 1320-1320.
Web of Science

 

1999

Full paper/article (Journal)

** Ferenci, P; Stauber, R; Steindl-Munda, P; Gschwantler, M; Fickert, P; Datz, C; Müller, C; Hackl, F; Rainer, W; Watkins-Riedel, T; Lin, W Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronic hepatitis C.
J Viral Hepat. 1999; 6 Suppl 1(7):53-58 Doi: 10.1046/j.1365-2893.1999.00005.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kessler, HH; Pierer, K; Santner, BI; Vellimedu, SK; Stelzl, E; Marth, E; Fickert, P; Stauber, RE Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
J Hum Virol. 1999; 1(5):314-319
PubMed

 

Review

** Trauner, M; Fickert, P; Stauber, RE New molecular aspects of cholestatic liver diseases.
Z Gastroenterol. 1999; 37(7):639-647
Web of Science PubMed

 

** Trauner, M; Fickert, P; Stauber, RE Inflammation-induced cholestasis.
J Gastroenterol Hepatol. 1999; 14(10):946-959 Doi: 10.1046/j.1440-1746.1999.01982.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Trauner, M; Zenz, R; Fickert, P; Kenner, L; Stauber, RE; Denk, H; Zatloukal, K Quantification of hepatobiliary transporter expression in liver biopsies from patients with cholestasis.
HEPATOLOGY 1999 30: 467A-467A.
Web of Science

 

1998

Full paper/article (Journal)

** Fickert, P; Trauner, M; Sill, H; Hinterleitner, TA; Stauber, RE Successful steroid treatment of idiopathic thrombocytopenic purpura after orthotopic liver transplantation for primary biliary cirrhosis.
Am J Gastroenterol. 1998; 93(10):1985-1986 Doi: 10.1111/j.1572-0241.1998.00561.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Heinemann, A; Horina, G; Stauber, RE; Pertl, C; Holzer, P; Peskar, BA Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
BRIT J PHARMACOL 1998 125: 1120-1127. Doi: 10.1038/sj.bjp.0702167 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Heinemann, A; Wachter, CH; Fickert, P; Trauner, M; Stauber, RE Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
Hepatology. 1998; 28(3):646-654 Doi: 10.1002/hep.510280307 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Heinemann, A; Horina, G; Pertl, C; Stauber, RE; Peskar, BA Vasopressin potentiation of adrenoceptor-mediated vasoconstriction: Functional evidence for a novel receptor of vasopressin in the rat mesenteric artery
NAUNYN-SCHMIED ARCH PHARMACOL 1998 358: R235-R235.
Web of Science

 

** Heinemann, A; Horina, G; Stauber, RE; Peskar, BA Different receptor mediation of direct vasoconstriction and potentiation of adrenoceptor-mediated pressor responses by vasopressin in the rat isolate mesentery
BRIT J PHARMACOL 1998 123: U163-U163.
Web of Science

 

** Kenner, L; Stumptner, C; Trauner, M; Fickert, P; Stauber, RE; Eferl, R; Denk, H; Zatloukal, K Tau overexpression in human alcoholic liver disease.
HEPATOLOGY 1998 28: 512A-512A.
Web of Science

 

** Kenner, L; Trauner, M; Fickert, P; Stauber, RE; Eferl, R; Denk, H; Zatloukal, K Overexpression of keratin-8 and -18 RNA associated with mallory body formation in patients with alcoholic hepatitis.
HEPATOLOGY 1998 28: 303A-303A.
Web of Science

 

** Nachbaur, K; Schlogl, A; Hackl, F; Stauber, R; Hubmann, R; Allinger, S; Datz, C; Vogel, W Prospective randomized open level study comparing two dose levels of interferon-alpha 2a according to the level of viremia.
HEPATOLOGY 1998 28: 704A-704A.
Web of Science

 

** Stauber, RE; Trauner, M; Fickert, P Soreness of mucosal membranes in patients receiving interferon-alpha plus ribavirin for treatment of chronic hepatitis C.
HEPATOLOGY 1998 28: 704A-704A.
Web of Science

 

1997

Full paper/article (Journal)

** Heinemann, A; Wachter, CH; Holzer, P; Fickert, P; Stauber, RE Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
Br J Pharmacol. 1997; 121(5):1031-1037 Doi: 10.1038/sj.bjp.0701220 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Uggowitzer, M; Kugler, C; Machan, L; Gröll, R; Stauber, R; Mischinger, HJ; Ratschek, M; Fotter, R Power Doppler imaging and evaluation of the resistive index in focal nodular hyperplasia of the liver.
Abdom Imaging. 1997; 22(3):268-273 Doi: 10.1007/s002619900187
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Stauber, RE; Jauk, B; Fickert, P; Hausler, M Effect of pregnancy on carbohydrate-deficient transferrin: Absolute or relative values? Reply
ALCOHOL ALCOHOLISM. 1997; 32(4): 537-538. Doi: 10.1093/oxfordjournals.alcalc.a008290 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Eferl, R; Kenner, L; Fickert, P; Stauber, R; Denk, H; Zatloukal, K Validation of quantitative reverse transcription polymerase chain reaction for analysis of gene expression in liver biopsies.
HEPATOLOGY 1997 26: 1496-1496.
Web of Science

 

** Ferenci, P; Stauber, R; Hackl, W; Datz, C; Gschwantler, W; Steindl, P A prospective, randomized controlled trial of high dose interferon-alpha plus ribavirin in interferon-nonresponders with chronic hepatitis C.
HEPATOLOGY. 1997; 26(4): 1148-1148.
Web of Science

 

** Heinemann, A; Horina, G; Pertl, C; Peskar, BA; Stauber, RE Functional evidence for a novel vascular receptor of vasopressin in the rat
NAUNYN-SCHMIED ARCH PHARMACOL 1997 356: 43-43.
Web of Science

 

** Kessler, HH; Pierer, K; Fickert, P; Stauber, RE Virological and biochemical response to combined interferon-alpha plus ribavirin therapy in patients with chronic hepatitis C.
GASTROENTEROLOGY 1997 112: A1300-A1300.
Web of Science

 

1996

Full paper/article (Journal)

** Ferenci, P; Stauber, R; Propst, A; Fiedler, R; Müller, C; Gschwantler, M; Schütze, K; Datz, C; Judmaier, G; Vogel, W; Krejs, GJ; Gangl, A Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
Dig Dis Sci. 1996; 41(12 Suppl):103S-1108 Doi: 10.1007/BF02087884
Web of Science PubMed FullText FullText_MUG

 

** Fickert, P; Ramschak, H; Kenner, L; Hoefler, G; Hinterleitner, TA; Petritsch, W; Klimpfinger, M; Krejs, GJ; Stauber, RE Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation.
Gastroenterology. 1996; 111(6):1670-1673 Doi: 10.1016/S0016-5085(96)70031-8 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Heinemann, A; Stauber, RE Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.
J Hepatol. 1996; 24(6):739-746 Doi: 10.1016%2FS0168-8278%2896%2980271-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Heinemann, A; Stauber, RE Vasodilator responses to nitric oxide are enhanced in mesenteric arteries of portal hypertensive rats.
Eur J Clin Invest. 1996; 26(9):824-826 Doi: 10.1046%2Fj.1365-2362http://dx.doi.org/10.1046%2Fj.1365-2362.1996.2340557.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stauber, RE; Heinemann, A Propranolol stereoselectively inhibits alpha-adrenoceptor-mediated vasoconstriction in mesenteric arterial beds of rats.
J AUTONOM PHARMACOL. 1996; 16(3): 125-129.
Web of Science PubMed Google Scholar

 

** Stauber, RE; Heinemann, A; Trauner, M; Krejs, GJ Divergent effects of propranolol and nadolol in isolated mesenteric arteries from normal and portal hypertensive rats.
Eur J Clin Invest. 1996; 26(8):676-680 Doi: 10.1111/j.1365-2362.1996.tb02152.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stauber, RE; Jauk, B; Fickert, P; Häusler, M Increased carbohydrate-deficient transferrin during pregnancy: relation to sex hormones.
Alcohol Alcohol. 1996; 31(4):389-392 Doi: 10.1093/oxfordjournals.alcalc.a008167 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stauber, RE; Vollmann, H; Pesserl, I; Jauk, B; Lipp, R; Halwachs, G; Wilders-Truschnig, M Carbohydrate-deficient transferrin in healthy women: relation to estrogens and iron status.
Alcohol Clin Exp Res. 1996; 20(6):1114-1117 Doi: 10.1111/j.1530-0277.1996.tb01955.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stoschitzky, K; Schumacher, M; Stark, G; Dimai, HP; Stauber, R; Stoschitzky, P; Krejs, GJ; Klein, W; Lindner, W Exercise increases plasma concentrations of (R)- and (S)-propranolol.
Eur J Clin Pharmacol. 1996; 50(4):339-342 Doi: 10.1007/s002280050119
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Stauber, RE; Stepan, V; Trauner, M; Wilderstruschnig, M; Leb, G; Krejs, GJ Superior Diagnostic-Accuracy of Carbohydrate-Deficient Transferrin over Gamma-Glutamyl-Transferase - Reply
ALCOHOL ALCOHOLISM 1996 31: 306-306. Doi: 10.1093/oxfordjournals.alcalc.a008152 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Abstract (Journal)

** Fickert, P; Ramschak, H; Kenner, L; Hoefler, G; Hinterleitner, TA; Petritsch, W; Klimpfinger, M; Krejs, GJ; Stauber, RE Acute Budd Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation.
HEPATOLOGY 1996 24: 1534-1534.
Web of Science

 

** Heinemann, A; Fickert, P; Stauber, RE The effect of vasopressin analogues on the in vitro vascular reactivity in portal hypertension
HEPATOLOGY 1996 24: 1585-1585.
Web of Science

 

** Heinemann, A; Wachter, CH; Horina, G; Stauber, RE Reversal of mesenteric hyperemia in portal hypertensive rats by vasopressin analogues and water restriction.
HEPATOLOGY 1996 24: 771-771.
Web of Science

 

1995

Full paper/article (Journal)

** Groell, R; Kugler, C; Aschauer, M; Rienmueller, R; Stauber, R; Trauner, M; Mischinger, HJ Quantitative perfusion parameters of focal nodular hyperplasia and normal liver parenchyma as determined by electron beam tomography.
Br J Radiol. 1995; 68(815):1185-1189 Doi: 10.1259/0007-1285-68-815-1185
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Heinemann, A; Stauber, RE The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats.
EUR J PHARMACOL. 1995; 278(1): 87-90. Doi: 10.1016%2F0014-2999%2895%2900138-B
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stauber, RE; Stepan, V; Trauner, M; Wilders-Truschnig, M; Leb, G; Krejs, GJ Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction.
Alcohol Alcohol. 1995; 30(2):171-176
Web of Science PubMed Google Scholar

 

** Trauner, M; Grasmug, E; Stauber, RE; Hammer, HF; Hoefler, G; Reisinger, EC Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis.
Gut. 1995; 37(1):136-139 Doi: 10.1136/gut.37.1.136 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Trauner, M; Klimpfinger, M; Stauber, RE; Schreiber, F; Stöger, H; Krejs, GJ Laparoscopic diagnosis of peritoneal serous papillary carcinoma.
Endoscopy. 1995; 27(4):337-341 Doi: 10.1055/s-2007-1005704 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** FERENCI, P; STAUBER, R; PROPST, A; FIEDLER, R; GSCHWANTLER, M; SCHUTZE, K; JUDMAIER, G; KREJS, GJ; GANGL, A DOSE INCREASE AUGMENTS THE RESPONSE RATE TO INTERFERON-ALPHA IN CHRONIC HEPATITIS-C
GASTROENTEROLOGY 1995 108: A1064-A1064. Doi: 10.1016/0016-5085(95)28557-1
Web of Science FullText FullText_MUG

 

** HAMDANI, R; CHAPPARELLA, R; STAUBER, R; WOOD, S; KRAMER, D; ROSENBLUM, E; KONDRACKI, M; VANTHIEL, DH INTESTINAL PERMEABILITY AS MEASURED WITH POLYETHYLENE GLYCOL-600 IN PATIENTS WITH CIRRHOSIS - CLINICAL INVESTIGATION
GASTROENTEROLOGY. 1995; 108(4): A1079-A1079.
Web of Science

 

** HEINEMANN, A; STAUBER, RE NITRIC OXIDE-DEPENDENT AND-INDEPENDENT VASCULAR HYPOREACTIVITY IN MESENTERIC VESSELS OF PORTAL HYPERTENSIVE RATS
HEPATOLOGY 1995 22: 1287-1287.
Web of Science

 

** STAUBER, RE; JAUK, B; FICKERT, P; HÄUSLER, MCH CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT) IS ELEVATED IN PREMENOPAUSAL AND IN PREGNANT-WOMEN
HEPATOLOGY 1995 22: 1550-1550.
Web of Science

 

1994

Full paper/article (Journal)

** BASISTA, MH; STAUBER, RE; VANTHIEL, DH; TAUXE, WN; DINDZANS, VJ Effect of isolated portal hypertension on Kupffer cell function.
Dig Dis Sci. 1994; 39(1):46-50 Doi: 10.1007/BF02090059
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Hausegger, KA; Sternthal, HM; Klein, GE; Karaic, R; Stauber, R; Zenker, G Transjugular intrahepatic portosystemic shunt: angiographic follow-up and secondary interventions.
Radiology. 1994; 191(1):177-181 Doi: 10.1148/radiology.191.1.8134566
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stauber, RE; Horina, JH; Trauner, M; Krejs, GJ; Ratschek, M; Klimpfinger, M Glomerulonephritis as late manifestation of severe alpha 1-antitrypsin deficiency.
Clin Investig. 1994; 72(5):404-408 Doi: 10.1007/BF00252839 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Trauner, M; Grygar, S; Stauber, RE; Brodatsch-Häusler, E; Klimpfinger, M Carcinoembryonic antigen, cytokeratin expression and mucin composition in hyperplastic and neoplastic polyps of the colorectum.
Z Gastroenterol. 1994; 32(11):626-631
Web of Science PubMed Google Scholar

 

Short report/Letter

** Gasser, R; Dusleag, J; Reisinger, E; Stauber, R; Grisold, M; Pongratz, S; Furian, C; Feigl, B; Klein, W A most unusual case of a whole family suffering from late Lyme borreliosis for over 20 years.
Angiology. 1994; 45(1):85-86 Doi: 10.1177/000331979404500114 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** HEINEMANN, A; TRAUNER, MH; STAUBER, RE NADOLOL INCREASES WHEREAS PROPRANOLOL REDUCES RESISTANCE IN MESENTERIC ARTERIAL BEDS OF RATS
GASTROENTEROLOGY. 1994; 106(4): A905-A905.
Web of Science

 

** HEINEMANN, A; WASCHER, T; STAUBER, RE DOES ELEVATED BLOOD-GLUCOSE LEVEL MEDIATE POSTPRANDIAL SPLANCHNIC HYPEREMIA VIA NITRIC-OXIDE
HEPATOLOGY. 1994; 20(4): A356-A356.
Web of Science

 

1993

Full paper/article (Journal)

** Hausegger, KA; Klein, GE; Flückiger, F; Sternthal, MH; Wilding, R; Stauber, R Clinical experiences with the transjugular intrahepatic portocaval shunt (TIPS)
FORTSCHR RONTGENSTRAHL NEUEN. 1993; 159(3): 229-235. Doi: 10.1055/s-2008-1032755
Web of Science PubMed FullText FullText_MUG

 

** Rosenblum, ER; Stauber, RE; Van Thiel, DH; Campbell, IM; Gavaler, JS Assessment of the estrogenic activity of phytoestrogens isolated from bourbon and beer.
Alcohol Clin Exp Res. 1993; 17(6): 1207-1209. Doi: 10.1111/j.1530-0277.1993.tb05230.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Review

** Stauber, RE; Mischinger, HJ; Trauner, M; Pristautz, H Indications for liver transplantation in neoplasms of the liver.
Acta Med Austriaca. 1993; 20(3):57-60
Web of Science PubMed Google Scholar

 

Abstract (Journal)

** HAMMER, HF; STAUBER, RE; KREJS, GJ EVALUATION OF THE ROLE OF FECAL SOLUTES FOR DETERMINING FECAL PH IN EXPERIMENTALLY-INDUCED DIARRHEA
GASTROENTEROLOGY. 1993; 104(4): A250-A250.
Web of Science

 

** HAMMER, J; HAMMER, HF; LIPP, RW; STAUBER, RE; GANGL, A; KREJS, GJ COLONIC TRANSIT AND ITS ROLE IN CARBOHYDRATE (COH) SALVAGE CAPACITY IN LACTULOSE-(LL) INDUCED DIARRHEA
GASTROENTEROLOGY. 1993; 104(4): A251-A251.
Web of Science

 

** STAUBER, RE; TRAUNER, MH; HAUSEGGER, K; PETRITSCH, W IMPROVEMENT OF LIVER-FUNCTION AFTER TRANSJUGULAR INTRAHEPATIC PORTASYSTEMIC SHUNT (TIPS) IN A PATIENT WITH CHRONIC BUDD-CHIARI SYNDROME
HEPATOLOGY. 1993; 18(4): A344-A344. Doi: 10.1016/0270-9139(93)92899-B
Web of Science FullText FullText_MUG

 

** TRAUNER, MH; HEINEMANN, A; STAUBER, RE EFFECT OF PROPRANOLOL ON PRESSOR-RESPONSES TO NOREPINEPHRINE IN MESENTERIC ARTERIAL BEDS OF NORMAL AND PORTAL HYPERTENSIVE RATS
HEPATOLOGY. 1993; 18(4): A287-A287. Doi: 10.1016/0270-9139(93)92672-M
Web of Science FullText FullText_MUG

 

1992

Full paper/article (Journal)

** Hausegger, KA; Lammer, J; Fluckiger, F; Klein, GE; Sternthal, MH; Wildling, R; Stauber, R Portal Decompression by Tipss (Transjugular Portosystemic Shunt)
VASA, J VASC DIS. 1992;
Web of Science

 

** Stauber, RE; Mochizuki, T; Van Thiel, DH; Tauxe, WN The use of quantitative scintigraphy in the measurement of portal-systemic shunting in rats.
Ann Nucl Med. 1992; 6(4):209-214 Doi: 10.1007/BF03164656
PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Gasser, R; Dusleag, J; Reisinger, E; Stauber, R; Feigl, B; Pongratz, S; Klein, W; Furian, C; Pierer, K Reversal by ceftriaxone of dilated cardiomyopathy Borrelia burgdorferi infection.
Lancet. 1992; 339(8802):1174-1175 Doi: 10.1016/0140-6736(92)90777-Z
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** GASSER, R; DUSLEAG, J; REISINGER, E; STAUBER, R; FEIGL, B; GRISOLD, M; BRUSSEE, H; PONGRATZ, S; LUHA, O; KLEIN, W REVERSIBILITY BY CEFTRIAXONE OF DILATED CARDIOMYOPATHY ASSOCIATED WITH BORRELIA BURGDORFERI INFECTION
CIRCULATION. 1992; 86(4): 807-807.
Web of Science

 

1991

Full paper/article (Journal)

** Stauber, RE; Rosenblum, E; Eagon, PK; Gavaler, JS; Van Thiel, DH The effect of portal-systemic shunting on hepatic sex hormone receptors in male rats.
Gastroenterology. 1991; 100(1):168-174 Doi: 10.1016/0016-5085(91)90597-E
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stauber, RE; Ruthardt, FW; Tauxe, WN; Van Thiel, DH Evaluation of portal-systemic shunting in rats from mesenteric and splenic beds.
Dig Dis Sci. 1991; 36(2):209-215 Doi: 10.1007/BF01300758
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** HAMDANI, R; CHAPARALA, R; STAUBER, RE; ROSENBLUM, E; HONDROUDAKI, J; WOOD, S; KRAMER, D; GAVALER, JS; VANTHIEL, DH PEG 600 ABSORPTION AND URINARY-EXCRETION IDENTIFIES CIRRHOTICS LIKELY TO DIE DURING HOSPITALIZATION
HEPATOLOGY. 1991; 14(4): A245-A245.
Web of Science

 

Full paper/article (Proceedings)

** VANTHIEL, DH; STAUBER, R; GAVALER, JS; FRANCAVILLA, A HEPATIC REGENERATION - EFFECTS OF AGE, SEX-HORMONE STATUS, PROLACTIN, AND CYCLOSPORINE
DIGEST DIS SCI. 1991; 36(9): 1309-1312. Doi: 10.1007/BF01307528
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1990

Full paper/article (Journal)

** Kajani, MA; Yoo, YK; Alexander, JA; Gavaler, JS; Stauber, RE; Dindzans, VJ; Van Thiel, DH Serum-ascites albumin gradients in nonalcoholic liver disease.
Dig Dis Sci. 1990; 35(1): 33-37. Doi: 10.1007/BF01537219
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kumar, S; Stauber, RE; Gavaler, JS; Basista, MH; Dindzans, VJ; Schade, RR; Rabinovitz, M; Tarter, RE; Gordon, R; Starzl, TE Orthotopic liver transplantation for alcoholic liver disease.
Hepatology. 1990; 11(2):159-164 Doi: 10.1002/hep.1840110202 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Petritsch, W; Pristautz, H; Schreiber, F; Stauber, R; Kullnig, P; Höfler, H; Smolle, J Cowden syndrome.
Z Gastroenterol. 1990; 28(7):358-362 (- Case Report)
Web of Science PubMed Google Scholar

 

** Van Thiel, DH; Stauber, RE; Gavaler, JS; Rosenblum, E Evidence for modulation of hepatic mass by estrogens and hepatic feminization.
Hepatology. 1990; 12(3 Pt 1):547-552 Doi: 10.1002/hep.1840120316
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** PENNER, E; WESIERSKAGADEK, J; LINDNER, H; HITCHMAN, E; STAUBER, R; VANTHIEL, DH; SAUERMANN, G ANTIBODIES TO CORE HISTONE H3 - A SEROLOGIC MARKER FOR PRIMARY SCLEROSING CHOLANGITIS
HEPATOLOGY. 1990; 12(4): 958-958.
Web of Science

 

** ROSENBLUM, ER; STAUBER, RE; BASISTA, MH; HONDROUDAKI, JE; GAVALER, JS; FUNG, J; STARZL, TE; VANTHIEL, DH CHOLESTEROL-BIOSYNTHESIS IN FK506 TREATED MALE-RATS
HEPATOLOGY. 1990; 12(4): 910-910.
Web of Science

 

1989

Abstract (Journal)

** STAUBER, RE; GAVALER, JS; VANTHIEL, DH FEMINIZATION IS A CONSEQUENCE OF PORTAL-SYSTEMIC SHUNTING (PSS)
HEPATOLOGY. 1989; 10(4): 722-722.
Web of Science

 

** STAUBER, RE; TAUXE, WN; VANTHIEL, DH OVERESTIMATION OF PORTAL-SYSTEMIC SHUNTING IN PORTAL HYPERTENSIVE RATS BY SPLENIC INJECTION OF MICROSPHERES
HEPATOLOGY. 1989; 10(4): 586-586.
Web of Science

 

1988

Full paper/article (Journal)

** Stauber, RE; Petritsch, W; Hönigl, KD; Pristautz, H; Hinterleitner, T Serum bile acids in diffuse liver parenchymal damage and their relation to ultrasound diagnosis.
Wien Med Wochenschr. 1988; 138(10):225-228
Web of Science PubMed

 

1987

Full paper/article (Journal)

** Petritsch, W; Pristautz, H; Eber, B; Schreiber, F; Stauber, R; Samonigg, H; Fereberger, W Pathologic enzyme patterns in sonographically verified liver metastases.
Wien Med Wochenschr. 1987; 137(24):582-584
Web of Science PubMed

 

Abstract (Journal)

** PRISTAUTZ, H; PETRITSCH, W; SCHREIBER, F; EBER, B; SOMMERSGUTTER, M; PFNISS, G; STAUBER, R INVITRO MEASUREMENT OF THE PROTECTIVE EFFECT OF SUCRALFATE ON HUMAN GASTRIC-MUCOSA
Z GASTROENTEROL. 1987; 25(8): 538-538.
Web of Science

 

1986

Full paper/article (Journal)

** Pristautz, H; Schreiber, F; Petritsch, W; Eber, B; Sommersgutter, M; Stauber, R Sonographic comparative studies of the portal vascular system before and following endoscopic sclerosing of esophageal varices.
Wien Med Wochenschr. 1986; 136(21-22):540-543
Web of Science PubMed

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint